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Evaluation of Novel Glass-Ionomer Cements for Hard 
tissue Repair using In Vitro and In Vivo methods 
SUMMARY 
Ionomeric cements (ICs) have a successful history as restorative materials in 
dentistry where they are called glass-ionomer cements (GICs). More recently they 
have potential for use as bone substitutes and cements in orthopaedic, 
otolaryngology and maxillofacial surgery. The influence of glass composition on 
IC properties such as biocompatibility has not been adequately studied. The broad 
aim of this research was to characterise a series of ICs of defined composition and 
evaluate their biocompatibility in vitro and in vivo. The hypothesis was that ICs 
could be optimised through their glass composition for clinical use as bone 
substitutes or cements. 
ICs are formed by the neutralisation reaction of an inorganic basic glass and organic 
polyelectrolyte acid. In vitro studies involved the determination of ions eluted from 
set cement discs and evaluation of the toxicology and biocompatibility of the ICs 
using cell culture techniques. In vivo studies involved the implantation of set and 
wet ICs into the midshaft of the rat femur. The osteoconduction and 
osseointegration of specified ICs were determined by histomorphometric analysis. 
Additionally, the role of noncollagenous extracellular matrix bone proteins were 
studied as they play an important role in the interactions of the healing of hard 
tissues with implants. 
The response of bone was dependent upon IC formulation with increase in fluoride 
and phosphate stimulating bone cell response. Bone response was negatively 
correlated with aluminium. It was concluded that the IC from the apatite 
stoichiometric series (designated LG26) had the most promising formulation for 
biomedical applications. This study confirmed that ICs have some potential 
clinical use as a bone substitute and cement. However, in vitro studies suggested 
that aluminium ions released from set ICs were responsible for some cytotoxicity 
and further work might usefully be directed at reducing the release of this ion from 
the cement. 
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Evaluation of Novel Glass-Ionomer Cements for 
Hard Tissue Repair using In Vitro and In Vivo 
methods 
"The biocompatibility of glas.~-ionomer cement.~ with lilling ti.~.~ue i~ a .~ubject of 
some importance" 
AD Wil.wm (1988) 
1. INTRODUCTION 
Biomaterials are used in various medical devices and new materials are continuously 
being developed and introduced for biomedical application. A wide variety of 
materials have been used for the repair and augmentation of bone that has been 
damaged by trauma or disease. I-HI For both hard and soft tissue implants, the 
biocompatibility of the material used has to be considered. A biomaterial has been 
defined as 'a non-viable material used in a biomedical device intended to interact 
with biological systems' .11. 12 The material of choice for bone augmentation is the 
patient's own bone tissue. This is not always practical and often necessitates the 
opening of a second surgical site for harvesting autogenous (bone from the patient's 
own body) grafts with associated increased morbidity. It is for this reason that 
alloplastic materials (other materials) are often employed. The most popular bone 
substitute material for filling defects is hydroxyapatite (HA) because of its apparent 
ability to enable bone to osseointegrate on their surface, a process described as 
"bioactivity" or osteoconduction. B-\S Despite this advantage over traditionally 
more biologically inert materials, problems remain with accurate surgical placement 
and migration of particulate forms ofHA or infection of porous blocks ofHA. 16-19 
For these reasons, a number of alternative bone substitutes have been proposed, 
they include bioglass. 20-23 Despite many of these materials exhibiting bioactive 
properties, there remains much debate on the underlying mechanisms responsible 
for osteoconduction and osseointegration. 
Bioactive glasses have been shown to be a potential bone substitute material, 
integrating well with bone ill vivo. 22.24 Osteoblasts cultured on 45S5 bioglass 
demonstrate a high proliferation rate and expression of osteoblast-like phenotype. 25 
In contrast to the applications of bone substitutes, bone cement is used in order to 
obtain stable fixation to bone and to reduce the number of patients from the pain of 
weight-bearing after surgery due to micromotion of metal prosthesis. The major 
disadvantage of the most commonly used bone cement, poly(methylmethacrylate) 
(PMMA), results from its exotherm on setting and creep 26-32 as at a high 
temperature there is an increase in cement volume and when the temperature is 
lowered there is a reduction in cement volume causing creep. Despite improvements 
in bone cement with the introduction of systems based on poly(ethyl methacrylate) 
and n-butyl methacrylate monomer an ideal bone cement has not yet been 
produced.9. 111.33 
2 
There is a need for improved materials for hard tissue repair and replacement. 34-44 
In addition, it is essential that we also improve our understanding of how so-called 
bioactive or osteoconductive materials interact with bone tissue. 
Ionomeric Cements (ICs) are a group ofbiomaterials used in restorative dentistry. 39, 
40, 4S, 46, 47 They otTer several potential advantages over ceramic or glass-based 
materials as they can be moulded into a variety of shapes. 411 They are formed by 
the neutralisation reaction of a basic ion leachable inorganic glass and an organic 
polyelectrolyte (poly(acrylic) acid. They set without an exotherm on mixing, are 
chemically adhesive to enamel, dentine and bone .36. 4~. 46. 411 These attributes and 
their apparent osteoconductive potential have led to the use of ICs as preformed 
implants and cement in otolaryngology and cranial surgery W.4/l 
The reason why ICs integrate with bone and in certain cases appear to stimulate 
bone formation is unclear. The release of potentially osteoconductive ions (e.g. 
fluoride, calcium and phosphate) and the biological effects of other ions (e.g. 
aluminium and silicate) have been linked with the biological response to ICs 
following implantation. 49 However, we lack a sound understanding of the 
mechanisms which are responsible for the biocompatibility and clinical performance 
of Ies. 
The overall aim of this thesis was to evaluate biocompatibility of novel ICs for 
biomedical applications as bone substitutes and cement material (see section 1.5 
Aims). It is helpful to firstly review the literature on ICs. 
1.1 Glass -ionomer (polyalkenoate) cements 
The most important landmarks in the development of ICs are in Table 1.1.1, pages 5-6 
Table 1.1.1 Significant published studies showing the history of the development of ionomeric cements 
Author 
Wilson AD 1965 
Kent BE & Lewis BG 1968 
Wilson AD & Kent BE 1969 
Wilson AD & Kent BE 1971 
McLean JW & Wilson AD 1974 
Wilson AD & Crisp S 1976 
McLean JW & Wilson AD 1977 
Powis DR, Folleras T, Merson SA 
& Wilson AD 1982 
ObSt!n'ation 
Cements were prepared by mixing dental silicate glass 
powder with aqueous solutions ofyarious organic acids. 
Poly(acl}'late) cement pastes set slowly and were hydrolytically stable. 
Hydrolytically stable cements could be produced by altering AbOJSi02 
ratio, which was crucial as it determines whether the glass network 
breaks down if exposed to acids, and the rate of breakdown. 
Original development of ICs 
ICs first reported 
ICs first reported to release fluoride and bond to enamel 
Tartaric acid modified the cement-forming reaction, 
improving working time 
First practical material:ASPA II 
ICs first used in restorative dentistIy 
Improved adhesion of ICs to dentine and enamel 
Reference 
50 
51 
50 
52 
53 
50 
54 
55 
53 
Table 1.1.1 (continued) 
Author 
Aboush YEY & Jenkins CBG 1986 
Jonck LM. Grobelaar CJ & 
Strating H 1989 
Jonck LM, Grobelaar CJ & 
Strating H 1989 
Jonck LM & Grobelaar CJ 1990 
Brook 1M, Craig GT & 
Lamb DJ 1991 
Brook 1M, Craig GT, Hatton PV 
and Jonek LM 1992 
Hatton PV & Brook 1M 1992 
Hatton PV, Craig GT & Brook 1M 1992 
Obsen'ation 
Cements based on poly(acI)'lic) acid (PAA) bond strongly to enamel and dentine 
First screening test for ICs (Ketac-O) to be used as a bone cement 
for orthopaedic use. 
Bulk testing of ICs (Ketac-O) for use as joint replacement. 
where lCs were found to be non-toxic in bulk. 
Normal haemopoietic and osteoblastic actiyity took place on the cement surface. 
E~, .. perimental and clinical eyaluation of ICs, Ionos bone cement. 
injoint replacement reported in baboon model and in selected patients 
in whom poly(methylmethacI)'late) cement was contra-indicated. 
A direct bone-bonding was demonstrated, and clinical results were satisfactoI)·. 
Initial in vivo evaluation of ICs cements for use as alveolar bone substitutes. 
Leaching of fluoride may stimulate osseo integration in vivo. 
Granular IC in primate baboon model and in in vitro primal)' bone organ 
cultures derived from neonate rat calvaria, both fonned osteoblast-like cells 
colonising the surface of the implant producing a collagenous eX1racelluiar matrix. 
Glass particles surrounded by a silaceous layer set in a hydrogel matrix. 
Mobility of ions from ICs in the matrix phase are important in detennining 
the biocompatibility and adhesive properties of ICs. 
X-ray microanalysis (XRMA) provided evideoce for the fonnation of a 
bioactive bonelIC bond, with movement of ions across the interface 
being demonstrated. 
Reference 
~o 
35 
~s 
~5 
~6 
57 
58 
59 
1.1.2 Properties 
les show a wide range of physical properties. The composition of the cement 
affects its properties. For example, compressive strength increases with an increase 
in alumina content. 51 A high powder/liquid (P/L) ratio produces thickly mixed 
materials with an increased strength and a shorter setting time. 60 
The temperature at which the cement is mixed affects its working time. The 
working time is prolonged as the temperature of cement and its surroundings is 
reduced. 51 
les are regarded as brittle materials. In the tirst few minutes after mixing they 
deform slightly under load. 51 Set ICs lack toughness, and although they can have a 
relatively high compressive strength (-200MP) they are comparatively weak in 
flexural strength (5 to 40 MP). 51 It has been reported that a twelve month old 
cement is approximately twice as strong as a one day old cement and approaches 
400 MP in compressive strength. ('1 However, it may be possible in the future to 
improve the physical properties of les. (,2 
At present, les are not suited for load-bearing purposes such as total hip 
replacement because of their poor mechanical properties. ICs are more suited to 
non-weight bearing applications where the ability exists to biomechanically match 
the Ie to the bone. This can be done by varying the volume fraction of the glass and 
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polymer components of the cement.61 Attempts are now being made by colleagues 
at The University of Limerick to improve the mechanical properties by altering the 
compositions of ICs. 2(), 22, 23, 63, (,4 
The clinical success of implanted biomaterials, such as ICs, for hard tissue 
replacement is dependent upon the formation of a stable bone-implant interface. A 
prerequisite for formation of this interface is believed to be the ability of the surface 
of the material to bind certain biological molecules and attract bone cells The 
surface of set IC is hydrophilic. 51 
The biological properties of an IC result from its surface chemistry, physical 
structure and bulk composition. Setting occurs by gelation of the cement with 
transfer of ions from the glass to the acidic matrix. Unset IC is able to chemically 
bond to both bone (apatite) and metals 51.65 and during gelation the IC does not 
undergo appreciable shrinkage.S' 65.66 ICs, ifused as a bone cement would not have 
to rely exclusively on a mechanical bond to achieve fixation, unlike acrylics. The 
adhesive properties oflCs and their stability in an aqueous environment have 
potential as a bone cement although they are mechanically inferior to acrylic 
cements. The stability oflCs and the increasing strength with time may mean that 
ICs would be less susceptible to the problems of late failure that is associated with 
I, 67 -71 the acry IC cements. 
1.1.3 Applications of ICs for dental and medical use 
Ies have remained an important class of dental restorative materials for almost 30 
years.~l. 6~. 72 In this role their attributes include adhesion to untreated tooth mineral 
and release of fluoride ions that are thought to confer resistance against recurrent 
and/or secondary dental caries.65 The favourable biological responses reported by 
Jonck et aI3~, 45, 4N led to their limited clinical application in orthopaedic surgery.45 
Set Ie bone substitutes used as granules and cement were applied successfully to 
cases where conventional care had failed 45 les are suited to situations where the 
strength of the cement is not a major factor in determining clinical success. Ie has 
also been used to reinforce osteoporotic femoral heads to improve the primary 
stability of hip screws?" 
It has been shown in vitro that a slow release of fluoride over a long time period 
milY have clinical advantages, fluoride released from Ie restorations may reduce 
microbial activity.7307s This antimicrobial property could also be beneficial to les 
implanted in bone reducing infections after surgery. 76 
Implanted les have made the most clinical impact in otological surgery, provmg 
highly successful in several otologic procedures when used either as a cement or as 
preformed prosthetic implants. for example, ear ossicles or granular bone 
substitute.37043 Geyer and Helms in 1990 reported 167 patients on whom they had 
performed reconstructive middle ear surgery, including reconstruction of the 
I) 
auditory canal with IC, reducing the size of the mastoid cavity with set IC bone 
substitute, and rebuilding of the ossicular chain n 
Further reports on the use of IC in otologic surgery followed a 94% initial four year 
success rate being reported in 945 cases of Ie ossicular implant placement. 40 
Revision surgery had to be undertaken in only 12 out of 74 cases of posterior canal 
wall repair using IC.4() The major applications in otologic surgery, where IC has no 
near rival for clinical efficacy, are in reconstmction of the ossicular chain where the 
cement can be used to repair the bony ossic1es in their normal position and in 
cementation of cochlear implants.3K 3'J. 41-43 
The early clinical reports of the successful use of Ie led to their wider application in 
neura-otological and skull base surgery, and for repair of cerebrospinal fluid (CFS) 
fistulas and skull defects.:w. 77 Concurrent with these developments, IC were being 
evaluated for their biological effect on neural tissue using neurophysiological 
techniques. The results of these in vilro tests conflicted with the positive clinical 
data, in that, following exposure of nerves to viscous Ie a block in nerve conduction 
(which may not be reversible) occurred. 66.7K However, it should be noted that for 
clinical use the manufacturers recommend that unset Ie should not come into 
contact with soft tissues and that it should be placed in a 'dry field'. 
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As a result of these studies the use of Ie as a bone cement was restricted to avoid all 
direct contact with neural tissue. Unfortunately this warning came too late to 
prevent four reported cases of post-otoneurosurgery aluminium encephalopathy (2 
deaths) following repair of skull base defects (post- acoustic neuroma or vestibular 
neurectomy surgery).79 The exact details of these and subsequent cases are difficult 
to establish. In all cases there appeared to have been a massive release of aluminium 
ions from the IC into the CSF resulting in encephalopathy. 7') 
Direct interaction of unset IC with neural tissue would, as seen in laboratory 
studies, be expected to produce tissue damage due to the release of polyacid.67. 79 
This together with possible disruption of the setting reaction by contamination of 
unset IC with CSF and/or blood is a possible explanation for the tragic consequences 
reported. 79 The large surface area ofIC's allows release of polyacid, large 
quantities of metal ions and glass particle.7') 
IC has found application in oral surgery as a set pre-formed particulate bone 
substitute where it has been shown to be of particular benefit in prevention of bone 
loss following tooth extraction and as a filler for graft donor sites and cyst cavities.80 
As a cement the use ofIC as a surgical dressing has been reported following 
exposure of teeth prior to orthodontic alignment 44 
11 
1.1.4 Ion release 
The main effect oflC composition on bioactivity is as a reservoir for ion release. 49. 
62.81 In general, the ionic species that are present are fluoride. sodium, potassium, 
aluminium, silicate, calcium, phosphate. strontium and zinc. Several investigators 
have proposed that ion release is a major factor in the bioactivity of different ICs.46-
116 
X-ray microanalytical (XRMA) studies of set Ie have shown that ions released 
from the glass particles during the gelation process are present in the matrix of the 
cement 59 and in adjacent bone.1I2 Even after gelation has occurred. there is mobility 
of ions within the IC and exchange of ions takes place with the (aqueous) 
environment.65. 70. 83 Early work into the bioactivity ofICs and their effects on 
osteogenic cells demonstrated that Ie composition was important. with non-fluoride 
glasses being the least toxic to cells ill vitro 34 but the least osteoconductive il1 
vivo. 46 
1.1.4 (a) Fluoride 
Fluoride is an essential constituent ofIes. The chemical and biological actions of 
fluoride on bone mineral are complex and imperfectly understood. The slow and 
sustained release of fluoride 84.85 from a bone cement may provide the sti mulus for 
sustained osteoblastic activity for the osteoconduction of the insert. It has been 
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shown that fluoride strengthens the adhesive bond of the cement to both enamel and 
dentine and probably bone. 1I6 
Jonck et al found that ICs used in patients for total joint replacement gave positive 
clinical results.4S This was postulated to be from the ICs fluoride releasing 
osteoconductive properties.45 Fluoride has been used successfully in the treatment 
of osteoporosis by stimulating osteoid formation 45,117 inhibiting resorption 118 and 
by increasing trabecular bone density. Fluoride and calcitonin have synergistic 
mitogenic activities and they increase proline incorporation into bone matrix.R9 
It is possible to speculate that the presence of a fluoride releasing IC at the time of 
bone formation would result in mineralization with fluorapatite. 45 Fluorapatite is 
more resistant to resorption than apatite. as bone formation is a dynamic process of 
deposition and resorption. a greater volume of bone should form in association with 
implanted IC compared to more inert ceramic bone substitutes. This hypothesis 
was confirmed by studies that have compared IC implants to ceramic implants and 
by more recent work which proposed increased fluoride release to increased bone 
formation.46 
The study of fluoride ion release from IC has been extensive but mainly related to 
I I, , ~() 51 7(),1l3 D t II th' 'd 'l' ' d the denta app lcatlOns:" en a y. e incorporatIOn unng .ormatlon an 
later uptake of fluoride by enamel increases the acid resistance of the 
hydroxyapatite.90 Fluoride has an effect on bacterial enzymes by combining with 
various trace metals that are necessary for activation of the bacterial enzymes. 
These enzymes are deprived of these trace metals as a result, they remain inactive 
and caries is reduced. 91 
The slow release of fluoride, over a sustained period from the Ie, R4.R5.92 has a 
similar beneficial effect on osteogenesis. Fluoride ions released from IC appear to 
act in a dose-dependant manner. At relatively high concentration, fluoride acts as an 
enzyme inhibitor in vitro but ill vivo it stimulates proliferation and alkaline 
phosphatase activity of bone-forming cells (osteoblasts).4(,· 'JJo'J~ 
It has been reported that sodium fluoride strengthens the bond of hydroxyapatite to 
both enamel and dentIne, 50. R(, and that the fluoride-hydrogen bond may be of 
consequence in promoting the calcification process on the IC. Further evidence 
shows that fluoride is potentially osteoconductive as there is an increase in 
endosteal bone resorption and periosteal bone formation in rats that were exposed 
to 30-100 mg FII in drinking water. C)6o ')') 
The lack of fluoride in in vivo studies has been shown to interfere with the 
integration OfIC.46 The slow release oftllloride ions at low doses is reported to 
stimulate bone formation in the chick and rat, however higher doses offllloride are 
reported to inhibit bone formation. X). X4 
l~ 
1.1.4 (b) Sodium 
The sodium monovalent cation has been reported to promote the release of fluoride 
from les.sl) Sodium fluoride is an etfective stimulator of osteoblastic proliferation in 
low turnover osteoporosis. 11K) Sodium ions in the body are important in extracellular 
fluid accounting for over 90% of the osmotic pressure of the extracellular fluidYI 
1.1.4 (c) Potassium 
The effects of potassium, also a monovalent cation, on bone needs further 
investigation. Physiologically, potassium channels play an important role in causing 
the voltage changes of nerve action potentials')) Potassium also has further 
important functions in the body as a low potassium concentration in the brain 
interstitial fluid is required for the correct functioning of neurones in the brain as 
they require an exact controlled environment, for normal function. The blood-brain 
barrier protects the cerebral tissue from detrimental substances in the blood, and the 
transport processes of the choroid plexuses and the brain capillary endothelium help 
provide the appropriate fluid environment for the brain.'H 
Experiments have shown that even when the circulating blood potassium rises to 
values almost two times normal, the potassium concentration in the cerebral spinal 
fluid still remains at its normal low value. Thus the barrier system, along with its 
carrier-mediated transport of potassium, not only maintains a low potassium 
concentration but also keeps this concentration constant, allowing the neurons to 
l:'i 
generate very high electrical potentials that do not change with the vagaries of the 
rest of the body.9l Any potassium release from ICs would thus be unlikely to affect 
the central nervous system (CNS). 
1.1.4 (d) Aluminium 
The effect of aluminium is more controversial. At low concentrations aluminium 
ions enhance stimulation and proliferation of osteoblasts and new bone 
formation. 101. 102 These findings are supported by the observations il1 vitro of 
aluminium particles inside cultured osteoblast cells without any impairment of bone 
formation or detrimental effect on the cells. x2. )(1."\. 104 Aluminium ion release from 
ICs play an important role in ill vivo biocompatibility, increasing the amount of 
osteoid formed. 102. iIl4. lOS Aluminium enhances the mobilisation of calcium from 
bone by a cell-independent mechanism and exerts an indirect effect on bone 
ti . h h h ' h'b' , f II h . 106 107 ormatlon t roug t e 10 litton 0 co agen synt eSIS. . 
Aluminium reduces bone mineralization by interfering with the early stages of this 
process 102.104. lOS and is the least biologically acceptable of all the inorganic species 
leached from these cements, compared to other ions such as fluoride, sodium, 
potassium, silicate, calcium and phosphate. Aluminium at high concentration has 
been associated with Alzheimers disease. xl Increased aluminium levels in the brain 
can lead to aluminium encephalopathyWx Cases of subacute aluminium 
encephalopathy have been reported after the implantation ofIC during 
translabyrinthic otoneurosurgery. lOX 
1.1.4 (e) Silicate 
Silicate ion species leach from IC's KI and in gel-form, has been reported to induce 
apatite nucleation on its surface in vitro. This ion may thus be important in 
determining the in vitro biocompatibility of IC's.34. 109 
1.1.4 (f) Calcium 
Calcium is released from ICs in very small amounts. It is the main inorganic 
constituent of both the teeth and bones as hydroxyapatite (CalO(P04)6(OH)2)' 
Apatite (calcium phosphate) seems to be the only calcium phosphate able to 
incorporate fluoride ions, lIO as natural non- biological calcium phosphate contains a 
lot of fluoride and the incorporation of this element occurs in apatite phases. llo 
1.1.4 (g) Phosphate 
Phosphate is involved with the mineral hydroxyapatite, so the IC acts as a source of 
natural mineralised tissue as hydroxyapatite is calcium phosphate. Phosphate 
improves translucency and adds body to the cement. 51 
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1.1.4 (viii) Strontium 
Strontium at high concentrations in the diet has been known to cause rickets. 
Strontium's release from ICs needs to be carefully controlled11I Strontium at low 
doses is used to treat osteoporosis. I 12 Strontium stimulates osteoblast proliferation. 
Radioactive strontium enables the detection of differences in the relative 
compartments in bone diseases like osteoporosis 1IJ and other bone disorders. 1l4 
The strontium in ICs would be useful in a dental cement enabling detection of 
microleakage and secondary caries using x-raysn~. 11(, 
1.1.4 (I) Zinc 
Zinc is an integral part of many enzymes. ')J Zinc is a component oflactic 
dehydrogenase and is therefore important for the conversion between pyruvic acid 
and lactic acid. Zinc is important in some peptidases for the digestion of proteins in 
the gastrointestinal tract. 91 
1.2 Bone cements and substitutes for hard tissue augmentation 
A wide range of materials, such as cements, ceramics, metals, and polymers are used 
for bone implants in many different applications including tissue augmentation, 
117 Th b b" " I" " b fracture fixation and joint replacement. e one- IOmatena InteractIOn may e 
significantly different for all these materials. For load-bearing implants, their 
superior fracture and fatigue resistance has made metals the materials of choice. 1111 
Development is proceeding on cements, ceramics, composites, polymers and 
biologically derived materials such as collagen, but suitable alternatives for metal for 
general use have yet to be introduced. I II< This section will focus on only a few 
current bone cements and substitutes. 
1.2.1 Poly(methylmethacrylate) 
Techniques were pioneered by Charnley in the 1960s for the treatment of hip joint 
dysfunction utilising PMMA for cementing prosthetic hips. I. 2 PMMA has been 
used widely as a bone cement and has enabled significant success with the 
rehabilitation of many elderly patients,J-5 and only in some cases for reconstructive 
surgery for diseased bone,1I9-124 and in cases where bone has lessened. J25. 126 
PMMA polymerisation continues after the placement of the primary insert with 
PMMA infiltrating the surrounding alveolar spaces, resulting in further bone-
implant interlocking.4K. 127. 12l< 
The main clinical problem with PMMA is with loosening of the implants, often 
associated with fragmentation and fracture of the supporting cement. 12J. 129-I:l3 
PMMAs exothermic polymerisation, creep and the presence of excess methacrylate 
monomer have been implicated as the major factor in the loosening and subsequent 
failure of hip prostheses. 26. 122. )3.."\. JJ4 PMMA causes thermal necrosis 27.21< and 
chemical necrosis of bone due to the unreacted monomer?')' J() and from the toxic 
leaching effects of this residual monomer on the osteoblast cells.JI. J2 PMMA 
cement has thus been identified as a calise of implant failure, and the cement is 
particularly unsuitable for bone reconstruction following cancer. I I'). J:H In cases of 
II) 
catastrophic failure, the subsequent need for revision surgery leads to loss of bone 
volume in which to place a second device. m The mechanical properties of PMMA 
decrease 10-15% over one year contributing to implant 100sening.45 
1.2.2 Calcium phosphates 
These materials are divided into two main groups: hydroxyapatite (HA) 
(Cato[P04]6[OHh) and ~-tricalcium phosphate (Ca1[P04h). Calcium phosphates 
are described as bioactive not because they are osteogenic, but because they are 
connected to the surrounding bone tissue by a strong chemical bond. lo Calcium 
phosphates are probably the most commonly utilised bone substitutes in oral 
surgery and may give satisfactory results in many cases. The major advantage of 
the calcium phosphates is their capacity to become functionally integrated with host 
bone without fibrous tissue encapsulation and with little inflammatory or foreign 
body response. 13.135·146 The favourable response seen on implantation of the 
calcium phosphate ceramics is attributed to the calcium and phosphate ions, the 
b h d · 141·14~ C 1 . h h commonest constituents of verte rate ar tIssue. . ,a clUm p osp ate 
ceramics appear to allow normal 'wound' healing following implantation on or in 
bone defects. BO, 147, 14K 
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1.2.2(a) Hydroxyapatite 
HA is the most popular artificial material used for bone augmentation and has 
proved well suited for use as a filler in low weight bearing situations in oral and 
orthopeadic surgery. It is used as a bone substitute in otolaryngology l42. 146. 149 
HA shows osseointegration when implanted in either soft tissue 147. ISO. m or hard 
tissue 142.146 and can form strong and intimate bonds with bone. 14t. 142. 146 Driskell 
et ai isl were the first to report that a chemical bond exists between bone and HA. 
LeGeros et al reported that the bioactivity of HA may be related to its dissolution 
rate. 1S2 It is generally accepted that degradation of HA can occur to a certain 
extent. 146. 153 
HA has been implanted together with autogenous iliac bone grafts for jaw 
reconstruction but failed to achieve HA-bonding J~4 Problems remain with HA as it 
lacks adhesiveness and plasticity. Difficulties also exist with accurate clinical 
placement ofHA and involve migration of the material or its loss from the implant 
site. HA can stress shield bone due to its high elastic modulus compared to that of 
bone. tsS·1S9 HA is mechanically weak in tension, which limits its use for load 
bearing applications. J60, 161 
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1.2.2 (b) ~ Tricalcium phosphate 
p-Tricalcium phosphate CP-TCP or whitlockite) is one of the most widely 
investigated calcium phosphate ceramics. It has been reported to exhibit good hard 
tissue integrationI62.16:1 and does not cause any significant inflammatory reactions in 
vivo. 6-9 It is considered less suitable as a plasma sprayed layer on metal implants 
than HA, due to its degradation characteristics,166 and is currently used primarily as 
a bone filler. 
1.3 The evaluation of biocompatibility 
Despite the fact that various biomaterials have been used for many years there is 
still a limited knowledge of the reactions which occur after the implantation of a 
non-biological material, in particular those occurring in the interface zone within a 
few microns from the implant surface. One reason for this is the difficulty of 
obtaining intact implant-tissue interfaces which permit analysis at a subcellular 
level. 
Biocompatibility is defined as "the ability of a material to perform with an 
appropriate host response in a specific application"ll. 12 The initial host response 
after implantation of a non-biological material is characterised by an inflammatory 
reaction. This reaction is elicited by the inevitable surgical trauma and subsequently 
modified by the presence of the implant. In normal tissues and most experimental 
implant models an inflammatory phase occurs prior to repair and integration of the 
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implant. Initially ill vitro cell and tissue culture tests provide essential information 
on the cellular and tissue response Materials when implanted attain and maintain 
contact with the body environment through their surfaces; the interfacial interaction 
between the implant bed and surface could be a determinant of the implant's 
performance. The next section looks at ill vitro and ill vivo studies evaluating the 
biocompatibility of les as implants. 
1.3.1 (a) Evaluation of les in vitro 
A wide variety of cell culture models have been used to test medical materials. In 
using these methods to evaluate les, and in interpreting the results, it is important 
to realise that this class of materials should be classified as bioactive rather than 
inert. It is now generally recognised that bioactive materials often perform less well 
in tissue culture tests than the more inert materials that they are designed to replace 
in clinical use.34 III vitro testing is not always effective in surface-active materials, 
hence in vivo testing is necessary. 
The biocompatibility of set les has been investigated by several groups using in 
vitro methods. Ideally, initial in vitro evaluation should be carried out using a model 
which mirrors the clinical situation. Through selection of cell source and culture 
conditions, and by addition of ~-glycerophosphate and ascorbic acid into the 
medium, in vitro formation ofa bone-like tissue may be induced. These techniques 
have been used to evaluate the response of cells and "hard tissue biocompatibility" 
ofa range oflCs including dental materials, bone substitutes and bone cements. 
Tissues or cells used include neonate rat calvaria, osteoblasts, fibroblasts, bone 
marrow cells and osteoclasts. llo• 167. IM( 
Previous studies of dental ICs show that toxicity appears to be due to the presence 
of a toxic leachate or rough fracture surface]4, 16K, 1(,<) Fluoride has been suggested as 
the most likely cause of cytotoxicity. 10') The improved in vitro biocompatibility of 
ICs based on non-fluoride MP4 glass supports this hypothesis. J4 Metal ions have 
been suggested as a possible inhibitory factor. Aluminium has been localised in cells 
cultured on the surface of set ICs where it had no visible detrimental effectK2• 16K 
Aluminium and fluoride are both reported to influence bone cells in vitro. 171l These 
effects may be stimulatory or inhibitory, depending upon ion concentration and 
culture conditions. 171l Further work on the factors influencing ion release from ICs 
would be beneficial in producing the optimal formulation for a bioactive bone 
cement/substitute. 
/11 vitro investigation of unset ICs has been hampered because of the extreme 
sensitivity of cultured cells to wet cements. Wet cements have been placed directly 
onto neonate rat calvaria cultures where consequently the calvaria cultures died?4 It 
is likely that meaningful results will be obtained from ill vivo testing of unset 
ionomeric bone cements. 
2~ 
1.3.2 (b) Evaluation of ICs in vivo 
It is essential that clinical trials of a new biomaterial are preceded by adequate ill 
vivo testing, especially given the limitations of tissue culture models. Set les have 
undergone initial il1 vivo evaluation with encouraging results.46 Osteoconduction was 
observed on the surface of certain formulations after only six weeks implantation in 
rat femora. This tissue was apparently stable over the course of one year. K2 In 
addition to demonstrating the osteoconductive nature of certain formulations, these 
experiments highlighted the danger of relying on tissue experiments when evaluating 
bioactive materials. An Ie based on non-fluoride MP4 glass was apparently 
biocompatible il1 vilro, yet failed to osseointegrate with bone after surgical 
placement.34 Direct contact between bone and material was only observed with les 
containing fluoride. The transmission electron microscope (TEM) confirmed that 
bone tissue was in direct apposition to the les and a stable interface was formed. 46• 
58,82 
1.3.3 Bone proteins 
It is desirable in implanted materials, where the aim is to establish osseointegration, 
that the material is able to bind factors that recmit osteogenic cells. There are many 
cell types involved in the response of the body to a polymeric implant. The early 
recruitment of osteogenic cells essential to this process is mediated by the 
extracellular matrix bone proteins. Noncollagenous extracellular matrix (ECM) 
proteins osteopontin (OPN), fibronectin (FN), and tenascin (TN) are known to 
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play an important role in the integration of biomaterials with bone171-1111 as with 
les. 
OPN is involved in the ossification process through its role in osteogenesis and 
chondrogenesis. 171 OPN messenger ribonucleic acid (mRNA) and the OPN protein 
have been detected in the premature osteoblasts and chondrocytes during 
embryogenesis. l72• 173 In adult bone, OPN mRNA is expressed in the osteoblasts of 
primitive woven bone formed in the initial phase of fracture healing suggesting it has 
a role in early bone formation. m 
FN appears to be important during wound healing and provides a substrate for 
fibroblasts migrating into wounds to initiate the repair process. 174 FN is reported to 
play an important role in maintaining the stmcture and relationship of mineralised 
tissues with soft connective tissues during skeletal morphogenesis and 
remodelling. m-177 
TN, an extracellular glycoprotein, is localised in hard tissues during wound healing 
and tissue remodelling.1711-1113 It is prominent during embryogenesi s, I 711 and 
1711 .. hi" h 1112 tumorigenesis, suggestmg It may ave a ro e m tIssue growt , and cell 
migration. 11I2. 1113 TN has been localised in new bone adjacent to implants and is 
thought to have a role in cell adhesion. 1113 
1.4 Hypothesis 
Biocompatibility of ICs is dependent on their chemical formulation and related to 
ion release. 
Ionomeric cements of different chemical formulations can be optimised for 
use as bone cements or substitutes. 
1.5 Aims 
The aim of this project is to investigate the relationship between composition and 
the biocompatibility of novel model formulations ofICs designed for use as bone 
substitutes or cements. This will give valuable information on the development of 
novel adhesive bone cements for use in medicine and dentistry; improved bone 
substitutes for use in plastic and maxillofacial surgery and improved dental cements 
for use as a restorative materials. The investigation will be undertaken using in 
vitro and ill vivo models to differentiate between defined formulations of novel ICs 
produced by the Department of Materials, University of Limerick, Eire. In 
addition, a feature of these ICs is their ability to release ions. A major part of this 
study will therefore determine the effect of these ions on biocompatibility. 
Specific objectives will be: 
(a) To determine if ICs can be selected on the basis of their setting and working 
times to produce an ideal bone substitute/cement. 
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(b) To evaluate and define parameters that determine the release of ions from IC's 
and relate ion release to initial composition and formulation of the Ie, and to 
biocompatibility . 
(c) To observe the ill vitro cellular response to products released from ICs. 
(d) To observe the ill vivo cellular response to products released during the 
transition from wet to the solid phase of les. 
2H 
2. MA TERIALS AND METHODS 
2.1 Materials 
All experimental glasses for preparation of glass polyalkenoate cements were 
obtained from Dr Robert Hill (Department of Materials Science, University of 
Limerick, Eire). 
The medical grade mercaptan-free freeze-dried poly(acrylic acid) (PAA) was 
obtained from Advanced Healthcare (Tonbridge, Kent, UK). PAA has the following 
general fonnula:-
Figure 2.1 Poly(acryJic) acid 
HH 
I I 
~----~-c.------~ 
I I 
H C=O 
I 
OH n 
The PAA used had a weight average molar mass of 1.68 x lOs g and a number 
average molar mass of2.29 x 104. 
Table 2.1 Commercial materials used for in vitro studies 
Cement Type Manufacturer 
Chemfil Dentsply Ltd, De Trey Division, 
Chemfil Express (Surrey, UK) 
Hydroxyapatite Howmedica GmbH lGermany) 
Po!!{tetrat1uoroeth~ene) (PTFEj ICIJ!!K) 
Vo-cem ESPE GmbH (Germany) 
Poly(methylmethacrylate) (PMMA) Howmedica GmbH (Germany) 
Surgical Simplex ~RO 
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2.1.1 Glass polyalkenoate cements 
The glass compositions are summarised from section 2.1.1 a) to j). 
a) Monovalent cation based :Sodium 
(i) General formula for the following glasses was as follows: 
Glass code LG2 LG6 LG4 
Z (mole fraction) 0 0.1 0.025 
NazO 
Glass code LG23 LG63 
Z (mole fraction) 0.15 0.2 
NazO 
(ii) General formula for the following glasses was as follows: 
Glass code LG65 LG66 LG67 LG68 
Z (mole fraction) 0.1 0.2 0.3 0.4 
NazO 
iii) Monovalent cation ba.fell:Pota.uiuni 
LG7: l.5Si02 l.OAhO) 0.5P20S 0.975CaO 0.75CaF2 0.02SK20 
LGS: l.5SiOz l.OAI20) 0.5PzOs 0.95CaO O.75CaF2 O.05K20 
LG22: l.5Si02 l.OAh03 O.5P20 S O.95CaO O.SCaF2 O.OSK20 
iv) Monovalent cation based:SolliumiPotauium 
LG69 
0.5 
LGIO: 1.5Si021.0Ah03 0.5P20 S 0.975CaO 0.75CaF2 0.0125Na20 0.0125 K20 
LGII: 1.5SiOz l.OAhO)0.5P20 s 0.9CaO O.75CaF20.05Na20 0.05 K20 
]0 
LG5 
0.05 
LG70 
0.45 
b) AJXltite-sloichiometric series 
General formula was as follows: 
LG26: 4.5Si02 3.0A120 3 1.5P20S 3.0CaO 2.0CaF2 
LG27: 6.0Si02 4.0Ah03 1.5P20 s 4.0CaO I.OCaF2 
LG28: 6.75Si024.5Ah031.5P20s 4.5CaO 0.5CaF2 
LG29: 7.125Si024.75AI2031.5P20s 4.75CaO 0.25CaF2 
LG30: 7.5Si02 5.0A120 3 1.5P20 s 5.0CaO 
c) Varying Calciumf1uoritle .~erie.~ 
General formula for the following glasses was as follows: 
Glass code LG3 LG26 LG2 LG42 
X (mole fraction) 0.5 0.67 0.75 1.0 
CaFz 
LG44 LG45 
0.25 0 
d) Varying SilicaiAlununa antI Calcium ... erie ... (~f gla ...... e ... LG53-LG57 anti LG72-
LG75 
LG53: 4.5Si02 3.0Ah03 1.0 P20 S 3.0CaO 2.0CaF2 
LG54: 6.0Si02 4.0Ah03 1.0 P20 S 4.0CaO 1.0CaF2 
LG55: 6.75Si02 4.5Ah03 1.0 P20 s4.5CaO 0.5CaF2 
LG56: 7.l25Si02 4.75AI20] 1.0 P20S 4.75CaO 0.25CaF2 
LG57: 7.5Si02 5.0AhO] 1.0 P20 S 5.0CaO 
LG72: 6.0SiOz 4.0Ah03 1.0 P20 S 4.0CaO 2.0CaF2 
LG73: 7.5Si02 5.0Alz03 1.0 P20s 5.0CaO 1.0CaF2 
LG74: 8.25Si02 5.5Ah03 1.0 P20 S 5.5CaO 0.5CaF2 
LG75: 8.625Si02 5.75Alz03 1.0 P20 S 5.75CaO 0.25CaF2 
e) Varying Silica:AlunUna ralio ba.~etl 
LG77: 6.25Si02 3.75AhO] 1.5 P20s 4.0CaO 1.0CaF2 
LG78: 6.5Si02 3.5Ah03 1.5 P20S 4.0CaO l.OCaF2 
LG80: 6.7Si02 3.3Ah0 31.5 P20 S 4.0CaO 1.0CaF2 
LG81: 6.75Si02 3.25AI20)1.5 P20 S 4.0CaO l.OCaF2 
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f) Generic composition.~ llerivellfrom LG26 
LG83: 4.1 Si02 3.0 Ah03 1.7P20s 2.8 CaO 2.0CaF2 
LG84: 3.7 Si02 3.0 AI20 3 1.9P20 S 2.6 CaO 2.0CaF2 
LG85: 3.3 Si02 3.0 Ah03 2.1P20s 2.4 CaO 2.0CaF2 
LG86: 2.9 Si02 3.0 AI20 3 2.3P20 S 2.2 CaO 2.0CaF2 
LG26: 4.5 Si02 3.0 Ah03 1.5P20 s 3.0 CaO 2.0CaF2 
g) High Calcium based series 
LG95: 4.5Si02 3.0A120 3 1.5 P20 S 2.8CaO 2.2CaF2 
LG96: 4.5Si02 3.0A120 3 1.5 P20 S 2.6CaO 2.4CaF2 
LG97: 4.5Si02 3.0A120 3 1.5 P20 S 2.4CaO 2.6CaF2 
LG98: 4.5Si02 3.0Al20 3 1.5 P20 S 2.2CaO 2.8CaF2 
LG99: 4.5Si02 3.0A120 3 1.5 P20 S 2.0CaO 3.0CaF2 
h)· High pho.~phate ba.~ell serie.~ 
LG91: 3.3Si02 3.0A120 3 2.1 P20 S 2.2CaO 2.2CaF2 
LG92: 3.3Si02 3.0A120 3 2.1 P20 S 2.0CaO 2.4CaF2 
LG93: 3.3Si02 3.0A120 3 2.1 P20 S I.8CaO 2.6CaF2 
LG94: 3.3Si02 3.0A120 3 2.1 P20 S 1.6CaO 2.8CaF2 
i) Raliiopatlue Strontium ba.~e{l 
General formula was as follows: 
Glass code LG26 
X(mole fraction) SrO 0 
j) Zinc ba.~ell 
General formula was as follows: 
Glass code LGl30 
X(mole fraction) ZnO 1.5 
32 
LGI19 LGI25 
1.5 3.0 
LGI32 
0.75 
Figure 2.2 Poly(methylmethacrylate) as the control has the general formula as 
shown below: 
H CH3 H CH3 H CH3 H CH3 
I I I I l I r 1 
---c-c-----c-c----c-c-----c-c--- . . . 
I I I I I I I I 
H e--Q H C:O H C:O H C::() 
I I I I 
a a a 0 
I I I I 
CH3 CH3 CH3 CH3 
Surgical PMMA consisted of the following:-
Poly(methylmethacrylate) 6.0 g 
Methyl-methacrylate 30.0 g 
Barium sulphate USP 4.0 g 
2.1.2 Ion release 
Distilled sterile highly pure water (Baxter's Healthcare Ltd, UK). 
Weighing machine (Mettler Bas BalBB2400Wycombe, Buckinghamshire, USA). 
Concentration/conductivity/pH direct readout meter (Orion SA 720 pHIISE, USA). 
Incubator (HarvardIL TE). 
Nalgene® bottles (Rochester, NY, USA). 
Fluoride electrode (Orion Model 94-09). 
Sodium electrode (Orion Model 84-11, 86-11 ROSS™). 
Electrode solution (Orion, USA). 
Total ionic strength adjustment butTer (TISAB, Boston, USA). 
Atomic absorption spectrometer (Perkin-Elmer M21 00). 
:n 
10.0 ml plastic clinical sampling tubes (Rochester, NY, USA). 
a-Minimal essential media (Sigma, USA). 
2.1.3 Cell culture 
Wash medium 
Ascorbic acid (Sigma, USA) 
Foetal calf-serum (heat-inactivated) (Gibco BRL, UK) 
Penicillin (Sigma, USA) 
Streptomycin (Sigma, USA) 
Amphotericin B (Sigma, USA) 
Fungizone (Sigma, USA) 
Basic medium(BM) 
a-Minimal Essential Medium (Sigma, USA) 
Foetal Calf Serum 
Penicillin/Streptomycin 
Fungizone (uglml) 
20.0 ml of BM was supplemented (BSM) with 
Dexamethasone(Sigma, USA) 
Ascorbic acid/~-glycerophosphate 
Glutamine 
50.0 Ilglml 
15.0% 
50.0 IUlml 
50.0 IUlml 
0.3 Ilg/ml 
2.0 ml 
85.0ml 
15.0 ml 
1.0 ml 
120 III 
200 III 
200 III 
200 III 
Ascorbic acid/B.-Glycerophosphate was made up of: 
Ascorbic acid 
I}-Glycerophosphate 
Water (Baxter's Healthcare Ltd, UK) 
S.Omg 
2.16 g 
10.0 ml 
Fresh I}-glycerophosphate and ascorbic acid solutions were freshly made up before 
use and were added to the culture media to give 10.0 mM and 50.0 ~g/ml 
concentrations. 
Ascorbic acid (Vitamin C) was used in the media as it is essential for normal 
formation of collagen. 
J}-Glycerophosphate was used for metabolic reasons as a phosphate donor for the 
process of mineralization. 
Dexamethasone is a defined medium supplement aiding mineralization by 
stimulating the differentiation of progenitor cells into osteoblasts, and induces 
expression of tyrosine aminotransferase activity constitutively. Dexamethasone, 
2.5 x to-S M. to ~glml (asoluble synthetic hydrocortisone analogue), improves the 
plating efficacy of human normal glia, glioma, fibroblasts, and melanoma, and chick 
myoblasts, and will give increased clonal growth (colony size) if removed 5 days 
after plating. Lower concentrations (to-7 M) have been found preferable for 
epithelial cells. 
Foetal calf serum was used to support the growth of the cells. 
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Streptomycin /penicillin were used to inhibit bacterial growth by interfering with 
the final stage of synthesis of the cell wall. 
Amphotericin B (fungi zone) was used to interfere with the permeability of cell 
membrane sensitive fungi by binding sterols. 
Glutamine is an amino acid and was used in the exogenous form as serially cultured 
cells, growing in the customary medium containing glutamine, typically exhibit low 
levels of the enzyme which catalyses the synthesis of glutamine from glutamic acid. 
Glutamine unlike most other amino acids, is labile in solution. 
Ros tell nutrient media 
Nutrient mixture F-12 (HAM) with I-Glutamine (Gibco BRL,UK) 500 ml 
Foetal Calf Serum 
Penicillin/Streptomycin 
Fungizone 
30.0 ml 
5.0 ml 
600 JlI 
200 Jl.l glutamine was added to 20.0 ml media as glutamine degrades with time. 
Protein assay reagents 
A) Lowry reagent solution 
40 ml water was added to a bottle of Lowry reagent (Sigma catalogue number 
LIOl3). The bottle was not shaken to minimise foaming and kept at room 
temperature to keep the reagent stable. 
B) Folin and Ciocalteau's Phenol reagent working solution 
5.0 ml distilled water 
90.0 m12.0 N Folin and Ciocalteau's Phenol reagent (sigma catalogue number 
F9252). Stored in the dark at room temperature (wrapped aluminium foil around 
the bottle, stored it in a cupboard). 
Protein standard solution (400 uglml) 
This is a reconstituted protein standard (Sigma catalogue number P7656) with the 
amount of water indicated on the vial label. The mixture was dissolved by gently 
mlxmg. 
Sodium Dodecyl solution (SDS solution) 
Sodium dodecyl sulphate (SDS) was dissolved in sufficient distilled water to 
produce a 0.1 % solution of SDS (for example, 300 mg in 300 mI). 
Phosphate buffered saline solution 
Phosphate buffered saline solution was warmed in a warm water bath (37°C). 
MTT reagents 
A) MTT sol uti on 
MTT powder* was dissolved in phosphate buffered saline to a concentration of 
5.0 mglml, and filtered through a sterile 0.2 Jlm membrane filter. Spare MIT 
solution was frozen at -20°C. 
*MTT powder=(3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide~ 
thiazolylblue). Sigma catalogue number MS6SS. 
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B) MTT solvent 
10 % Triton X-I00 was prepared in acidic isopropanol (0.1 N Hel in absolute 
isopropanol). 
2.1.4111 vivo 
Table 2.2 Ionomeric cements tested for surgical implantation 
l" .. m .. nt tvnp l"nm nncitinn ~ . tvn" ~ .. t w .. t 
LG2 I.S Sio,. A1.0, O.)P,o,.CIO 0.7~ CaF, Monovalent .. 
I.n6 1.5 Sio,. A1.0, 0.5P.o,.0.9 CoO 0.75 CaF,O.lNazO Monovalent .. 
Ir~ 1.5 Sio,A1,o, o.sP,o,.O.R ('..0. 0.75 ('aF,O.2N.JO Monovalent .. 
LG231~2~3 I.S Sio,. A1,o,0.5P,o,.0.R5 Coo. 0.7S coF,O.15NazO Monovalent .. 
LG23 t~2~2 1.5 SiD .. A1,o,0.5P,O,.0.R5 Call 0.75 c.IF,O.15NazO Monovalent .. 
LG26 4.5 SiD,. lAl,o, 1.5P,0,.3 ('ael 2 C.F z Apatite-S .. .. 
LG27 6 Sio,. 4A1,O, I.SP,o,.4 CoO ICaFz Apatite-S * 
LG30 7.5 Sio,. SAl,!), I.SP,O, .5C.0 Apatite-S .. .. 
LGl19 4.5 SiD,. 3Al,o, 1.5P,o,.1.5 (,,,0. 2 ("F,I.SSrJO Strontium .. 
LG125 4.5 SiD,. MI,o, I.SP,O,. 2 ('uF,lSrzO Strontium .. 
LGl30 4.5 Sio,.lAl,o, l.SP,o,.l.S (',,0. 2 coF,I.5ZnO Zinc • 
J~l'n 4.5 SiC.. 3Al,o, 1.5P,o,.2.2S c..o. 2 eIF,II.75ZnO Zinc .. 
A~rvlic (''Hz-CH-COOH Polymer .. .. 
The monovalent cation (monovalent) cements were selected on the. basis of their 
varying monovalent cation sodium concentrations. LG23 was tested using a 
composition of 1 :0.2:0.3 ratio and at a high powderlliquid ratio i.e. 1 :0.2:0.2 as wet 
cements to investigate any difference in the cements adhesive properties and thus in 
osseointegration. Apatite-stoichiometric cements were selected on the basis of their 
varying CaF2 concentrations with LG26 having a high fluoride content. Apatite-
stoichiometric cements were chosen as they have the same calcium:phosphate ratio 
as that of apatite (1.67). LG26 a high apatite stoichiometry glass, was chosen for 
substitution by strontium because it is known that strontium can substitute for 
calcium in the apatite lattice. LG 119 and LG 125 cements were chosen as strontium 
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is known to stimulate osteoblast proliferation. 1 1 1-114 Zinc cements were selected to 
determine its osteoconductive properties l1l4 . 
Stains used for histological sections: 
Hematoxylin 
Absolute alcohol 
Potassium alum 
Distilled water 
Mercuric acid 
Glacial acetic acid 
2.5 g 
25.0 ml 
50.0g 
SOOml 
1.25 g 
20.0 ml 
The hematoxylin was dissolved in the absolute alcohol, and was then added to the 
alum which had previously been dissolved in the warm distilled water in a two-litre 
flask. The mixture was rapidly brought to the boil and the mercuric oxide was then 
added. The stain was rapidly cooled by plunging the flask into cold water. When 
the solution was cold the acetic acid was added. The stain was then ready for 
immediate use. The glacial acetic acid was optimal but its inclusion gives more 
precise and selective staining of nuclei. For the best results a fresh batch of stain 
was made up every week. 
Eosin Y (Eosin yellowish, eosin water soluble) 
Eosin 
Calcium chloride 
Distilled water 
0.2% 
0.2% 
1000 ml 
As a cytoplasmic stain it is usually used as a 0.5 or ] .0% solution in distilled water, 
with a crystal of thymol added to inhibit the growth of fungi. The addition of a 
little acetic acid (O.Sml to 1000 ml stain) is said to sharpen the staining. 
Differentiation of the eosin staining occurs in the subsequent tap water wash, and a 
little further differentiation occurs during the dehydration through the alcohols. 
2.15 Immunohistochemical techniques materials 
Rabbit polyclonal primary antibodies raised against fibronectin (Daleo, UK, dilution 
1:100) 
Rabbit polyclonal primary antibodies raised against tenascin (Chemicon, UK, 
dilution 1:100) 
Monoclonal mouse primary antibodies raised against osteopontin (Ohio Hybridoma 
Bank, USA, Dilution 1:100) 
Secondary FITe conjugated antibodies raised against mouse immunoglobulins 
(Sigma, UK) 
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2.2 Methods 
2.2.1 Material properties testing of glass ionomer (polyalkenoate) cements 
To obtain quantitative measurements for the handling properties assessed clinically, 
the setting and working times of all the ICs surgically implanted were determined. 
The working time (seconds) was from the point where the glass, polyacryJic acid 
and water were al1 mixed until the wet IC was successfu]]y implanted into the bone. 
For set ICs working time was from the point where the set IC rod was extracted 
from the silicone mould to the point where the set IC rod was implanted into the 
bone. The setting time was from the point where the IC ingredients were mixed ti11 
the Ie had successfully set in the medical grade silicone tubing or was set in the 
bone. Nine tests for the working and setting times were performed. 
2.2.2 Ion release 
Ionomeric cements were made up in fractions of the foHowing ratio: 
1.0 g Glass 
0.2 g Poly(acryJic acid) 
0.3 ml Water. 
For ion release studies cement discs (20.0 mm diameter x 2.0 mm thick) were 
prepared by mixing 6.0 g of the appropriate glass powder with 1.2 g of mercaptan -
free freeze dried PAA and 1.8 ml of distilled sterile highly purified water on a pre-
cooled, clean slab. Discs were then cured for at least 24 hours at 37"C at 100 % 
humidity in a HarvardIL TE incubator. 
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Cement discs were then placed into Nalgene bottles with 50.0 ml aliquots of sterile 
non-pyrogenic water (Baxter's Healthcare Ltd, UK) at 37 (Ie, for elution to take 
place under sink conditions i.e. in the mechanical shaker. Samples of the solutions 
with IC discs were collected at 1 day, 3 days, 5 days, 7 days, and 84 days. 
1.1.1 (a) Ion selective electrode 
The ion selective electrode was used by: 
1) Connecting electrodes to the Orion SA 720 pHIISE direct readout meter (USA). 
2) The mains connected to the meter were switched on. 
3) Electrode solution (Orion, USA) was placed into the electrode and left for at 
least 2 hours for the electrode to stabilise. 
4) The standards were prepared with a ten-fold difference in concentration in the 
range of the expected sample concentration i.e. 10.0 parts per million (ppm) and 
100 ppm. 100 ppm was prepared by using 5 .Oml of Total ionic strength 
adjustment buffer (TISAB III) (Orion, Boston, USA) in SOml of water, and 10.0 
ppm would be prepared by using 0.5 ml ofTISAB III in 50ml of highly purified 
water. TISAB III contains a reagent, COT A that preferentially complexes AI3+ or 
Fe3+ in the sample. Thus, higher levels of A1 3+ and Fe3+ were complexed, obtaining 
the total fluoride concentration of the solution. This was carried out for sodium ion 
measurements, where sodium ionic adjustor (ISA, Orion cat. number 841111 *) was 
used in place of TISAB III. 
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5) The 'calibration' button on the meter was switched on and the electrode was 
placed into the 10.0 ppm solution until the reading on the meter was 10.0 ppm or 
near 10.0 ppm, the lowest concentration. This was repeated for the 100 ppm 
solution, the higher concentration. 
6) The 'sample' button was then pressed and the electrode was placed into the 
sample solution and the reading was taken. 
7) The electrode was then rinsed in highly pure water and the next sample reading 
was measured. 
8) Baxter's highly pure water was used as a control, and was also sampled at the 
given times. 
Fluoride ion measurements were taken, using an Orion model 94-09, 96-09 
fluoride/combination fluoride electrode with reference filling solution (Orion cat. 
number 900001 (see Figure 2.3). Sodium measurements were taken using an Orion 
model 84-11, 86-11 ROSS TM sodium electrode with reference filling solution 
(Orion cat. number 900012). Fluoride and sodium detection limits were in the 
range 10 ppm to 100 ppm) and the percentage accuracy for fluoride measurements 
were 97.3% accurate and for sodium 95.4% accurate. 
2.2.2 (b) Atomic absorption spectroscopy 
The atomic absorption spectroscopy (AAS) procedures were carried out 
by Analytical services at the University of Sheffield. Ions such as calcium, 
aluminium, silicon, phosphate and potassium were measured by AAS. The 
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samples requiring calcium were analysed on a Perkin-Elmer M2100 AAS with an 
AS-50 autosampler. The samples were measured using a Perkin-Elmer calcium 
hollow cathode lamp, and the instrument was calibrated (1 ppm to 10 ppm) using 
standards prepared from a pre-concentrated calcium standard (10,000 ppm) 
purchased from the Laboratory of the Government chemist. 
Five standards were used to calibrate the instmment, these were 0.5 ppm, 1.0 ppm, 
2.0 ppm, 3.0 ppm and 5.0 ppm of Analytical Quality Control Standard (AQCS) . 
After every five samples an AQCS standard was mn whose value is noted on 
control charts to ensure accuracy. After every ten samples the instrument was re-
calibrated to avoid drift. Detection limits for calcium measurements were in the 
range of 1 ppm to 10 ppm and were 92.1% accurate. 
Table 2.3 Instrument Conditions for ea Analysis 
Wavelength 422.8 
Slit Width (nm) 0.7 High 
Lamp Current(mA} l.5 
Int~ation Time -'sec) 4 
Hold Time (sec) 4 
Re~licates 2 
Oxidant Air 
Fuel Ac~Iene 
Oxidant Flow (L/min) 12.0 
Fuel Flow (L/min) 3.4 
Standard Units (ppm) 
Sample Units (Qp_m) 
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The samples requiring silicon (Si) were analysed on a Perkin-Elmer M21 00 AAS 
with a HGA-700 graphite furnace and an AS-70 autosampler. The samples were 
measured using a S&J Juniper silicon hollow cathode lamp, and the instrument was 
calibrated using standards prepared from a pre-concentrated silicon standard (1000 
ppm) purchased from the Sigma chemicals. 
Five standards were used to calibrate the instrument, these were 100 ppm, 200 
ppm, 300 ppm, 400 ppm and 500 ppm. After every five samples a separate 
standard was run, this was a separately prepared AQC, whose value is noted on 
control charts to ensure accuracy. Again, after every ten samples the instrument 
was re-calibrated to avoid drift. Detection limits for silicon measurements were in 
the range 100-500 ppm and were 91.2% accurate. 
Table 2.4 Instrument Conditions for Si Analysis 
Wavelength (nm) 251.6 
Slit Width (nm) 0.7 Low 
Lamp Current (rnA) 30 
Signal Processing Peak Area 
Integration Timelsec) 5.0 
Replicates 4 
Standard Units ppm 
Sample Units ppm 
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Table 2.5 Furnace Parameters 
Step Furnace Ramp Hold Gas Flow Read On Descript-
Number Temp(OC) Time Time (l/min) Ion 
(sec) (sec) 
1 140 10 40 300 Drying 
2 1400 5 10 300 Ashina 
3 2650 0.1 10 0 0 Atom-
sation 
4 3000 1 3 300 Clean-up 
5 30 1 5 300 Cool 
The samples requiring aluminium were analysed on a Perkin-Elmer M21 00 AAS 
with an AS-50 autosampler. The samples were measured using a Perkin-Elmer 
aluminium hollow cathode lamp. and the instrument was calibrated (0.1 ppm to 1.0 
ppm) using standards prepared from a pre-concentrated aluminium standard (10,000 
ppm) purchased from the Laboratory of the Government chemist. Standards were 
analysed using the same method as that of calcium. Aluminium detection limits 
were in the range 0.1 ppm to 1.0 ppm and were 93.3 % accurate. 
The samples requiring potassium were analysed on a Perkin-Elmer M21 OOAAS 
with an AS-50 autosampier. The samples were measured using a hollow cathode 
lamp, and the instrument was calibrated (1 ppm to 10 ppm) using standards 
prepared from a pre-concentrated potassium standard (l0,000 ppm) purchased 
from the Laboratory of the Government chemist. The procedure followed was the 
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same as described in calcium analysis. Potassium detection limits were in the range 
of 1 ppm to 10 ppm and were 94.1 % accurate. 
The samples requiring phosphate were analysed on a DIONEX 200001 high 
pressure liquid chromatography (HPLC) with an autosampler and Trivector 
integration package. The instrument was calibrated using standards prepared from 
the separate salts purchased from BDH chemicals. Five mixed standards were used 
to calibrate the instrument, (containing chloride. nitrate. sulphate and phosphate) 
these were 5.0 ppm, 10.0 ppm, 15.0 ppm. 25.0 ppm and 40.0 ppm. 
After every seven samples a separate AQCS was run. this was a separately 
prepared AQC, whose value is noted on control charts to ensure accuracy. After 
every twenty samples the instrument was re-calibrated to avoid drift. The Dionex 
uses an ASA4 Dionex ionpac anion chromatography column. The eluent is a 1.98 
mM sodium bicarbonate mixture with 0.025N sulphuric acid as the suppresser 
regenerant inhibiting the measurement of recycling ions. Phosphate detection limits 
were from 5 ppm to 40 ppm and were 94.8% accurate. 
2.2.2 (c) pH readings 
The pH and conductivity was measured for selected solutions with IC discs. 
Measurements were taken using a pH electrode using an Orion SA 720 pH/ISE 
direct meter (USA). 
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2.2.3 Cell culture techniques 
This was supervised by Dr AJ Devlin. 
(i) Making discs for in vitro studies 
Cement discs were made using the same method as that for the ion release studies 
(10.0 mm diameter x 1.0 mm depth). The cement discs were cleaned by rinsing 
them with 15.0 ml of 1 % Decon 90 (E.Sussex, England) in separate universals. The 
discs were then ultrasonicated for 5 minutes (F51 OOb Decon, UK). This wash was 
then repeated and then rinsed with highly pure water (water that had been purified 
giving water with the least number of contaminant ions, such as calcium, sodium, 
potassium, aluminium, chlorides, nitrates, sulphates and bicarbonates making it 
highly pure water, Baxters, UK) three times. The discs were then autoclaved at 120 
°C for 20 minutes at 100 % humidity for sterilisation. 
2.2.3 a) Bone marrow culture 
2.2.3 a) i) Dissection of the femur 
Weaned Wistar rats (3 weeks old) (Field Laboratories, University of Sheffield, 
UK) were harvested using Schedule I killing (a method used to kill protected 
animals rapidly and in a painless manner). The rats were initially overdosed with a 
general anaesthetic, halothane, then dislocation of the cervical vertabrae was carried 
out. The overlying fur and skin of the right femur was cut away working towards 
the pelvis to expose the right femur. The tibia just below the tibiafemoral joint 
4M 
(knee) was initially snipped off and again above the coxal joint (hip). The whole of 
the right femur was then removed cutting away soft tissues from the femur. The 
femur was then placed into the sterile wash medium. This whole procedure was 
then repeated for the left femur. 
2.2.3 a) ii) Extraction of the bone marrow cells 
Asceptic techniques were used to reduce infection from bacteria and fungi by 
carrying out work in the ICN flow TC4 (USA) laminar flow cabinet to make media 
and extract cells. The femora together with the wash medium were placed in a water 
bath at 37 (lC for ten minutes. The femora were then washed three times every ten 
minutes. The muscle and periosteum were asceptically removed by carefully 
cutting and teasing away the tissues. Each femur was then placed in 10.0 ml of 
basic medium to rinse otT antibiotics in the laminar flow cabinet. 
The marrow tissue was then gently flushed out of the bone using 20.0 ml of basic 
medium in a syringe. The cellular debris was allowed to settle, and the medium 
containing the cell suspension was then decanted into a vented 135 cm2 tissue 
culture polystyrene disposable sterile flask [T75](Corning. UK). The whole 
procedure was then repeated for the remaining femur and labelled as such. 10.0 ml 
ofBSM was then added, so that mixed bone cells were suspending in 30.0 ml of 
medium. The flasks were placed in an LEEC incubator at 37 (lC in an atmosphere 
of 5 % CO2, Every two-three days the flasks were checked for normal growth and 
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for any bacterial and fungal infections. ~-glycerophosphate 1 M solution and 
ascorbic acid were made up and added to media prior to use. The media was 
replenished every three to five days with 30.0 ml fresh BSM per flask. 
2.2.3.a) iii) Trypsinisation of bone marrow cells 
When cells were confluent they were washed twice with 20.0 ml of 1 % PBS. To 
remove any remaining debris in the culture flask. Cells were then treated with 20.0 
ml of 0.25 % trypsin in a 37 "C mechanical shaker for 5 minutes to lift cells off the 
surface of the flask. The cells were then observed under the inverted phase-contrast 
microscope (Nikon TMSITMS-F, Japan) at x 10 magnification. Round-shaped cells 
indicated that the cells were trypsinised. 
The trypsinised cells were placed into a sterile 20.0 ml universal container 
(Catalogue No. 3276 and 3376, Costar, Cambridge, MA, USA), and centrifuged at 
1500 rpm for 5 minutes. The trypsin media was then removed with a sterile pipette 
and placed into bleach prior to disposing. The pelleted cells in the bottom of the 
universal container were resuspended by adding 20.0 ml ofBSM. 
2.2.3 b) Ros Cell line 
In addition to primary cells ICs were studied using a cell line ROS 17/2.8, which 
has well-defined osteoblastic properties .IK~ ROS cells have many advantages such 
as having no cellular heterogeneity, no phenotypic changes in culture and they are a 
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permanent cell line and they give more consistent results in toxicology testing than 
primary cell lines. ROS cells were kindly donated by Dr GA Rodan (Merck- Sharp 
and Dohme, Philadelphia, USA). Studies were carried out in the same way as for 
the bone marrow cultures, except that cells were grown in Ham's F12 containing 5 
% foetal calf serum, 50 IU/ml penicillin, 50 ~l Streptomycin, 0.3 ~g/ml amphotericin 
Band 2 mM glutamine ( Materials section 2.1.3, Ros cell media). 
2.2.3 b) i) Chamber Slide Cultures 
The same procedure was used as above to grow Ros cells in Chamber slide culture 
chambers (Lab-Tek, Nunc Inc, Illinois, USA). This method was used for staining 
the cells, and determining calcium deposits in live cells by staining with Alizarin 
Red S. The objective of the Alizarin Red S method is to detect calcium deposits. 
After fixation with 4% neutral buffered formalin for 10-15 minutes, cell layers were 
rinsed in distilled water. 2% Alizarin Red S (Sigma, UK) solution (pH 4.2) was 
added for 1-5 minutes and the reaction monitored under an inverted phase-contrast 
microscope (Nikon TMSITMS-F, Japan) until completion. The layers were 
differentiated in a 0.05% hydrochloric acid/95% ethanol solution for 15 seconds. 
The layers were rinsed in 100% ethanol two times and rinsed in histoclear twice for 
5 minutes. 
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2.2.3 b) ii) Multiwell plates 
Multiwell plates were set up for both bone marrow cells and Ros cells. Sterile 
cement discs were placed into individual wells of the multiwell tissue culture plates 
(Costar, Cambridge, MA, 02140, USA). 1.0 ml of sterile BSM and O.S ml of dilute 
media with bone marrow cells and Ros cells were placed into each of the wells. The 
plate was placed into the incubator, and was regularly observed for the healthy 
growth of bone marrow cells and Ros cells, and for the attachment of cells to the 
cement discs under the Nikon phase-contrast microscope. Media was changed 
every two or three days to feed the cells. 
2.2.3 b) iii) Scanning electron microscopical examination of cultures 
This was supervised by Mr John Proctor. Specimens were fixed by replacing the 
culture medium with 2.5% glutaraldehyde in O.IM cacodylate buffer (pH 7.2-7.4) 
for 24 hours. Cultures were secondarily fixed with 2% aqueous osmium tetroxide 
for 1 hour, followed by dehydration through a graded acetone series, critical-point 
from CO2 (Polaron critical point drier) and coated with a thin layer (approximately 
20nm) of gold (Nanotech sputter coater) for scanning electron microscopy (SEM) 
(Cambridge Stereoscan 600, set at 25kV). 
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2.2.3 c) Quantitative assessment of cytocompatibility 
2.2.3 c) i) Total protein 
The Lowry procedure has been found to be the most reliable and satisfactory 
method for quantification of soluble proteins. 1f!6 The procedure used was based on 
Peterson's modification of the micro-Lowry method and utilised sodium 
dodecylsulfate, included in the Lowry reagent, to facilitate the dissolution of 
relatively insoluble Iipoproteins. 1R6 
For many proteins, the Lowry reaction can be run directly on the protein solution. 
However, interference in the direct Lowry procedure is caused by commonly used 
chemicals, such as Tris, ammonium sulphate, EDT A, sucrose, citrate, amino acid 
and peptide buffers and aromatic amino acids such as tyrosine and phenylalanine are 
detected. The procedure with protein precipitation, which uses deoxycholate 
(DOC) and trichloracetic acid (TCA), eliminates these interferences with the 
exception of phenols. However, the amount of various proteins recovered through 
the precipitation step may vary depending on the particular protein assayed. 
A purple-blue colour is formed when alkaline cupric tartrate reagent complexes with 
the peptide bonds when the phenol reagent is added. Wavelengths at which the 
absorbances are read are between 500 nm and 800 nm, and the protein 
concentration is determined by a calibration curve. 
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Direct protein procedure-without Protein precipitation 
1) Standard tubes were prepared by diluting Protein Standard Solution with water 
to a volume of 1.0 ml in appropriately labelled test tubes: 
Table 2.6 Protein concentrations 
Protein Standard Solution Water(ml) Protein Concentrationij.lglml) 
(ml) 
0.125 0.875 50 
0.250 0.750 100 
0.500 0.500 200 
0.750 0.250 300 
1.000 0 400 ' 
2) 1.0 ml of water in a test tube was labelled 'Blank'. 
3) Samples were added to appropriately labelled test tubes and diluted to 1.0 ml 
with water. 
4) 1.0 ml of Lowry reagent solution was added to the standard, blank and sample 
tubes, and were then well mixed. 
5) Solutions were then left to stand for 20 minutes. 
6) O.Sml of Folin & Ciocalteu's phenol reagent working solution samples were 
added to each tube and mixed rapidly. 
7) The colour was allowed to develop for 30 minutes. 
8) Solutions were then transferred to cuvettes and the absorbance was measured for 
all the standards and sample tubes vs. the blank at a wavelength from 500 nm to 
800 nm. Readings were completed within 30 minutes. 
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9) The absorbance values of the standards vs. thei r corresponding protein 
concentrations were plotted to prepare a calibration curve. 
10) The protein concentration of the sample tube was determined from the 
calibration cUlVe. The result was multiplied by the appropriate dilution factor to 
obtain the protein concentration in the original sample. 
1.1.3 c) ii) Methyltetrazolium Test (MTT) 
Traditionally, in vitro determination of toxic effects of unknown compounds have 
been performed by counting viable cells after staining with a vital dye. 1117 
Alternative methods have been to measure the radioisotope incorporation as a 
measurement of DNA synthesis, counting by automated counters and others which 
rely on dyes and cellular activity. The MTT system is a means of measuring the 
activity of living cells via mitochondrial dehydrogenases. IK7 
The key component is (3-[4,5-dimethylthiazol-2-yl]-2.5-diphenyl tetrazolium 
bromide) or MIT. Solutions ofMTT dissolved in medium or balanced salt 
solutions without phenol red, are yellowish in colour. Mitochondrial 
dehydrogenases of viable cells cleave the tetrazolium ring yielding purple crystals 
which are insoluble in aqueous solutions. The crystals are dissolved in acidified 
isopropanol. The resulting purple solution is measured using a spectrophotometer. 
An increase or decrease in cell number results in a concomitant change in the amount 
formed, indicating the degree of cytotoxicity caused by the test material. 
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The MIT method of monitoring ill vitro cytotoxicity is well suited for use with 
multi well plates. For best results, cells in the logarithmic phase of growth should 
be employed and the final cell number should not exceed 106 cellslcm2. Each test 
included a blank containing complete medium without the cells. 
1 The culture was removed from the incubator and into the laminar flow hood. 
2 Each vial reconstituted with MTT was used with 3.0 ml of medium, the 
reconstituted MTT was added in equal amounts to 10 % of the culture medium 
volume. 
3 The cultures were then returned to the incubator for 2-4 hours. Incubation times 
were consistent when compared with other samples. 
4 Cultures were then removed from the incubator and the resulting formazon 
crystals were dissolved using an equal amount of MTT solubilization solution to 
that of the original culture medium. 
5 The plate was then placed in the mechanical shaker to enhance dissolution. 
Occasionally, pipetting up and down, i.e. titration, was required to completely 
dissolve the MTT formazon crystals. 
6 Tests performed in multi well plates were read by transferring the well contents to 
appropriate size cuvettes for spectrophotometric measurements. 
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7 The absorbance measurements were taken at 570 nm and 670 nm wavelengths to 
measure the background absorbance of the multiwell plates. The absorbances at 670 
nm were then subtracted from the 570 nm absorbance measurements. 
8 Plates were read within 1 hour after adding MIT solvent. 
1.1.4 In vivo techniques 
1.1.4 a) Production of set ionomeric cement rods 
ICs were produced using a ratio of 1.0 g glass, 0.2 g freeze dried mercaptan free 
poly(acrylic) acid (Advanced Healthcare, UK) and 0.3 ml sterile non-pyrogenic 
water. Smooth rods (nominally 2.0 mm length x 1.0 mm diameter) were produced 
by placing unset material in silicone moulds. The silicon tube containing the IC was 
placed into a device specially made by the Department of Medical Physics 
(University of Sheffield, UK) (see Figure 2.3 Set rod cutter). The set rod cutter 
took the exact measurement of the length of the tube, i. e. 1.0 mm, 2.0 mm, 3.0 mm, 
and 4.0 mm. 2.0 mm lengths. A scalpel was used to cut rods. The rods were cured 
for at least 5 hours at 37 DC at 100 % relative humidity. The rods were then 
autoclaved for 20 minutes and returned to room temperature and stored overnight at 
100 % humidity in an incubator (HarvardlL TE) until surgical implantation. 
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2.2.4 b) Formulation of wet cements for surgical implantation 
Glasses and poly(acrylic) acid were weighed out into clean bijou plastic bottles and 
y-irradiated (Swann Morton, Sheffield, UK) a few weeks prior to the day of 
implantation. ICs were produced using the same ratio for wet implants as that for 
set rods, i.e. 
1.0 g Glass 
0.2 g Poly(acrylic) acid, 
0.3 ml Sterile non-pyrogenic water 
with the exception of LG23 as this was tested with the above quantities and with 
0.2 ml of sterile non-pyrogenic water (high powderlliquid ratio) as osseointegration 
in varying powderlliquid ratios was investigated. 
All contents were mixed just prior to implantation and were placed into dental 
tubing (Odus Full Tuben-transparent, Zurich, Switzerland) where the end of the 
tube was snipped ofT and the wet cement was squeezed into the drilled hole of 1.0 
mm in diameter and 2.0 mm in length. The remaining procedure was the same as 
that for set rod implantation. 
2.2.4 c) Surgical Implantation 
The Animal (Scientific Procedures) Act 1986 provided for the licensing of 
experimental and other scientific procedures carried out on 'protected animals'. The 
act aimed to provide the maximum protection for laboratory animals without 
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unnecessarily hindering biomedical research. The person applying the 'regulated 
procedures' held a personal licence. For the work carried out in this thesis the 
personal licence was Home office approved and given the following personal licence 
number PIL 5003510. The procedures must be part of a programme of work 
authorised by a project licence. The Home office approved project licence number 
for the work carried out in this thesis was PPL 50 01281. No work was done until 
the procedure, the animals used, and the place where the work was done, were 
specifically authorised by the Home Office in both Personal and Project licences. 
The room used for implantation was thoroughly cleaned the day before surgical 
implantation. The surgical drill and all instruments were cleaned and sterilised and 
gas tanks were checked for sufficient amounts ofN02 and O2, For each of the set 
materials used in vivo a single rod was implanted, under anaesthesia (Halothane 2.0 
%, May & Baker, UK) in oxygen 25.0 % and nitrous oxide 75.0 %), into the 
midshaft of the femora of groups of five male weaned (3 weeks) inbred Wistar rats. 
The skin was initially swabbed with Chlorhexidine (OePuy® Healthcare, Leeds, 
UK) left to dry for approximately 1 minute and then with a pair of forceps lifted 
the skin orientating the cut from the the tibia below the tibiafemoral joint (knee) to 
the coxal joint (hip) with a sharp pair of surgical scissors. 
Under saline (0.9 % wlv Sodium chloride intravenous infusion BP, Braun Medical 
limited, Aylesbury, Bucks, UK) irrigation a slow speed 1 mm diameter tungsten 
carbide burr was used to cut a hole matched to the diameter of the implant, through 
one cortex into the marrow space. Implants were placed to lie level with the outer 
surface of the bone penetrating through the cortex into the marrow cavity. The 
overlying periosteum and soft tissues were replaced and the wound sutured using 
vicryl sterile synthetic absorbable sutures (Ethicon, Edinburgh, UK) antibiotics 
were not used and no there was no evidence of inflammation. 
Post-operatively, wounds were inspected to monitor healing and rats were 
maintained on a standard laboratory diet. After 4 weeks,S animals were sacrificed, 
femora removed, fixed in neutral buffered formalin, and decalcified in 4N formic 
acid for one week prior to trimming. Routine histological processing was carried out 
and paraffin wax embedded. Two femurs were fixed in neutral buffered formalin for 
ground sectioning. Two femurs were fixed in 3.0 % Glyceraldehyde for electron 
microscopy. 12 week implants were also carried out for all the radiopaque and 
radiolucent glasses (LG119, LG125, LG130 and LG132) in the rat femora. 
2.2.4 d) Light microscopylHistomorphometry 
Five stepped serial sections 7.0 J..lm thick, each separated by 70.0 J..lm, were cut 
from the implant bed in each femora using a rotary microtome (Leitz 1512, 
Germany), dewaxed by taking the section through a series of xylene and dehydrating 
alcohol's and stained using Harris hematoxylin (Shandon, USA) and eosin Y 
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(Midland Laboratories equipment, Lichfield, Staffordshire, UK), dehydrated 
through alcohol's. cleared in xylol and mounted in DPX. 
The biological response to the different ionomer implants was studied blind to the 
IC by covering the labels by determining the degree of osteoconduction (amount of 
new bone formed adjacent to the implant) IKK and percentage osseointegration (the 
length of bone lim plant interfacial contact), 1119 using the transmission Nikon 
Optiphot 2 microscope linked to an image analyser system (Optimas 4.1, Biosoft, 
USA. The software was then updated to Optimas 5.1, Biosoft, USA. 1995. In 
1996 it was updated to Optimas 5.2, Biosoft, USA). 
2.2.4 e) Using the Optimas Image Analysis software 
The perimeter of the implant and the perimeter of bone in contact with implant was 
drawn using the pointer to obtain the percentage osseointegration. 
Osteoconduction was determined by taking six points at random around the 
perimeter of each ionomeric rod measuring the thickness of new bone formed. The 
degree of osteoconduction being taken as the average thickness of new bone 
produced on the implant surface. An average often sections were analysed to carry 
out measurements for each ionomeric cement to obtain the mean bone thickness for 
lamellar bone. Obliquity has to be taken into account as the measurements of new 
bone was neither completely parallel nor perpendicular to the IC and not all sections 
were perfectly plane therefore obliquity had to taken into account. Fields of 
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interest gave the most sharp, crisp image for analysis of bone-implant interface. 
Statistical analysis was undertaken using the Unistatistical package (University 
software, UK) and by applying Student's t-Test (unpaired) for some of the 
implants and later the t-Test from the Excel 5.0 package was used. 
2.2.4 f) Immunohistochemical detection of bone proteins 
The three set ICs LG2, LG6 and LG23 of the monovalent cation sodium based 
glasses were produced (section 2.2.4a) and were surgically implanted as previously 
described in section 2.2.4c. For each set sodium based glass nine samples were 
implanted. After four weeks, femora were harvested snap frozen in isopentane 
over liquid nitrogen and embedded in carboxymethyl cellulose at -25 0 C. 
Serial cryosections, 1OJ.1m thick, were fixed in neutral butTered formalin, decalcified 
in 20% EDT A and washed in PBS then stained using rabbit polyclonal primary 
antibodies raised against FN (Dako, UK, dilution 1: 100), TN (Chemikon, UK, 
dilution 1 :40), using fluoroisothiocyanate (FrrC) conjugated secondary antibodies 
to visualize the protein raised against rabbit immunoglobulins (lgs). FITC was used 
as a fluorescent label. Monoclonal mouse primary antibody raised against OPN 
(Ohio Hybridoma Bank, USA, dilution I: 100), using FITC conjugated secondary 
antibodies raised against mouse Igs. When the femora was embedded in 
carboxymethylcellulose resin at -25°c the femora may have been slightly slanted in 
the frozen block as a result sometimes sectioning showed that the set Ie implant 
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was part of an oblique transverse section, Not all sections were perfectly plane 
therefore obliquity had to be taken into account. A secondary conjugate was used 
on a secondary site on an antibody as this gives a greater intensity for specific 
proteins such as OPN, FN, and TN coupled by FITC, the fluorescent probe, which 
in this case is fluorescent green under the fluorescence microscope, 
Sections were mounted in DABCO and examined under UV light using a Zeiss 
Axoplan microscope, Micrographs we're taken using Agfa l00ASA colour film. 
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Figure 2.3 Set rod cutter used to cut Ionomeric cement rods (1 mm in 
diameter) covered in medical siliconegrade tubing to tmm, 2mm, 3mm and 4 
mm in lengths. Metal ring device pushes out the Ie rod with the medical 
silicone.grade tubing. 
3. RESULTS 
3.1 Results for Setting! Working Time 
The setting and working time required for the ill vivo surgical placement of ICs for 
use as a bone substitute were studied. The setting time was from the point where 
the glass, poly(acrylic) acid and water were mixed until the IC had successfully set 
in the medical grade silicone tubing or had set in the bone. The working time for wet 
cements was from the point where the glass, poly(acrylic) acid and water were all 
mixed up to the time when the wet IC was implanted into the bone. Results are 
given in Table 3.1 to 3.5. 
Particular results of interest for the working and setting times are added as footnotes 
where appropriate for Tables 3.1 to 3.5. 
Table 301 Working and setting time (s) test for the monovalent cation series of ICs· 
l.SSiOzAI,O) O.SPzO~ (l-Z) CaO O.75CaFzZNazO 
Material Me.1n SO 
LG2 Working Time 84 2.U 
l;o:O Setting Time 9() 3.7 
LG6 Working Time 84 2.1l 
Z=Ool Setting Time 102 (l.9 
LG23 1:0.2:0.3 Working Time 6() 6.7 
Z=Oo15 Setting Time 63 2.1 
LG23 1 :0.2:0.2 Working Time 20 4.2 
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Z=O.IS 
LG63 
Z=O.l 
Setting Time 
Working Time 
Setting Time 
35 U.4 
l)() 1.2 
114 U.5 
Cements were mixed at room temperature at 2UoC. *The data is the arithmetic mean of one analysis 
of each of nine specimem (n=9). 
LG23, with a composition ratio of 1 :0.2:0.2, had the fastest setting time of35 
seconds and the fastest working time of 20 seconds from all the ICs implanted as 
bone cements or bone substitutes. LG63 had the longest setting time of 114 
seconds and the longest working time of 90 seconds for the monovalent cation 
senes. 
Table 3.1 Working and setting time test (S) for the apatite-stoichometric based ICs*. 
(P)Si02(Q)AhO~ 1.5P20~ (5-X)CaO XCaFz 
Material Meml SO 
LG26 X=l Working Time 12U U.7 
Setting Time 15U U.7 
LG27 X-I Working Time 120 U.7 
Setting Time 156 5.7 
LG30 X=O Working Time 156 5.6 
Setting Time 175 7.9 
Cements were mixed at room temperature at 2UoC. *The data is the aritlunetic mean of one analysis 
of each of nine specimem (0= 9). 
LG30 had the longest setting time of 175 seconds and working time of 156 seconds 
for the apatite-stoichiometric based ICs and from all the ICs implanted as bone 
cements or bone substitutes. LG26 had the shortest setting time for this series of 
150 seconds, and the shortest working time of 120 seconds. 
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Table 1.1 Working and setting time test (S) for the mdiopaque strontium based les* 
4.5Si02 3.0Ah 0) 1.5P2 O~ (l-X) CaO 2.0CaF2 xSrO 
Material Mean SD 
LG1l9 Working Time 90 1.2 
X-I.S Setting Time 93 3.6 
LG12S Working Time 78 2.4 
X-l.O Setting Time 90 0.7 
Cements were mixed at room tempemture at 20°e. *The data is the aritlunetic mean of one analysis 
of each of nine specimens (n= 9). 
For the radiopaque ICs LG 125 had a shorter setting time of 90 seconds and working 
time of 78 seconds. 
Table 1.4 Working and setting time test (S) for the zinc based ICs* 
4.SSi0z3.0AhO) I.SP20~ (3-X) CaO 2.0CaF2XSrO 
Material Me.1n SD 
LG130 Working Time 81 1.4 
X-I.S Setting Time 84 n.7 
LG132 Working Time 73.2 n.s 
X=O.7S Setting Time I)(). () n.4 
Cements were mixed at room temperature at 20°C. *The data is the aritlunetic mean of one analysis 
of each of nine specimens (0= 9). 
For the zinc based ICs LG 132 had the longest setting time. LG 130 llc1d a longer working time than 
LG132. 
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Table 3.5 Working and setting time test (S) for the acrylic cement (control)* 
Material 
Acrylic Working Time 
Setting Time 
Mean 
5CMI 
540 
so 
0.6 
0.8 
Cements were mixed at room temperature at 2()OC. *The data is the aritlunetic mean of one analysis 
of each of nine specimens (n= 9). 
The acrylic cements had the longest setting time of 540 seconds and the longest 
working time of 500 seconds to implant into the femur. 
Ideally, when formulated for use as a bone cement ICs should mix to a paste which 
can be loaded into a syringe and encapsulated for injection placement. 
Encapsulation and machine mixing would help to standardise the mix and is usually 
more rapid than hand mixing in effect allowing for a longer placement time. At 
delivery the IC should be of sufficiently high viscosity not to flow at the shear 
stresses employed in manipulation/placement. preventing undue spreading of 
material and enabling accurate placement at the implant site. Once placed, 
contamination by body fluids e.g. blood would rapidly occur so a snap set is 
required. In achieving the above aims the mixing times are not critical but should be 
of sufficient length to allow manipulation. Under simulated surgical conditions this 
was in the order of 200 seconds, which is close to the setting time ofLG30 (Table 
3.2). However, the actual setting time needs to be known accurately so that 
placement can be timed to be followed immediately by a snap set. LG30 having the 
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longest working and setting time. and LG23 with a composition ratio of 1 :0.2:0.2 
with the least working and setting time. 
3.2 In vitro experiments 
3.2.1 Ion release studies 
(a) Fluoride by ion selective electrode 
A fluoride ion selective electrode was used to measure the concentration of ions 
released from the set discs of Ie (see Section 2.2.1). Fluoride release data from all 
fonnulations examined are summarised in Table 3.6 to 3.17 on the following pages. 
Particular areas of interest of fluoride ion release data are added as footnotes where 
appropriate in Tables 3.6 to 3.17. 
Table 3.6 Fluoride ion release (Jlmol gel) from discs of ion orne ric cements from the 
monovalent cation series. 1.5Si<h Ah <h O.5P20\ (l-Z) CaO O.75CaF1 ZNaaO 
Material Time (d) 
3 5 7 W 14 21 42 84 
lO2 z=o 0.7 m 0.8 SA na III 28.4 43.2 6().l 
lO3 Z=O 2.9 5.6 7.8 9.6 11.7 13.9 15.2 19.5 m 
L04 Z=O.02SNa m m III 13.6 '1.1 nil 26.1 39.3 53.1 
LOS Z=O.OSNa na III III 20.1 Oil III 36.7 52.7 69.() 
LG6 Z=O.lNa III III III 27.1 na III 48.3 66.4 83.8 
lO7 Z=O.02SK m m III 11.6 III na 22.4 36.4 50.4 
lOB Z=O.OSK m m m 16.2 III III 30.3 46.6 63.6 
lOlO Z=O.OI2SNalKm m m 12.6 na III 22.9 35.4 49.7 
LGI lZ=O.OSNalK m III m 17.3 na III 33.3 49.1 64.8 
lO22 Z=O.OSK 3.1 5.2 8.2 9.1 W.4 12.3 14.4 18.6 22.8 
L02l Z=O.ISNa 6.2 11.9 17.9 20.1 23.8 29.3 35.2 46.0 na 
LG6l Z-o.2Na 8.8 17.2 25.1 28.7 33.4 38.5 46.3 64.6 m 
LG6S Z=O.INa 2.8 5.U 6.8 8.3 W.2 12.3 15.5 21.7 III 
LG66 Z=O.2 Na 3.0 5.8 8.0 9.5 11.6 14.1 17.1 25.8 III 
LG67 Z=O.3 Na 3.3 6.U 7.8 9.6 12.0 14.7 19.0 26.6 III 
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LG68 Z=OA Na 4.7 s.O w.o 12.0 1-t.7 IR.O 22.0 30.0 na 
LG69 Z=O.SNa 9.3 17.0 25.0 30.0 37.0 45.0 56.0 78.0 na 
W70 Z=O.4SNa 5.0 9.0 B.O IR.O 20.0 24.0 3().() 41.0 na 
Data obtained from discs (20 mm by 2 mm ) in SO ml water at 37°C •. Release data is the 
aritlunetic mean of one analysis of each of six specimens. The standard deviation did not exceed 
10010 . 
• Analyses perfonned in presence of TISAB III buffer to give total fluoride concentration. 
na-Not applied-reading was oot taken as there was no sample 
LG69 released the greatest amount of fluoride to 42 days, however LG22 eluted the least amount of 
fluoride up to the same time period. 
Detection limits of fluoride ion selective electrode were 10 ppm to 100 ppm. 
Figure 3.1 to Figure 3.3 illustrate increasing fluoride ion release and a positive 
relation with sodium glass content with the exception of 0.2 -0.3 mole fraction of 
sodium oxide glass content, where fluoride release decreases (Correlation coefficient 
of sodium glass content and fluoride release at day 1=0.56, day 7=0.49 and at day 
21 =0.33). This relation is persistent up to 21 days. This decrease in fluoride 
release would be an error in fluoride ion measurements as after 0.3 mole fraction of 
sodium oxide glass content fluoride release increases as shown in Figure 3.1 to 
Figure 3.3. 
There is also a relation between fluoride ion release and potassium glass content (see 
Table 3.6, however a wider range of potassium glass concentrations were required 
for adequate plots). Hence, sodium and potassium increase release of fluoride. 
Figure 3.4 illustrates increasing fluoride ion release from LG26 during 42 days 
showing a positive relation between fluoride ion release and time with a correlation 
coefficient of 0.97. 
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Figure 3.1 Fluoride ion release of varying compositions of Sodium 
based ICs at day 1. Linear regression, y=9,45x+O. Correlation 
coefficieot=O.56 (0=6). 
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Figure 3.2 Relation of Sodium glass composition 
and Fluoride ion release at 7 days. Linear 
regression, y=52.1x+5. Correlation 
coefficient=O.49 (n=6). 
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Figure 3.3 Relation between Sodium glass composition and 
Fluoride ion release at 21 days. Linear regression, y=93.01x+29. 
Correlation coefficient=O.33 (n=6). 
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Figure 3.4 Fluoride ion release of LG26 upto a period of 42 days 
Linear regression, y=O.59x+(-1). Correlation coefficient=O.97 
(n=6). 
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Table 3.7 Fluoride ion release (J..lmol gol) over time from discs of ion orne ric 
cements from the apatite stoichiometric series (Ca:P-l.66 ). 
(P)Si02 I.SP2 OS (Q)Ah 0 3 (S-X) CaO XCaF1 
Material Time (d) 
3 5 7 21 42 
LG26X-l.O 0.1 5.0 5.2 9.8 18.4 26.0 
LG27X-l.O na 2.3 na 4.3 7.3 11.3 
LG28 X==O.5 na 1.2 m 2.3 4.0 6.4 
LG29 X=O.15 m 1.0 m 1.1) 3.U 4.7 
LG30X=O na (U15 m 0.01 0.2 u.2 
Data obtained from discs (20 mm by 2 mm) in So tnl water at 37"C *. Release data is the 
aritlunetic mean of one analysis of each of six specimens. The stand.1rd deviation did not exceed 
10%. 
* Analyses performed in presence ofTiSAB III buffer to give total fluoride concentrntion. 
na-Not applied-reading was not taken as there was no sample. 
LG26 released the greatest amount of fluoride to 42 days, however LG30 eluted the least amount of 
fluroide up to the same time period. Detection limits of fluoride ion selective electrode were 10 ppm 
to 100 ppm. 
There was a positive relation between fluoride glass content and fluoride ion release 
as shown in Figure 3.S where the relation has a correlation coefficient of 1. This 
indicates a strong relation between the two parameters and that fluoride ion release 
is dependent on fluoride glass content. 
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Figure 3.5 Relation between Fluoride glass 
composition and Fluoride ion release at 42 days. 
Linear regression, y=12.5x+O. Correlation 
coefficient=l (n=6) 
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Table 3.8 Fluoride ion release (J.1mol gol ) over time from discs of i onom eric 
cements from the series varying in calcium fluoride. 
l.5Si02 l.OAIzO) O.5P20s l.OCaO XCaF1 
Material Time (d) 
1 3 5 7 HI 14 21 42 84 
LG4SX-o 0.2 0.3 1.1 1.2 1.2 1.2 1.3 1.4 1.4 
LG44 X=O.15 2.0 5.0 7.4 8.0 8.0 8.2 9.0 11.0 11.5 
LG3 X-o.S 2.9 5.6 7.8 9.6 11.7 13.9 15.2 19.5 III 
LG26 X=O.67 0.1 5.0 5.2 9.8 na na 18.4 26.0 III 
LG2X=O.7~ 0.7 na 0.8 S.4 na na 28.4 43.2 60.1 
LG42 X-=1.0 6.0 11.(1 IS.7 17.7 20.-' 23.2 26.1 35.0 43.8 
Data obtained from discs (20 mm by 2 mm ) in SO ml water at 37"C *. Release data is the 
arithmetic mean of one analysis of each of six specimens. The standmd deviation did not exceed 
HI%. 
• Analyses perfonned in presence ofTlSAB III buffer to give total fluoride concentration. 
LG42 released the greatest amount of fluoride to 42 days. I¥.l\vever LG4S eluted the least amount of 
fluoride up to the same time period. Detection limits of fluoride ion selective electrode were 10 ppm 
to l(K) ppm. 
Table 3.9. Fluoride ion release (J.1mol gol) over time from discs of ionomeric cements 
from the series varying in silica:alumina and calcium. 
Material Time (d) 
(SiOz:AIzO):CaF z) 1 3 S 7 10 14 21 42 84 
LOS) (4.5:3.0:2.0) 4.5 7.9 12.3 14.0 17.5 19.6 25.6 36.0 45.11 
LOS4 (6.0:4.0:1.0) 1.2 2.7 3.7 4.6 5.K 6.3 8.2 12.2 16.3 
LOSS (6.75:4.5:0.5) 0.6 1.6 2.2 2.K 3.4 3.7 4.8 6.5 8.4 
LOS6 {7.115:4.75:11.25)O.3 0.7 0.9 1.2 1.4 1.6 2.1 2.S 3.6 
LOS7 (7.5:5.1I:0) 0 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < O.t < 0.1 < O.l 
L072 (6.0:4.11:2.0) 3.6 7.0 9.0 11.11 D.O 15.0 IS.O 24.0 III 
L07J (7.5:5.0:1.0) 1.7 3.5 4.5 5.7 6.7 7.9 10.1 12.9 m 
L074 (1.25:5.5:0.5) O.S I.S 1.9 2.3 2.7 3.2 4.1 5.4 m 
LG7S (11.625:5. 75:fI.Z5)O. 3 0.7 1.0 1.4 1.6 1.9 2.5 3.3 m 
Data obtained from discs (20 mm by 2 mm ) in 50 ml water at 37"C *. Release data is the 
arithmetic mean of one analysis of each of six specimens. The standard deviation did not exceed 
10%. 
* Analyses perfonned in presence ofTlSAB III buffer to give total fluoride concentration. 
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na-Not applied-reading was not t.1ken as there was no sample 
LGS3 released the greatest amount of fluoride to ~2 days. however LGS7 eluted the least amount of 
fluoride at the same time period. Detection limits of fluoride ion selective electrode were 10 ppm to 
100 ppm. 
Table 3.10 Fluoride ion release (J.lmol gol ) over time from discs of ionomeric 
cements from the series varying in silica:alumina ratio based . 
Material Time (d) 
SiOz:AlzOl 3 S 7 to 14 21 42 
L077 (6.25:3.75) 1.7 3.3 4.7 S.6 6.7 7.S 8.9 11.4 
L078 (6.5:3.5) 1.1 1.9 2.9 3.6 ~.4 5.2 6.S 8.9 
L080 (6.7:3.3) I.S 2.8 4.1 5.3 6.6 7.9 W.O n.o 
LOSI (6.75: 3.15) 1.8 3.0 4.4 S.6 7.1 8.3 W.O IS.0 
Data obtained from discs (20 mm by 2 mm ) in 50 ml water at 37"C *. Release data is the 
aritlunetic mean of one analysis of each of six specimens. The standard deviation did not exceed 
10%. 
* Analyses perfonned in presence of TISAB III buffer to give total fluoride concentration. 
LGS1 released the greatest amount of fluoride to 42 days. however LG78 eluted the least amount of 
fluoride at the same time period. Detection limits of fluoride ion selective electrode were 10 ppm to 
100 ppm. 
Table 3.11 Fluoride ion release (J.lmol gol) over time from discs of i onom eric 
cements from the series varying in generic compositions derived from the apatite-
stoichiometric based glass LG26. 
Material Time (d) 
SiOZ:Pl0~:CaO 3 5 7 10 l~ 21 42 
L026 (4.5:1.5:3.11) 0.1 S.U 5.2 9.8 na na 18.4 26.0 
L083 (4.1:1.7:1.8) 2.2 3.9 5.4 6.7 S.4 lO.1 12.4 17.2 
LG84 (3.7:1.9:1.6) 3.1 6.4 9.4 12.1 15.3 IS.I 22.6 28.6 
LOSS (3.3:l.1 :1.4) 2.6 4.6 6.2 7.4 S.6 9.9 11.8 14.7 
Data obtained from discs (20 mm by 2 mm ) inS() ml water at 37"C *. Release data is the 
aritlunetic mean of one analysis of each of six specimens. The standard devi.1tion did not exceed 
to%. 
* Analyses perfonned in presence ofTISAB III buffer to give total fluoride concentrntion. 
LGS4 released the greatest amount of fluoride to 42 days. I¥>wever LGSS eluted the 1e.1st amount of 
fluoride at the same time period. Detection limits of fluoride ion selective electrode were In ppm to 
}(K) ppm. 
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There was a relation between fluoride ion release and phosphorus pentoxide. 
however the graph was not adequate enough to submit as there was an error with 
LG84 (1.9P20s) fluoride ion measurements which gave a correlation coefficient of-
0.43 (and linear regression=11.6). 
Table 3.12 Fluoride ion release (J..lmol g') ) over time from discs of ion orne ric 
cements from the calcium based series . 
Material Time (d) 
CaO:CaFz 3 5 7 10 14 21 42 
LG26 (3.0:2.0) 0.3 5.0 5.2 9.X na na 18.4 26.0 
LG95 (2.8:2.2) 6.4 8.9 12.8 15.9 20.0 24.9 30.6 39.0 
LG96 (2.6:2.4) 4.8 9.1 12.2 14.8 HUI 22.2 27.5 35.5 
LG97 (2.4: 2.6) 4.9 8.5 11.3 13.3 16.0 11) .0 23.5 21.6 
LG98 (2.2: 2.8) 5.6 9.8 l3.o 15.7 19.4 28.8 29.3 38.3 
LG99 (2.0: 3.0) 5.0 9.2 12.6 14.8 17.8 21.3 26.7 35.0 
Data obtained from discs (20 mm by 2 mm ) in 50 lUI water at 37"C *. Release data is the 
aritlunetic mean of one analysis of Cc1ch of six specimens. The stand.1rd deviation did not exceed 
10% . 
• Analyses perfonned in presence ofTiSAB III buffer to give total fluoride concentration. 
LG95 released the greatest amount of fluoride to 42 days. however LG97 eluted the least amount of 
fluoride at the same time period. Detection limits of fluoride ion selective electrode were 10 ppm to 
100 ppm. 
Table 3.13 Fluoride ion release (J..lmol g.l ) over time from discs of ionomeric 
cements from the LG2 and LG26 in a.-MEM . 
Material 
CaFz 
LG2 (0.75) 
LG26 (2.0) 
I 
0.3 
2.7 
Time (d) 
5 
0.7 
3.2 
7 
4.7 
6.6 
Data obtained from discs (20 mm by 2 mill) in 50 1111 water at 37"C *. Release de1ta is the 
aritiunetic mean of one analysis of Cc1ch of six specimens. The standard deviation did not exceed 
10%. 
* Analyses perfonned in presence of TlSAB III buffer to give total fluoride concentration. 
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LG26 released the greatest amount of fluoride to 7 days in a-MEM. however LG2 eluted the least 
amount of fluoride to the same time period. Detection limits of fluoride ion selective electrode were 
10 ppm to IO() ppm. 
Table 3. 14 Fluoride ion release (Jlmol g-I ) over time from discs of glass ionomeric 
cements controls. 
Material 
Chemfll 
Chemfll Express 
Water 
a-MEM 
4().4 
8.7 
() 
n 
3 
73.7 
lS.0 
In 
113 
Time (d) 
5 7 
lOo.n l1S.0 
21.4 2S.7 
0 0 
() 0 
10 14 21 42 
13S.0 169.0 192.0 273.() 
31.3 37.9 46.S 63.4 
In In In III 
na 113 113 na 
Data obtained from discs (20 mm by 2 mm ) in 50 Illi water at 37"C *. Release dc1ta is the 
arithmetic mean of one an.1lysis of each of six specimens. The standard deviation did not exceed 
10% . 
• Analyses performed in presence of TlSAB III buffer to give total fluoride concentration. 
na-Not applied-reading was not taken as there was no Sc1mple. 
The commerciallC Chemfil released the greatest anlOunl of fluoride to 42 days. however Chemfil 
Express eluted less fluoride to the same time period. Detection limits of fluoride ion selective 
electrode were )() ppm to UK) ppm. 
Table 3. 15 Fluoride ion release (Jlmol g-l ) over time from discs of autoclaved 
ionomeric cements. 
Material Time (d) 
(KzO:CaFz) 3 7 21 42 
LG7 (0.015:0.75) 6.9 11.3 B.2 23.5 
LG7 Autoclaved 3.5 S.79 10.6 15.3 
LG8 (0.05: 0.75) 113 16.2 3n.3 ~6.6 
LG8 Autoclaved 3.4 5.S 9.1) 13.6 
LG26 ( 0:1.0) S.O 9.8 IK.4 2o.n 
LG26 Autoclaved 4.6 8.7 16.1 2~.() 
Data obtained from discs (20 mm by 2 mm ) in so ml water at 37"C •. Release data is the 
aritlunetic mean of one analysis of each of six specimens. The standard deviation did not exceed 
100/0 . 
• AnalYSes performed in presence ofTlSAB III buffer to give total fluoride concentration. 
Autoclaved LG26 released the greatest alllOunt of fluoride to 42 dews. however autoclaved LG8 
eluted the least amount of fluoride to the Sc1me time period. Detection limits of fluoride ion selective 
electrode were HI ppm to UK) ppm. 
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Table 3. 16 Fluoride ion release (J,lmol g.l) over time from discs of monovalent 
cation based series. 1.5 Si02AI20 JO.5 P20J (I.O-Z) CaO O.75CaF2ZNazOlKzO 
Material 
WlZ-O 
W4Z-O.015 
W5z-o.05 
W6z-o.1 
W77J- 0.015 
WSz-o.05 
WIO z-o.OU5Io.OUS 
Wll z-cL05IO.115 
7 
12.5 
13.8 
19.7 
31.0 
15.0 
2U.7 
16.9 
19.3 
21 
28.4 
26.3 
37.U 
54.5 
26.7 
35.8 
28.3 
36.1 
Time (d) 
42 84 
44.1 60.9 
38.9 52.0 
52.2 67.8 
72.4 89.6 
4U.U 53.8 
51.1 66.7 
40.7 54.0 
51.0 66.1 
Data obtained from discs (2U nun by 2 mm ) in 50 Illi water at 37"C. Release data is the arithmetic 
mean of one analysis of each of six specimens. The standard deviation did not exceed 10%. 
LG6 released the greatest amount of free fluoride up to K4 days. however LG4 eluted the least 
amount of free fluoride to the same time period. Detection limits of fluoride ion selective electrode 
were 10 ppm to 100 ppm. 
Table 3. 17 Fluoride ion release (J,lmol g.l) over time from discs of apatite 
stoichiometric based series. (P)Si02 1.SP20~ (Q)AI2 OJ (5-X)CaO XCaF1 
Material Time (d) 
3 7 21 42 
LG26X-l.O 4.2 7.4 13.5 20.2 
LG27 X-I.O 2.S 4.4 7.7 11.4 
LG28X-o.5 1.3 2.4 4.2 6.S 
LG29 X-o.15 0.9 1.7 3.1 4.6 
LG3()X-o 0.1 U.S U.S 0.6 
Data obtained from discs (2U nun by 2 mm ) in SO ml water at 37"C. Release data is the arithmetic 
mean of one analysis of each of six specimens. The standard deviation did not exceed to%. 
LG26 released the greatest amount of free fluoride to 42 days. however LG3U eluted the least amount 
of free fluoride to the same time period. Detection limits of fluoride ion selective electrode were 1 () 
ppm to ilK) ppm. 
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(b) Sodium by ion selective electrode 
A sodium ion selective electrode was used to measure the concentration of ions 
released from set discs ofIe (see section 2.2.1). Sodium release data from all the 
formulations examined is summarized in Tables 3.18 to 3.19 on the following pages. 
Particular results of interest of sodium ion release are added as footnotes in Tables 
3.18 and 3. 19. 
Table 3. 18 Sodium ion release (Jlmol g-l ) over time from discs of ionomeric 
cements of the monovalent cation series. 
Material Time (d) 
7 21 42 H4 
LG2Z=O 3.1 4.9 5.1 5.1 
LG4 boO.015N a 7.5 16.0 2().8 22.9 
LG5 Z=O.05Na 9.1 9.1 25.5 2K.R 
LG6Z=O.lNa 9.2 23.1 4().2 51.2 
LG7 Z=O.025K 4.0 5.2 5.H 5.1) 
LG8 Z=C1.05K 3.4 5.3 5.7 5.H 
LGIO Z=O.Ol25NaIK 7.6 ILl 14.2 IS.() 
LGll Z-O.05NaIK 8.0 14.() 17.7 19.2 
Data obtained from discs (20 mm by 2 mm) in 50 ml water at 37"C *. Release data is the 
aritJunetic mean of one analysis of each of six specimens. The standard deviation did not exceed 
HI%. 
* Analyses perfonned in presence of sodium ionic strength adjustor (ISA) buffer to keep a constant 
background ionic strength and adjust pH. 
LG6 released the greatest amount of sodium up to R4 days. however LG2 eluted the least amount of 
sodium up to the same time period. Detection limits of sodium ion selective electrode were In ppm 
to 100 ppm. 
There was a positive relation between sodium glass content and sodium ion release 
as can be shown in Figure 3.6, with a correlation coefficient of 0.99 and linear 
regression of 543.4. This indicates that sodium ion release was dependent on 
sodium glass content. 
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Figure 3.6 Relation between Sodium glass content and Sodium 
ion release at 84 days. Linear regression, y=543.4x+5. 
Correlation coefficient=O.99 (n=6) 
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Table 3. 19 Sodium ion release (Jlmol gO') over time from discs of ionomeric 
cements of the apatite stoichiometric based series. (P)Si02 1.5P2 Os (Q)Ah 0 3 (5-X) 
CaOXCaFz 
Material Time (d) 
3 7 21 42 
LG26 X=2.0 6.4 9.3 14.4 17.3 
LG27 X=1.0 35.6 36.8 40.6 43.6 
LG28X=O.5 19.8 20.S 24.5 27.1) 
LG29 X=O.25 35.2 37.4 31).5 41.X 
LG30 X=O 16.9 18.6 25.0 25.7 
Data obtained from discs (20 mm by 2 mm ) in 50 ml water at 37"e *. Release data is the 
arithmetic mean of one analysis of each of six specimens. The stamL1rd deviation did not exceed 
10% . 
• Analyses perfonned in presence of ISA to keep a constant background ionic strength and adjust 
pH. 
LG27 released the greatest amount of sodium to 42 days, however LG26 eluted the least amount of 
sodium to the same time period. Detection limits of sodium ion selective electrode were to ppm to 
l(Kl ppm. 
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(c) Potassium by atomic absorption spectroscopy 
Atomic absorption spectroscopy was used to measure the concentration of ions 
released from set discs of IC ( see section 2.2.2). Potassium release data from all the 
fo~ulations exam~ned is summariz~d in. Tables 3.20 to 3.21 on the following pages. 
Particular areas of mterest of potassIUm Ion release results are added as footnotes in 
Tables 3.20 and 3.21. 
Table 3. 20 Potassium ion release (J.1mol g.1 ) over time from discs of ionomeric 
cements of the monovalent cation series. 
1.5Si02 Ah 0 3 O.5P2 Os (I-Z) CaO O. 75CaF2 ZNaz 0 
Material Time (d) 
7 21 42 84 
LG2 Z=O 0.3 0.6 0.7 0.7 
LG4 Z=O.025Na 0.1 0.2 0.3 0.-' 
LGS Z=O.05Na 0.1 0.2 0.3 0.3 
LG6 Z=O.INa (1.1 0.1 0.2 0.3 
LG7 Z=O.025K 5.2 8.5 11.7 14.0 
LG8 Z=OO5K 7.1 13.9 19.9 24.6 
LGlO Z=O.()125NalK2.6 4.5 5.7 6.6 
Data obtained from discs (20 mm by 2 mOl) in 50 Illl water at 37"C. Release data is the arithmetic 
mean of one analysis of each of six specimens. The standmd deviation did not exceed l()O/e. LG8 
released the greatest amount of potassium to 84 d~lYS. however LG6 and LGS eluted the least amount 
of potassium to the same time period. Detection limits of pot~lssium ion selective electrode were 1 
ppm to 10 ppm. 
Table 3.21 Potassium ion release (J.1mol g,l ) over time from discs of ionomeric 
cements of the apatite stoichiometric based series. (P)Si02 1.5P2 Os (Q)Ah 0 3 (S-X) 
CaOXCaF2 
Material Time (d) 
7 21 42 84 
LG26 X=2.U 1.0 1.7 2.3 2.K 
LG27 X=1.0 1.2 1.8 2.4 2.8 
LG28 X= 0.5 1.2 1.6 1.9 2.1 
LG29 X=0.25 1.6 2.2 2.6 3.0 
LG30 X=(l 1.6 2.1 2.4 2.7 
Data obtained from discs (20 mm by 2 mm) in SO lUI water at 37"C. Release data is the arithmetic 
mean of one analysis of each of six specimens. The standard deviation did not exceed 10%. LG29 
released the greatest amount of potassium to 84 days. however LG21t eluted the least amount of 
potassium to the same time period. Detection limits of sodium ion selective electrode were I ppm to 
10 ppm. 
{d} Aluminium bI atomi( absorl!tion sl!ectros(ol!I 
Atomic absorption spectroscopy was used to measure the concentration of ions 
released from set discs ofIC ( see section 2.2.2). Aluminium release data from all 
the formulations examined is summarized in Tables 3.22 to 3.27 on the following 
pages. Particular areas of interest are added as footnotes where appropriate. 
Table 3.22 Aluminium ion release (nmol g.1 ) over time from discs of ionomeric 
cements of the monovalent cation series (Na+ and K+). 
1.5Si02Ah030.5P20s(I-Z) CaO O.75CaF2ZNal0 
Material Time (d) 
3 5 7 10 14 21 42 
1..02Z-O m m m 0 m m n.2 n.4 
1..03 z-o <0.1 <OJ <0.1 <0.1 n .1 (l.1 0.1 0.2 
1..04 Z-O.015Na m m m <(l.1 m m n.3 n.3 
LGS=O.05Na m na m (l.2 m na n.1 0.5 
LG6=O.INa m na m <0.1 na na OJ n.3 
1..07=O.015K m na na <(l.1 m na n.3 n.3 
1..OK=O.OSK na na na 0.1 na na 0.1 n.s 
LG IOsO.0115NIlIK na na na n na na n.1 n.2 
LG 11 =O.OSNIlIK m m na n.1 m m n.2 n.S 
LG23=O.15Na <n.1 <n.1 n.1 n.1 n.3 (l.3 n.4 n.6 
LG63=O.lN. <n.1 <n.1 n.2 n.2 n.4 (l.5 n.6 n.9 
LG6S=O.INa <n.1 <n.l <n.1 <(1.1 0.1 (1.2 n.2 n.3 
LQ66=O.2Na <n.l <n.1 0.2 (l.2 0.2 (l.3 (l.3 n.4 
LG67=O.3Na <n.t n.t (l.2 (l.3 OA (I.s (I.S (l.9 
LG6K=O.4N. <().I n.2 0.4 n.6 n.7 n.9 1.2 1.5 
LG69=O.5N. O.l 0.3 0.6 0.9 . 1.4 1.6 2.1 2.6 
LG70-0.45N. 0.1 0.2 0.5 n.s 1.2 1.4 1.8 2.3 
Data obtained from discs (2n mm by 2 mm ) ill SO ml water at :n"C. Release dc1ta is the arithmetic 
mean of one analysis of each of six specimens. The stalldmd deviation did not exceed 101!!.,. 
na-Not applied-reading was mt taken as there was no smnple 
LG69 released the greatest amount of aluminium to 42 days. however LG22 eluted the least amount 
of alumium to the same time period < n.1 ImlOl g'l. Detection limits of the AAS for aluminium 
were (1.1 ppm to I ppm. 
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Figure 3.7 to Figure 3.9 illustrate aluminium ion release and its positive relation with 
sodium and potassium solubilising ions from monovalent cation glasses at various 
time lengths. Figure 3.7 shows a positive relation of aluminium ion release and 
sodium glass content with a correlation coefficient of 0.97 (n=6). Figure 3.8 shows 
a positive relation between aluminium ion release and sodium glass content with a 
correlation coefficient of 0.96 (n=6). Figure 3.9 shows a positive relation between 
aluminium ion release and potassium glass content with a correlation coefficient 
=0.87 (n=6). Figure 3.10 shows an increase in aluminium ion release ofLG26 up to 
a period of 42 days showing a relation between aluminium ion release and time as it 
has a correlation coefficient of 0.82 
LG26 released the greatest amount of aluminium to 42 days with 0.2 nmol g"1 . 
LG28, LG29, and LG30 eluted the least amount of aluminium at the same time 
period i.e. < 0.1 nmol g"l. Detection limits of the AAS for aluminium were 0.1 ppm 
to 1 ppm. Data was obtained from discs (20 mm by 2 mm ) in 50 ml water at 37()C . 
Release data is the arithmetic mean of one analysis of each of six specimens. The 
standard deviation did not exceed 10%. 
LG42 of the series varying in calcium fluoride released the greatest amount of 
aluminium to 42 days i.e. 0.3 nmol gol. However, LG44 and LG4S eluted the least 
amount of aluminium to the same time period ie < 0 1 nmol gO" Detection limits of 
the AAS for aluminium were 0.1 ppm to I ppm Data was obtained from discs (20 
mm by 2 mm ) in SO ml water at 37"C . Release data is the arithmetic mean of one 
analysis of each of six specimens The standard deviation did not exceed 1 0%. 
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Figure 3.7 Relation between Aluminium ion release and Sodium 
glass composition at 7 days. Linear regression, y=O.67x+O. 
Correlation coefficient=O.97 (n=6) 
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Figure 3.8 Relation between Aluminium ion release and Sodium 
glass composition at 21 days. Linear regression, y=3.89x+O.22. 
Correlation coefficient=O.96 (n=6) 
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Figure 3.9 Relation between Aluminium ion release and 
Potassium glass composition at day7. Linear regression,y= 
2.32x+0.09. Correlation coefficient= 0.S7 (n=6). 
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· Figure 3.10 Aluminium ion release of LG26 up to a period of 
42 days. Linear regression, y=O.032x-0.OS. Correlation 
coefficieot=O.82 (0=6) 
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Table 3.23 Aluminium ion release (nmol g-I) over time from discs of ion om eric 
cements from the series varying in silica alumina and calcium. 
Material Timc (d) 
(SiOz:AIzOJ:CaF 1)1 3 5 7 10 14 21 42 
LGS3 (4.5:3.0:1.0) <().I <0.1 <0.1 0.2 02 11.2 0.3 0.4 
LGS4 (6.0:4.0:1.0) <().I <0.1 <0.1 <(1.1 <11.1 <(1.1 0.1 0.2 
LG72 (6.0:4.0:1.0) 0 <11.1 <0.1 <(1.1 (II 112 0.2 0.3 
Data obtained from discs (20 mm by 2 mm ) in 5(1 Illi water at 37°C. Release data is the arithmetic 
mean of one analysis of each of six specimcns. The standard dcviation did not exceed W%. 
LOS3 released the greatest mnount of aluminium to 42 days. howeycr LG55. LG56. LG57. LG74 
and L075 eluted the least amounl of aluminium to thc samc limc period i.e. < 11.1 mool g' •. 
Detection limits of the AAS for aluminium wcre (I I ppm to I ppm 
Table 3.24 Aluminium ion release (nmol g-I ) over time from discs of ion om eric 
cements from the series varying in silica alumina ratio based . 
Material 
L080(6.7:3.3) 0.2 
L081 (6.75:3.1~) 11.1 
3 
0.3 
11.2 
5 
11.3 
112 
Timc (d) 
7 
111 
02 
14 
01 
02 02 
21 
0.4 
11.3 
11.4 
11.3 
Data obtained from discs (20 mOl by 2 nUll) in 50 ml water at H"C. Release d,1ta is the arithmetic 
mean of one analysis of each of six specimcns. Thc standard dcviation did not exceed W%. 
LG80 released the greatest amount of aluminium to 42 days. howcycr LG77 and LG7K eluted the 
least amount of aluminium to the samc timc period ie < 0 I nmol g' •. Detection limits of the AAS 
for aluminium were 0.1 ppm to I ppm. 
Table 3.25 Aluminium ion release (nmol g-I) over time from discs of ion om eric 
cements from the series varying in generic compositions derived from the apatite-
stoichiometric based glass LG26 
Material Timc (d) 
SiOz:p,O,:CaO 3 S 7 10 14 21 42 
LG26 (4~: 1.5:J.CI)O 11.1 o I III o I o I 01 11.2 
LG83 (4.1:1.7:1.1)<0 I <0.1 II I II I II I 02 0.2 (1.3 
LGM (3.7:1.9:1.6)0.1 0.2 112 1I'l 111 114 04 liS 
L08S (3.3:1.1:1A)II.2 11.3 II 1 II 'l 04 0.4 11.4 04 
-- ---~- .--~-
1)2 
Data obtained from discs (20 mOl by 2 mm ) in 50 Illi water at 17"C. Release data is the arithmetic 
mean of one analysis of each of six specimens. The standard dcnation did not exceed J()'y' •. 
LG84 released the greatest amount of aluminium to ~2 days. howe"er LGR1 eluted the least amolUlt 
of aluminium to the same time period. Detection limits of the AAS for aluminium were 0.1 ppm to 
1 ppm. 
There was a positive relation between aluminium ion release and phosphate glass 
content. For example a phosphate mole fraction of 2.1 gave a high amount of 
aluminium ion release i.e. 0.2 nmol/g. However, a phosphate mole fraction of 1.5 
gave an aluminium ion release of 0 nmol/g. Graphs were not included for this 
observation as a wider range of phosphate glass concentrations were required for 
adequate plots. 
Table 3.26 Aluminium ion release (nmol g-t) over time from discs of ion orne ric 
cements from the calci urn based seri es 
Material Time (d) 
CaO:CaFz I 3 5 7 10 14 21 42 
1.095(1.1:1-1) ().I 0.2 (),3 ()1 O~ 05 0.6 ().7 
L096 (2.6:1.4) O. 1 0.2 0.3 03 OA II) 0.5 0.7 
L097 (2.4:1.6) <0.1 () .1 0.2 0.1 II.J OA O.~ 0.6 
1.091 (1.1:l.I) <0.1 0.2 0.2 ()1 OJ O~ O.S 0.7 
L099 (1-0:3_0) () .1 0.2 0.3 0.1 O~ O.~ O.S (1.7 
Data obtained from discs (20 mm by 2 nun) in 50 Illi water at J7"C . Release ct.1ta is the arithmetic 
mean of one analysis of each of six specimens. The standard deviation did not exceed W'Yo. 
LG9S released the greatest amount of aluminium to ~2 days. 11OWe\'er LG\)7 eluted the least arrlOlUlt 
of aluminium to the same time period. Detection Iinllts of the AAS for aluminium were 0.1 ppm to 
1 ppm. 
I)J 
Table 3.27 Aluminium ion release (nmol g-I) over time from discs of glass 
ionomeric cements controls. 
Material 
Chemfll 
Cbemfil Express 
0.5 
0.1 
3 
0.7 
0.3 
Time (d) 
5 
1.1 
0.-' 
7 
0.5 
10 
1.7 
0.6 
14 
1.9 
0.7 
21 
2.3 
O.S 
42 
2.9 
0.9 
Data obtained from discs (20 nun by 2 nun) in 50 ml water at 3iC. Release data is the arithmetic 
mean of one analysis of each of six specimens. The standmd deviation did not exceed 10%. 
Chemfil released morc aluminium to -'2 days than Chemfil Express to the same time period. 
Detection limits of the AAS for aluminium were () I ppm to I ppm. 
{e} Silicon bI atomic absorl!tion sl!l"ctroscol!I 
Atomic absorption spectroscopy was used to measure the concentration of ions 
released from set discs ofIe (section 22.2). Silicon release data from all the 
formulations examined is summarized in Tables 3.28 to 3.35 on the following pages. 
Particular results of interest are added as footnotes where appropriate. 
Table 3.28 Silicon release (!lmol g-I ) over time from discs of ionomeric cements of 
the monovalent cation series (Na· and K· ). 
1.5Si01 Alz OJ O.5Pz O~ (I-Z)CaO 0 75CaF 2 ZNa20 
Material Time (d) 
3 5 7 10 1-' 21 "'2 K4 
L03 z-o 4.7 10.1 1-'.7 171) 217 2(d B.3 55.9 na 
1.04 z,.o.015Na na m na -'6. X nil na 6XO IOX.7 156.2 
L05 z-oo!Na na na na XO.6 na na 122.0 173.1 1')4.2 
1.06 Z-O.INa na na na 7X2 llil na 11').0 1-'').6 20S.4 
L07 ~o.025K m m na 51 3 llil llil 760 IOK.O 128.8 
LOB ~o.05K na m llil 5XX llil na n;} na m 
LOID z-o.Oll5NalKm m na 55-' n:l llil llil llil na 
LO II z,.o.05NaIK na m m 3 3 n:l na -'X.O X-'.I 102.4 
LOllz,.o.05K 3A 7.5 II.X 135 IX I) 26 X 30; -'2.7 m 
LOl3 z,.o.lSNa 4.9 ').6 15 -l 1(,5 2-' X 32.5 -lOA 53.2 m 
1.063 Z-O.lNa 7.1 14.0 (1)(1 DO ~I () "X X 47K (,5.X m 
1.065 z,.e.INa 5.3 II .6 I(d 20 (I 2-' () 2X 2 "6.0 (ICI.K m 
L066 Z-O.lNa 5.2 1112 15~ II) (I 21 I 2K I "5.; 51).1 m 
94 
L067 z.4t.JN II 4.6 1).3 1·1.2 17.K 220 27.t 35.2 5K.6 m 
L06I1 Z- O.4Na 4.6 8.J 15.0 IX.9 227 2X . .t 35.7 50.6 m 
L069 Z-O.5NII 7.8 15.6 H.O 30.7 )'}.I ~XA 60.7 1)8.2 m 
W70 Z-O.45Na 6.4 12.8 11).6 253 31.2 38.6 41) .1) 85.3 na 
Data obtained from discs (2() mm by 2 mm ) in 50ml water at 37"C . Release data is tre arithmetic 
mean of one analysis of each of SLX specimens. Thc stimdmd dcviation did not exceed W%. 
na-Not applied- reading not taken as there was no SiUllpJC. 
LGS released the least amount of measured silicon to 42 days, however LG22 eluted 
the least silicon to the same time period. Detection limits ofthe AAS for silicon 
were 100 ppm to 500 ppm. 
Figure 3.11 (next page) shows that there was no relation between measured silicon 
release and sodium glass content ions from the glass of the monovalent cation series 
at 42 days. There was a drop in measured silicon release after 0.1 mole fraction of 
sodium (see Figure 3.9) thereafter there was no pattern emerging from the data. 
Measured silicon ion release and sodium glass content ions from monovalent cation 
series ofIes had a correlation coefficient of -0.3 However, there may be a 
positive relation between release and potassium ions from LG7, LG8 and LG22 
glass composition however a wider range of potassium based glasses were required 
to confirm this and to obtain an adequate plot 
Figure 3.11 Relation between measured Silicon release and 
Sodium glass composition at day 42. Linear regression, 
y=222.Ox+49. Correlation coefficient=-O.3 (n=6). 
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Table 3.29 Silicon release (J.1mol g<1 ) over time from discs of ionomeric cements 
from the apatite stoichiometric series (Ca:P-l 66). (P)Si02 1.5P2 O~ (Q)Ah03 (5-
s)CaO sCaFl 
Material Time (d) 
7 21 42 
LG26 s-Z.O 2.3 10.6 23.6 50.1 
LG27 s=l.O 6.3 15.2 21).6 52.5 
LG28 s-O.~ 7.1 18.1) 42.3 70 I 
LG29 s-o.l~ 8.6 24.3 47.3 K65 
LG30 sat. 8.2 21.6 "'5"' 770 
Data obtained from discs (20 nun by 2 nun) 11\ :'iO ml waler al 3T'C . Release data is tre arithmetic 
mean of one analysis of each of six specimens The stand:ud dc .... atioll did nol exceed Hr~. 
LG29 released the grealest amounl of silicon to "'2 days. llOWC\'er LG26 eluted the least amount to 
the same time period. Detection limits of Ihe AAS for silicon were lUCI pplll to son ppm. 
Table 3.30 Silicon release (J.1mol g<1 ) over time from discs of ionomeric cements 
from the series varying in calcium fluoride 15Si02 l.OAI20 3 O.5P20~ l.OCaO 
sCaFl 
Material Tune (d) 
3 5 7 10 I"' 21 "'2 
LG3 s=O.S 4.7 10.1 I"' 7 17 '} 217 2(,] 33.3 55.1) 
LG26 so:().67 2.3 III m 10.6 na na 23.6 50.1 
LG42 s=l.() 3."' 7.0 lO.O II K I() ') 210 25.2 35.3 
LG44 s=0.2S 3.9 8.2 1I:'i 117 II) :'i 270 34.7 50.8 
LG4Ss=O HU) 170 222 277 51 'J 51 I) 5KO 76.9 
Data obtained from discs (20 nUll by 2 11\11\ ) \1\ 50 ml water al H"C Release de11a is Ire arithmetic 
mean of one amlysis of each of six specimens The siandard deviation did not exceed lUufo. 
LG4S released the greatest amounl of SlllCOlllO 42 days. llOwc\,cr LG",2 cluled the least amount 10 
the same time period. Detection linllts of the AAS for silicon were 11M. ppm to 500 ppm. 
'17 
Table 3.31 Silicon release (J.1mol g.l) over time from discs of ion om eric cements 
from the series varying in silica:alumina and calcium. 
Material Time (d) 
(Si(}z:AIzOJ:CaF 1) I 3 5 7 10 14 21 42 
LO'3 (4.5:3.0:1.0) 5.0 10.0 14.7 17.2 219 25.7 3().6 41.3 
LO'4 (6.0:4.0:1.0) 4.5 9.1 B.8 17.2 214 25.2 3().S 41.8 
LO" (6.75:4.5:0.5) 5.8 11.9 17.7 21.2 25.8 27.3 36.8 49.9 
LO'6 (7.115:4. 75:0.15)2().5 43.5 63.() 79.6 n.4 1117 B2.1 179.0 
LO" (7.5:5.0:0) 5.6 11.9 17.7 21.8 26.1 3().9 37.1 46.5 
L072 (6.0:4.0:1.0) 7.6 14.7 21.5 26.9 no 373 44.2 55.4 
L073 (7.5:5.0:I.CI) 8.3 16.2 24.3 31)') 377 ·B7 52.7 64.1 
L074 (1I.l5:5.5:0.5) 8.2 15.2 23.2 28.9 366 42.9 5().0 78.6 
LO" (11.615:5.75:11.15)9.6 UU) 27.7 338 424 49.8 59.4 78.6 
Data obtained from discs (2() mm by 2 mm ) in 50 m) water at 37"C. Release data is the aritlunetic 
mean of one analysis of each of SlX specimens. The standard deviation did not exceed 10%. 
LOS6 releases the greatest amount of silicon to 42 days. however LG53 elutes the least amount of 
silicon to the same time period. Detection limits of the AAS for silicon were UK) ppm to 5(K) ppm. 
Table 3.32 Silicon release (J.1mol g.l) over time from discs of ion om eric cements 
from the series varying in silica:a1umina ratio based 
Material Time (d) 
Si01:AIzOJ I 3 5 7 10 14 21 42 
L077 (6..15:3.75) 3.4 7.4 11.2 14() 17.1 20.4 25.3 40.9 
L07I (6.5:3.5) 3.6 9.3 B.7 17.3 221 25 9 31.6 5().6 
LOll) (6.7:3.3) 5.1 11.8 17.7 214 27') 344 42.8 79.1 
LORI (6.75:3.25) 6.5 9.5 12.3 15 (I 18"~ 255 36.5 66.9 
Data obtained from discs (20 mm by 2 nun) in 50 ml water at 37"C. Release <l.1ta is the aritlunetic 
mean of one analysis of Cc1ch of six specimens The standard deviation did not exceed 100/ ... 
LOBO releases the greatest amount of silicon to 42 days. howe"er LG77 elutes the 1e.1st amount of 
silicon. Detection limits of the AAS for SIlicon were lOti ppm to 5(K) ppm. 
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Figure 3.12 Relation between Phosphorus pentoxide glass 
composition and Silicon release at 42 days. Linear regression, 
y=28.8x+46.5. Correlation coefficient=O.96 (n=6) 
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Table 3.33 Silicon release (Jlmol gO' ) over time from discs of ion om eric cements 
from the series varying in generic compositions derived from the apatite-
stoichiometric based glass LG26. 
Material Timc (d) 
SiOz:PzO,:CIIO 3 5 7 10 I~ 21 42 
L026 (4.5:t.5:3.0) 2.3 In In nil na na 23.6 50.1 
LOll (4.1:1.7:1.1) 2.9 9.2 14.5 15.7 21.4 29.3 35.4 50.8 
LOI4 (3.7:1.9:1.6) 6.3 10.8 14.6 llU U 2!U 37.9 52.6 
LOII5 (3.3:1.1 :1.4) 5.8 11.9 15.5 216 24 '} 29.7 36.1 55.9 
Data obtained from discs (20 mOl by 2 n1ln ) in 50 ml water at 37"C . Release d.1ta is the aritlunetic 
mean of one analysis of each of six specimens. The standard dcviation did not exceed l()ftll •. 
LGSS releases the gl'Cc1test amount of silicon to ~2 days. howcvcr LGX3 elutes the 1e.1st amount of 
silicon to the same time period Detection linnts of the AAS for silicon wcre 100 ppm to 500 ppm. 
Figure 3.12 shows that there was a positive relation between phosphorus pentoxide 
glass content and measured silicon release at 42 days, that was detected by AAS, as 
there was a correlation coefficient of 0 96 (and linear regression =28.8). 
Table 3.34 Silicon release (Jlmol g.' ) over time from discs of ion om eric cements 
from the calcium based series 
Material Tunc (d) 
CaO:CaFz 3 5 7 10 I~ 21 ~2 
LG95 (1.1:1.1) 4.5 w.o IXI 230 29X 35 9 43.3 52.3 
L096 (1.':1.4) 5.1 105 IX 3 230 27 9 3~ 0 4U 52.5 
L097 (1.4:1.6) 4.1 87 12(. 16 X 21 7 273 357 ~7.5 
L098 (2.1:1.1) 5A 107 I(d 20 X 2(, (, "l2 I) 42.K 5~.7 
L099 (1.0:3.0) 4.6 8.7 140 IX I B2 21) (, 392 50.X 
Data obtained from discs (2() mm by 2 mm ) 11\ :'\Oml water at "l;'C . Release data is the aritlunetic 
mean of one analysis of each of six SpeclllICllS Thc standard deviation did not exceed 10%. 
LG9S releases the greatest amount of slhcon to 42 dol\s. howcver LG97 elutes the least amount of 
silicon to the same time period Detection IlIInts of the AAS for Silicon were !Uo ppm to 5UU ppm. 
ItMI 
Table 3. 35 Silicon release (J.lIIlol g-1 ) over time from discs of glass ionomeric 
cements controls . 
Material Time (d) 
Cbemfil 
Cbemfil Express 
3.6 
3.5 
3 
7.7 
6.1 
5 7 10 14 21 42 
1l.0 1l.6 16.2 2l.6 25.3 36.0 
8.6 10.6 1l.8 14.8 20.6 27.2 
Data obtained from discs (20 mm by 2 mm ) in 50 ml water at 3rC. Release data 
is the arithmetic mean of one analysis of each of six specimens. The standard 
deviation did not exceed 10%. 
Chemfil released more silicon to 42 days than Chemfil Express. Detection limits of 
the AAS for silicon were 100 ppm to 500 ppm. 
From these tables of results it may be shown that there is a relation between the 
sodium, potassium and phosphorus pentoxide glass content increase and measured 
silicon release. 
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H) Calcium bl: atomic absorl!tion sl!ectroscol!l: 
Atomic absorption spectroscopy was used to measure the concentration of ions 
released from set discs of IC (section 2.2.2). Calcium release data from all the 
formulations examin~d is summarized in Tables 3.36 to 3.42 on the following pages. 
Particular results of mterest are added as footnotes where appropriate. 
Table 3. 36 Calcium ion release (Jlmol g-' ) over time from discs of ionomeric 
cements of the monovalent cation series (Na+ and K+). 
1.5Si02 Ah 0 3 O. 5P2 Os (I-Z)CaO O.7SCaF2 ZNa20 
Material Time (d) 
3 5 7 10 l-t 21 42 H4 
L03 z-tl (l.5 0.9 1.6 2.2 21) -t.2 5.9 X.4 na 
L04 Z-O.1I1SNII na na na 2.0 na I\a 6.5 12.0 14.5 
LG6 z-t1.1 Nil na na na 0 na na (13 2.4 4.1 
L07 Z-O.1I25K na na na 2.f, m na 5.6 12.3 15.1 
LOS Z-O.IISK na na na 2.(' na I\a 6.2 12.0 14.9 
LOW Z-1I.11125NalKna na na 1.5 na I\a 3.6 10.1 12.8 
LOll Z-O.(I5NalK na na na 2.(' na na 6.4 12.2 14.8 
L022 Z-O.(I5K <(1.1 <0.1 <0.1 O. I III 11.2 1.3 1.2 na 
LG69 Z-O.SNII 0.3 <0.1 na na na na na na na 
Data obtained from discs (20 mm by 2 mm ) in 50 1111 water at 37"C. Release data is the arithmetic 
mean of one analysis of each of six specimens. The slandmd deviation did not exceed 10%,. 
na-Not applied-reading not taken as there was no sample. 
LGII released the greatest amount of calcium 10 H-t days. however LG6 elutes the least amount of 
calcium to the same time period. LG67 and LG6X eluted <0.1 ~mol g.1 throughout the time of the 
experiment. Detection limits of the AAS for calcium were I ppm to 10 ppm. 
There was no relation between calcium ion release and sodium glass composition. 
There is no relation between calcium ion release and potassium glass content. There 
was no relation between sodium ions of monovalent cation ICs and calcium ion 
release. A wider range sodium based glasses were required for plots and to confirm 
a definite relation between sodium based ICs and calcium ion release. There was 
also no relation between potassium ions in the monovalent cation ICs and calcium 
til 2 
ion release. A greater range of potassium based glasses were required for a definite 
relation to be confirmed. Hence calcium was not influenced by increasing sodium 
and potassium ions of the monovalent cation based series of glasses. 
Table 3.37 Calcium ion release (J.lmol gol ) over time from discs of ionomeric 
cements from the apatite stoichiometric series (Ca:P-1.66 ). (P)Si02 1.5P2 Os (Q)Ah03 (5-x)CaO xCaFz 
Material Time (d) 
3 7 21 42 
LG26 Fl.O 0.9 l.8 3.3 4.9 
LG27 r-I.O 0.7 1.4 2.4 3.6 
LG29 :1=0.5 1.0 1.4 1.9 2.6 
LG30x-O 0.8 1.1 1.3 1.6 
Data obtained from discs (20 mm by 2 mm ) in 50 ml water at 31'C. Release data is the arithmetic 
mean of one analysis of each of six specimens. The standard deviation did not exceed 1 ()o1o. 
na-Not applied- reading not taken as there was no sample. 
LG26 released the greatest amount of calcium to 42 days, however LG30 eluted the least amount of 
calcium. Detection limits of the AAS for calcium were 1 ppm to 10 ppm. 
Table 3.38 Calcium ion release (J.lmol gol) over time from discs of ion om eric 
cements from the series varying in calcium fluoride upto the same time period. 
1.5Si021.0Ah030.5P20S 1.0CaO xCaFz 
Material Time (d) 
3 5 7 10 14 21 42 
LG3pU 0.5 0.9 1.6 2.2 2.9 4.2 5.9 8.4 
LG26P'G.67 na 0.9 na 1.8 na na 3.3 4.9 
LG42pl.O 0.7 1.0 1.4 137 2.2 2.9 3.9 6.3 
LG44s-O.2S <0.1 0.2 0.3 0.5 0.8 1.2 1.8 3.9 
L04SPI 0.8 1.5 1.5 2.1 2.8 3.9 5.0 7.8 
Data obtained from discs (20 mm by 2 mm ) in 50 ml water at 31'C. Release data is the arithmetic 
mean of one analysis of each of six specimens. The standard deviation did not exceed 10%. 
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na-Not applied- reading was not taken as there was no sample. 
LG4S released the greatest amount of calcium to ~2 days, however LG~~ eluted the least amount of 
calcium. Detection limits of the AAS for calcium were I ppm to 10 ppm. 
Table 3.39 Calcium ion release (~mol g.1 ) over time from discs of ionomeric 
cements from the series varying in silicate:alumina and calcium. 
Material Time (d) 
SI:AI:Ca 1 3 5 7 10 14 21 42 
LO'3 (4.5:3.0:1.0) 1.5 3.2 5.4 6.2 8.~ 10.3 12.9 17.9 
L054 (6.0:4.0:1.0) 0.4 0.9 1.9 2.6 3.3 4.3 5.4 8.1 
LO'S (6.75:4.5:0.5) n.3 0.7 1.4 1.9 2.5 3.2 4.4 6.8 
LOS6 (7.1l5:4.75:0.Z5)O.4 0.7 1.3 l.X 2.5 3.2 ~.2 6.5 
LOS? (7.5:5.0:5.0) 0.1 0.3 0.7 1.1 \.6 2.1 2.9 4.9 
L072 (6.0:4.0:4.1) 0.5 1.2 1.9 VI 3.5 ~.3 5.6 8.2 
L073 (7.5:5.0:1.0) (l.5 1.3 1.1) 2.6 3.5 ~6 5.9 8.5 
L074 (8.15:5.5:5.0) 0.6 1.3 20 2.X 3.7 ~.I) 5.9 7.4 
L015 (1.615:5.75:0.15)0.6 1.7 2.6 3.3 ·u 4.1) 5A 6.2 
Data obtained from discs (20 mm by 2 mm ) in 50 ml water at 37"C . Release data is the arithmetic 
mean of one analysis of each of six specimens. The st:mdmd deviation did not exceed 10% •. 
na-Not applied-reading was not taken as there was no sample. 
LG53 released the greatest amount of calcium to ~2 days. however LG57 eluted the least amount of 
calcium to the same time period. Detection limits of the AAS for calcium were I ppm to III ppm. 
Table 3.40 Calcium ion release (~mol g.l) over time from discs of ion orne ric 
cements from the series varying in Silica:Alumina ratio based. 
Material Time (d) 
SlOz:AlzOz 3 5 7 10 14 21 42 
L077 (6.15:3.75) <n.1 0.2 n.2 0.3 ().~ 0.1) 1.5 2.6 
L078 (6.5:3.5) <n.1 0.3 n.7 (l.1) l.5 \.8 2.3 3.2 
L080 (6.7:3.3) 0.4 0.8 1.4 1.9 2.5 3.1) 5.6 7.5 
L081 (6.75:3.15) 0.3 0.4 0.5 (l.6 n.x 2.3 3.9 5.8 
Data obtained from discs (2n mm by 2 nUll) in 50 011 water at 37"C. Release data is the arithmetic 
mean of one analysis of each of six specimens. The standmd deviation did not exceed 10%. 
LG80 released the greatest amount of calcium to 42 days. however LG77 elutes the least amount of 
calcium to the same time period. Detection limits of the AAS for calcium were I ppm to 10 ppm. 
Table 3.41 Calcium ion release (IImol g-I ) over time from discs of ionomeric 
cements from the series varying in generic compositions derived from the apatite-
stoichiometric based glass LG26. 
Material Time (d) 
SlOz:pzO.:CaO 3 5 7 10 14 21 42 
L0264.5:1_5:3_0) na 0.9 na LX na na 3.3 4.9 
L083 (4.1:1.7:2_8) 0.1 0.8 1.4 1.1) 2.8 3.3 4.0 5.4 
L084 (3.7:l.9:2.6) 0.7 0.8 0.9 1.0 1.2 2.9 4.9 7.4 
L08S 3.3:2_1:2.4) 0.2 0.4 0.6 0.9 1.2 1.8 2.8 4.3 
Data obtained from discs (20 mm by 2 mm ) in 50 Illi water at 37"C . Release data is the arithmetic 
mean of one analysis of each of six specimens. The standard deviation did not exceed 10%. 
LG84 released the greatest amount of calcium to 42 days. however LG85 eluted the least amount of 
calcium to the same time period. Detection limits of the AAS for calcium were I ppm to 10 ppm. 
There was a relation between decreasing calcium ion release with an increase in 
phosphorus pentoxide glass content. A wider range of phosphate glasses were 
required for an adequate plot (correlation coefficient =-0.87 and linear 
regression=0.38). 
Table 3.42 Calcium ion release (IImol g-I) over time from discs of ion orne ric 
cements from the Calcium based series. 
Material Time (d) 
CaO:CaFz 3 5 7 III 14 21 42 
L095 (2.8:2.2) 1.4 3.1 4.9 6.2 !U I) .1) 12.5 15.1 
L096 (2.6:2.4) 0.8 2.1 3.2 4.3 5.X 7.3 9.6 12.8 
L097 (2.4:2.6) 0.7 1.6 2.5 3.3 4.5 5.6 7.5 10.5 
L098 (2.2:2.8) 1.7 3.6 5.2 6.6 X.X 10.6 13.4 16.9 
L099 2.0:3.0) 1.2 2.5 3.6 4.X 6.4 X.3 11.2 14.8 
Data obtained from discs (20 mm by 2 mm) in 50 ml water at 37"C. Release d1ta is the arithmetic 
mean of one analysis of each of six specimens. The stand1rd deviation did not exceed 10%,. 
LG98 released the greatest amount of calcium to 42 days. however LGIJ7 eluted the least amount of 
calcium to the same period of time. Detection limits of the AAS for calcium were I ppm to 10 ppm. 
HI~ 
tgl Phosphate by high pressure liquid chromatography 
High pressure liquid chromatography was used to measure the concentration of ions 
released from set discs ofIC (section 2.2.2). Phosphate release data from all the 
formulations examined is summarized in Tables 3.43 to 3.49 on the following pages. 
Particular areas of interest are added as footnotes where appropriate. 
Table 3.43 Phosphate ion release (~mol gO') over time from discs of ionomeric 
cements of the monovalent cation series (Na+ and K+). 
1.5Si02 Ah 0 3 O.5P2 Os (l-Z)CaO O.75CaF2 ZNa10 
Material Time (d) 
3 5 7 to I-t 21 42 84 
L02z-0 m na na na na na 6.3 8.8 11.2 
L03 z-O 0.2 0.4 0.5 06 0.7 08 0.9 1.2 m 
LG4 z-o.025Na m na na 2 . .t na na 3.9 4.9 5.9 
LG6 pO.INa m m m 5.5 na na 8.1 9.7 11.7 
L07 z-O.015K m m na 1.3 1\1 I\:1 1.9 2.5 3.4 
LOB z-O.05K m m m 2A na 1\1 2.6 4.8 6.0 
LOIO po.0125NalK na m na 1.7 na na 2.1 2.7 3.5 
LOll z-O.05NaIK na na na 2.6 na 1\1 4.1 5.3 6.5 
L022 z-o.05K 0.2 0.3 0.4 0.5 05 0.6 0.7 0.9 na 
L067 z-O.lNa 0.4 0.7 0.8 0.9 1.1 1.3 1.7 2.2 na 
L06B z-O.4Na 0.5 0.8 1.1 1.3 1.6 1.8 2.1 2.7 na 
L069 z-o.5Na 1.7 2.7 3.6 4.0 4.7 5.3 6.4 8.2 na 
Data obtained from discs (20 mm by 2 01111 ) in 50 ml water at 37"C . Release d.:1ta is the arithmetic 
mean of one an,1lysis of each of six specimens. The standard deyiation did not exceed 10%,. 
na-Not applied-reading oot taken as there was no sample. 
LG6 released the greatest amount of phospl1.1te to 42 days. however LG22 eluted the least amount of 
phosphate to the same time period. Detection limits of Ihe HPLC for phosphate were 5 ppm to 40 
ppm. 
Table 3.42 shows that there was no relation between phosphate ion release and 
sodium solubilising ions of the monovalent cation based series ofICs hence no plots 
were included. There may be a relation between phosphate ion release and 
potassium glass content however more potassium based glasses were required for 
analysis to confirm this. 
Table 3.44 Phosphate ion release (J.1mol gol ) over time from discs of ionomeric 
cements from the apatite stoichiometric series (Ca:P-1.66 ). (P)Si02 1.5P2 Os (Q)Al203 (5-x)CaO xCaF 2 
Material 
LG26X-2.0 
W27X-U 
LG28X".s 
W29X".2S 
LG30X" 
3 
0.1 
l.2 
1.6 
3.3 
2.2 
Time (d) 
7 
l.7 
l.9 
2.0 
4.1 
2.9 
21 42 
2.6 3.8 
2.7 3.5 
2.8 3.7 
5.5 7.7 
4.0 5.8 
Data obtained from discs (20 mm by 2 mm ) in 50 ml water at 3 T'C. Release data is the arithmetic 
mean of one analysis of each of six specimens. The standard deviation did not exceed 10010. 
LG29 released the greatest amount of phosphate to 42 days, however LG27 eluted the least amount 
of phosphate to the same time period. Detection limits of the HPLC for phosphate were 5 ppm to 40 
ppm. 
Table 3.45 Phosphate ion release (J.1Mol gol) over time from discs of ion om eric 
cements from the series varying in calcium fluoride. 1.5Si02 1.0Al20 3 O.5P20S 
l.OCaO xCaF2 
Material Time (d) 
1 3 5 7 10 14 21 42 
W2 .... 75 na na na na na na 6.3 8.8 
W3r8.5 0.2 0.4 0.5 0.6 0.7 0.8 0.9 1.2 
W26P4.67 na 0.1 na l.7 na na 2.6 3.8 
LG42 poLO 0.5 0.2 0.3 0.3 0.3 0.4 0.4 0.4 
W44 .... 2S 0.4 0.6 0.8 0.9 0.1 1.2 1.4 1.9 
[.045"- 1.6 2.5 2.9 3.4 3.8 4.6 5.3 6.4 
Data obtained from discs (20 mm by 2 mm ) in 50 ml water at 3T'C. Release data is the arithmetic 
mean of one analysis of each of six specimens. The standard deviation did not exceed 10010. 
LG45 released the greatest amount of phosphate to 42 days, however LG42 eluted the least amount 
ofpbosphate to the same time period. Detection limits of the HPLC for phosphate were 5 ppm to 40 
ppm. 
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Table 3.46 Phosphate ion release (~mol gol ) over time from discs of ion om eric 
cements from the series varying in silica:alumina and calcium. 
Material Time (d) 
SiOz:AIzOJ:CaFzl 3 5 7 10 14 21 42 
LO'3 (405:3.0:1.0) 0.1 0.2 (1.3 (1.3 (1.3 O.J 0.4 0.5 
LO'4 (6.0:4.0:1.0) 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.4 
LO" (6.75:4.5:0.5) 0.2 0.3 0.4 OA OS 0.5 U.6 U.8 
LOS6 (7.125:4.75:0.25)0.2 0.4 U.5 0.5 U.5 0.5 0.6 U.8 
LO" (7.5:5.0:0) 0.2 0.3 0.4 0.4 0.'" 0.5 0.5 0.6 
LOn (6.0:4.0:1.0) 0.8 1.4 1.6 I.X 1.9 2.1 2.3 2.8 
L073 (7.5:5.0:1.0) 0.8 1.2 1.5 1.7 1.9 2.1 2.4 2.7 
L074 (8.25:5.5:0.5) 0.7 1.0 I.3 1.4 1.5 1.7 1.9 2.3 
LO" (8.625:5.75:0.15)0.9 1.4 I.X 1.9 2.1 2.3 2.6 3.1 
Data obtained from discs (20 mm by 2 mm ) in 50 Illi water at 37"C. Release data is the arithmetic 
mean of one analysis of each of six specimens. The standard deviation did not exceed 10% •. 
LG72 released the greatest amount of phosphate to 42 days. however LG54 eluted the least amount 
of phosphate to the same period of time. Detection limits of the HPLC for phosphate were 5 ppm to 
40 ppm. 
Table 3.47 Phosphate ion release (~mol gol) over time from discs of ion om eric 
cements from the series varying in silica:alumina ratio based. 
Material Time (d) 
SiOz:AIzOJ 3 5 7 10 14 21 42 
L077 (6.25:3.75) 0.3 (1.5 0.7 O.X O.X 0.9 (1.9 1.1 
L078 (6.5:3.5) 0.4 0.8 1.2 1.3 1.5 1.6 1.7 1.9 
LOHO (6. 7:3.3) 1.0 1.6 2.0 2.2 2.5 2.7 3.U 3.6 
LORI (6.75:3.25) 1.1 I.3 1.4 1.5 1.7 2.0 2.5 2.9 
Data obtained from discs (2(1 mm by 2 mm ) in 50 1111 water at 37"C. Release data is the aritlunetic 
mean of one analysis of each of six specimens. The st;mdard deviation did not exceed 10% •. 
LG80 released the greatest amount of phosphate to 42 days. however LG77 eluted the least amount 
of phospahte to the same time period. Detection limits of the HPLC for phosphate were 5 ppm to 40 
ppm. 
ttlH 
Table 3.48 Phosphate ion release (~mol g-I ) over time from discs of ionomeric 
cements from the series varying in generic compositions derived from the apatite-
stoichiometric based glass LG26. 
Material Time (d) 
SiOz:PzO, CaO 3 5 7 to 14 21 42 
L026 (4.5:1.5:3.0) na 0.1 na 1.7 na na 2.6 3.8 
L083 (4.1:1.7:2.8) 0.3 1.1 1.6 I.K 2.2 2.4 2.5 2.9 
L084 (3.7:1.9:2.6) 1.0 1.6 2.1 2.4 2.6 3.0 3.7 4.7 
L08S 3.3:1.1:2.4) 1.6 1.9 1.9 2.1 2A 2.7 2.9 3.9 
Data obtained from discs (20 mm by 2 mm ) in 50 ml water at 37"C . Release data is t~ arithmetic 
mean of one analysis of each of six specimens. The standmd deviation did not exceed 10%. 
LG84 released the greatest amount of phosphate to 42 days. however LGR3 eluted the least amount 
of phosphate. Detection limits of the HPLC for phosphate were 5 ppm to 40 ppm. 
Figure 3.13 shows a positive relation between phosphorus pentoxide glass content 
and P04 3· ion release at 3 days. where the parameters have a correlation coefficient 
of 0.97 (linear regression =0.69). There is an increase in P04 3· release as 
phosphorus pentoxide glass content increases. 
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Figure 3.13 Relation between Phosphorus pentoxide glass 
composition and phosphorus ion release at 3 days. Linear 
regression, y=O.69x-6. Correlation coefficient=O.97 (n=6) 
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Table 3.49 Phosphate ion release (J.1mol gol ) over time from discs of ionomeric 
cements from the Calcium based series. 
Material Time (d) 
CaO:CaFl 1 3 5 7 10 14 21 42 
LG9S (2.8:1.2) 0.6 0.9 1.2 1.0 1.4 1.7 2.0 2.6 
L096 (2.6:2.4) 0.6 0.9 1.1 1.3 1.4 1.6 1.8 2.3 
LG97 (2.4:2.6) 0.5 0.8 0.9 l.0 1.2 1.2 1.4 1.9 
LG98 (2.2:2.8) 0.5 0.7 0.9 0.9 1.1 1.3 1.5 1.9 
L099 (2.0:3.0) 0.6 0.9 1.1 1.2 1.2 1.3 1.5 1.9 
Data obtained from discs (20 mm by 2 mm) in 50 rnl water at 37"C. Release data is the arithmetic 
mean of one analysis of each of six specimens. The standard de-.iation did not exceed 10010. 
LG95 released the greatest amountof phosphate to 42 days, however LG98 eluted the least amount of 
phosphate to the same time period. Detection limits of the HPLC for phosphate were 5 ppm to 40 
ppm. 
Chemfil and Chemfil Express released equal amounts of phosphate to 42 days i.e. 0.1 J.I.Dlol 80 \ • 
Detection limits of the HPLC for phosphate were 5 ppm to 40 ppm. Data obtained from discs (20 mm 
by 2 mm ) in 50 rnl water at 37"C. Release data is the arithmetic mean of one analysis of each of six 
specimens. The standard deviation did not exceed 1 0%. 
3.2 (h) pH of autoclaved and non-autoclaved discs in solution 
Table 3.50 pH of eluting water as a function of cement disc immersion time 
1.5Si02Ah03 0.5P20s (l-Z) CaO O.75CaF2ZNazO 
Number of Days 
Sample 1 3 7 10 14 
LG2z-G 7.6 6.8 6.5 6.7 6.7 6.8 
LG6Z=O.1 7.7 7.4 6.9 7.0 7.3 7.2 
Control 5.7 5.6 5.6 5.4 5.5 6.0 
Data obtained from discs (20 mm by 2 mm) in 50 ml water at 37°C. Data is the arithmetic mean of one analysis 
of each of six specimens. The standard deviation did not exceed 10%. Watcr treated with LG6 is less acidic than 
water tl'e8tCd with LG2. 
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Table 3.51 Mean pH of eluted water of autoclaved ICs at 7 days 
LG7 and LG8 are from the monovalent cation based series of ICs with the following 
formulae: 1.5SiOzAh03 O.5PzOs (I-Z) CaO O.75CaFzZNa10 
LG26 from the apatite stoichiometric has the foHowing formulae series (Ca:P-I.66 ). 
(P)SiOz l.5P2 Os (Q)Ah03 (5-x)CaO xCaF2 
Sample Mean pH 
LG7 Z=0.025K 6.(, 
AutcLG7 Z==O.025K 6A 
LG8 Z=O.05K 6.7 
AutcLG8 Z=O.1I5K 6.5 
LG26 x=2.0 6A 
AutcLG26 X=2.0 6.0 
Control 6.2 
Autc-autoclaved 
Data obtained from discs (20 nun by 2 nun) in 501111 water at )70e. Data is the aritlunetic mean of one 
analysis of each of six ~-pecimens. The standard deviatioll did not exceed 10% •. pH measurements 
were taken using a pH electrode attached to an Orion AS 720pWISE direct readout 
meter (USA). Water treated with autoc1aved ICs showed a reduction in pH. 
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Table 3.S2 pH ofLG2 and LG26 in 50ml of water 
LG2 is a monovalent cation with the following formula: 
LG26 is from the apatite stoichiometric based series (Ca:P-l.66) formula as 
follows: (P)Si02 1.5P2 Os (Q)AI20 3 (S-x)CaO xCaF2 
Number of Days 
Sample 1 3 7 
L02 Z=O 6.4 6.6 6.6 
L026 x-2.0 4.7 5.4 5.4 
Control 5.4 5.4 5.4 
Data obtained from discs (20 nun hy 2 nun) in 50 Ill! water at :n°c. Data is the uritlulletic mean of one 
analysis of each of six specimens. The standard deviation did not exceed ! OOX.. Water treated wi th 
LG26 was more acidic compared to water treated with LG2. 
Table 3.S3 pH of LG2 and LG26 in SOml of a-minimal essential media 
LG2 is a monovalent cation with the following formula: 
1.5Si02 Al2 0 3 O.5P2 Os (l-Z) CaO O.75CaF2 ZNa20 LG26 is from the apatite 
stoichiometric based series (Ca:P-1.66) formula as follows: (P)Si021.5P20 s 
(Q)AI20 3 (S-x)CaO xCaF2 __________ _ 
Numher of Days 
Sample 1 3 7 
L02 8.1 6.8 6.9 
L026 6.4 6.5 6.4 
Control 7.1 7.0 7.0 
IlJ 
Data obtained from discs (20 mm by 2 mm) in 50 ml a-minimal essential media at 37°C. Data is the arithmetic 
mean of one analysis of each of six specimens. The standard deviation did not exceed 10%. a-MEM treated 
with LG26 was more acidic than a-MEM treated with LG2. 
Ion balance calculation for LG26: 
3.0CaO. 2.OCaFl 
Anions Cations 
4F 
Total of anions 28 J.1Illoles of a charge + total of cations -32.5 J.1Illoles of a charge 
gave -4.5 J.Lmoles of a charge for LG26. 
O.8CaO. O.2NazO 
Anions Cations 
0.5P04 3-
1.5F 
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Total of anions 9.5 J.lMoles of a charge + total of cations -11 J.1tlloles of a charge 
gave -1.5 J.1moles of a charge for LG63. 
By totaling the number of positive and negative ions released and calculating the 
cumulative ion balance there was a surplus of negative ions over positive ions 
leaving the cement at all times, as can be shown for the above examples LG26 and 
LG63. As a result of this outflow of negative ions the surrounding fluids, i.e. a-
MEM in cell culture, shows a colour change from red to yellow, indicating a drop 
in pH (Table 3.50). The ion balance thus strongly indicates that fluoride ions 
released were mediated by an exchange of hydroxyl ions from the elution fluid 
leaving It ions resulting in a drop in pH. 
3.3 Tissue culture results 
3.3.1 Bone marrow cell culture 
Scanning electron microscopical examination of cultures. 
Osteoblast-like cells were found on the surfaces of the IC disc LG27 after 14 days 
(see Figure 3.14). Cracking did appear for some of the IC discs. Defects did appear 
on the IC disc LG26 (see figure 3.15) as were used for tissue culture. Confluent cell 
monolayers formed on the discs as can be seen with LG6 (see Figure 3.16). 
liS 
Figure 3.14 Scanning electron micrograph of a 14 day rat osteoblast-type cell 
derived from bone marrow cell culture: disc of ionomeric cement (LG27). Cell 
processes in close apposition to surface of IC (Field of width 40J..lm) 
Original magnification x 1000 . 
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Figure 3. J 5 Scanning electron photomicrograph at high power showing defect on 
surface of typical set ionomeric cement as used for cell culture (LG26) after 14 days 
(Field width 200~) Original magnification x1850. 
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Figure 3.16 Scanning electron photomicrograph showing confluent osteoblast- like 
cells (from bone marrow cell culture) on the surface of set ionomeric cement (LG6) 
after 14 days cell culture (Field width=120J.1m) Original magnification x 800. 
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3.3.2 Quantitative assessment of Cytocompatibility Results 
3.3.2 (a) Total protein and MTT results for bone marrow cell cultures 
Figures 3.17 to 3.22 present data clearly showing the difference between the 
different les performance in the MTT test and Protein assays for rat bone marrow 
cell cultures. Particular results of interest are added as footnotes. 
3.3.2 (b) Total protein and MTT results for Ros cell cultures 
Figures 3.23 to 3.30 present data clearly showing the difference between the various 
les performance in the MTT and Protein assays for Ros cell cultures. Particular 
results of interest are added as footnotes. 
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Figure 3.17 BMC cultures associated with the monovalent cation 
series IC LG2 had the greatest concentration of total protein. BMC 
cultures associated with LG70 had the least concentration of total 
protein from all the monovalent cation based ICs. This was 
detennined by using the protein assay (as described in chapter 2.0 
Materials and Method section 2.2.3i). LG2 BMC cultures compared 
to LG70 BMC cultures were statistically significant by using the 
Student t-Test (N=6. Error bar ISD) as P<O.05. LG8 BMC cultures 
compared to LG 11 BMC cultures were not significantly different as 
the Student t-Test showed that they had a P>O.05. LG23 BMC 
cultures compared to LG69 BMC cultures were not significantly 
different as the Student t-Test showed that P>(U)5. All other BMC 
cultures exposed to monovalent cation Ies were significantly different 
e.g. LG5 BMC cultures compared to LG70 BMC cultures had a 
P<O.05 and were thus significantly different. 
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Figure 3.18 LG22 associated BMC cultures were the most 
active (12 x 105cells) from all the monovalent cation based 
ICs used in this study. LG69 BMC cultures were the least 
active from all the monovalent cation based ICs. This was 
determined using the MTT assay (as described in chapter 
2.0 Materials and Method section 2.2.3 ii). LG22 BMC 
culture activity compared to LG69 BMC culture activity 
were statistically significantly different with P<0.05 using 
the Student t-Test (N=6, Error bar ISD). All BMC 
cultures associated with ICs were compared against each 
other and were all found to be significantly different with 
P<0.05. 
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Figure 3.19 BMC cultures associated with the 
apatite-stoichimetric based IC LG29 had the greatest 
concentration of total protein. BMC cultures associated 
with LG27 had the least concentration of total protein 
from all the apatite-stoichiometric based ICs. This was 
determined using the protein assay as described in 
chapter 2.0 section 2.2.3 ii. LG27 BMC cultures 
compared to LG29 BMC cultures were significantly 
different as P<0.05 using the Student t-Test (N=6, Error 
bar 1 SD). All IC-BMC cultures were compared to each 
other and were all found to be significantly different 
with P<0.05. 
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Figure 3.20 LG27 associated BMC cultures were the most 
active (9.5 x Hfcells) from all the apatite-stoichiometric 
based IC cultures used in this study. LG26 associated BMC 
cultures were the least active from all the 
apatite-stoichiometric based IC cultures. This was 
determined using the MIT assay (as described in chapter 2.0 
Materials and Method section 2.2.3 ii). LG27 BMC culture 
activity was compared to LG26 BMC culture activity and 
were found to be signiticantly different with PcdH15 using 
the Student t-Test (N=6. Error bar ISD). LG28 BMC 
culture activity and LG29 BMC culture activity were 
compared using the Student t-Test and were also found to be 
sifgnificantly different with P«U)5. 
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Figure 3.21 BMC cultures associated with the 
commercial cement hydroxyapatite had the greatest 
concentration of total protein compared to all the 
commercial cements used in this study. BMC 
cultures associated with acrylic had the least 
concentration of total protein from all the 
commercial based cements. HA BMC cultures 
were compared to Acrylic BMC cultures and were 
found to be significantly different with P<O.05 
using the Student t-Test (N=6, Error bar ISO). 
Vo-cem BMC cultures were compared to Acrylic 
BMC cultures and were significantly different 
(P<O.05). PTFE BMC cultures were compared to 
Acrylic BMC cultures and were significantly 
different with P<O.05. Vo-cem BMC cultures were 
compared to PTFE BMC cultures and were 
significantly different (P<O.05). All comparisons 
were made using the Student t-Test. 
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Figure 3.22 HA associated BMC cultures were the most 
active cells (13.8 x lifcells) from all the BMC cultures 
associated with commercial based materials. This was 
determined using the MIT assay (as described in chapter 
2.0 of the Materials and Method section 2.2.3 ii). HA 
BMC culture activity was compared to Vo-cem BMC 
culture activity by using the Student t-Test and were found 
to be statistically significant (N=6, Error bar 1 SD) with 
P<0.05. Acrylic BMC culture activity was compared to 
PTFE BMC culture activity by using the Student t-Test 
and were not significantly different from each other as 
P>0.05. Chemfil BMC culture activity was compared to 
Chemfil Express BMC culture activity but were found to be 
significantly different with P<0.05 using the Student t-Test. 
Chemfil Express BMC culture activity was compared to 
Acrylic BMC culture activity and were significantly 
different using the Student t-Test as P<0.05. 
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Figure 3.23 Ros cell cultures associated with the monovalent 
cation series IC LG23 had the greatest concentration of total 
protein. Ros cell cultures associated with LG3 had the least 
concentration of total protein from all the monovalent cation 
based ICs. This was detemined using the protein assay (as 
described in chapter 2.0 of the Materials and Method section 
2.2.3 i~ LG23 associated Ros cell culture protein 
concentrations were compared to LG3 Ros cell culture 
protein concentrations and were significantly different as 
P<0.05 using the Student t-Test (N=6). LG69 Ros cell 
culture protein concentrations were compared to LG70 Ros 
cell culture protein concentrations using the Student t-Test 
and were significantly different. LG2 Ros cell culture 
protein concentrations were compared to LG6 Ros cell 
culture protein concentrations using the Student t-Test and 
were not significantly different as P= 1. 
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Figure 3.24LG23 associated Ros cell cultures were the most active 
(13 x lOs cells) from all the Ros cell cultures associated with 
monovalent cation based ICs. LG3 Ros cell cultures were the least 
active compared to all other Ros cell cultures associated with 
monovalent cation based ICs. These were determined by using the 
MIT assay (as described in Chapter 2.0 of the MateriaI5 and Method 
section 2.2.3 ii). Ros cell culture activity associated with LG23 was 
compared to Ros cell culture activity associated with LG3 using the 
Student t-Test (N=6, Error bar ISD) and were significantly different 
as P<0.05. LG2 Ros cell culture activity was compared to LG6 Ros 
cell culture activity using the Student t-Test and were significantly 
different as P<0.05. LG63 Ros cell culture activity was compared to 
LG6 Ros cell culture activity and were significantly different as 
P<O.OS. LGS Ros cell culture activity was compared to LG69 Ros 
cell culture activity and were significantly different as P<O.OS. LG3 
Ros cell culture activity was compared to LG70 Ros cell culture 
activity and were not significantly different as P>O.OS. 
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Figure 3.25 LG74 Ros cell cultures had the greatest concentration of 
total protein from all the Ros cell cultures associated with ICs varying 
in silica/alumina and calcium. LG57 Ros cell cultures had the least 
concentration of tot a! protein compared to all the ICs varying in 
silica/alumina and calcium concentration. The protein concentration 
was determined by using the protein assay (as described in chapter 2.0 
of the Materials and Method section 2.2.3 ii). LG74 Ros cell culture 
protein concentrations were compared with LG57 Ros cell culture 
protein concentratiorsby using the Student t-Test (N=6, Error bar 
ISD) and were significantly different as P<0.05. LG72 Ros cell 
culture protein concentrations were compared to LG53 Ros cell 
culture protein concentrations and were significantly different as 
P<0.05. LG55 Ros cell culture protein concentrations were compared 
to LG67 Ros cell culture protein concentrations and were also 
significantly different with P<0.05. However, LG67 Ros cell culture 
protein concentrations were compared to LG76 Ros cell culture 
protein concentrations and were not significantly different as P>0.05. 
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Figure· 3.26LG72 associated Ros cell cultures were the most active (11 x 
105 cells) from all the other cultures associated with ICs varying in 
silica/alumina and calcium. LG57 associated Ros cell cultures were the 
least active from this series. These was determined using the MTT assay 
(as described in chapter 2.0 of the Materials and Method section 2.2.3. 
ii). LG72 Ros cell culture activity was compared to LG57 Ros cell 
culture activity by using the Student t-Test (N=6, Error bar 1 SD) and 
were significantly different as P<O.05. LG55 Ros cell culture activity 
compared to LG57 Ros cell culture activity using the Student t-Test 
showed that the cell activities of these Ros cell cultures were significantly 
different as P<O.05. 
129 
Total Protein of Ros cell cultures with ICs 
varying in calcium fluoride 
50~--------------------------~ 
40-
T 
Material 
Figure 3.27 LG45 Ros cell cultures had greater total 
protein concentrations than LG42 Ros cell cultures 
total protein concentrations. The protein 
concentration was measured by using the Protein 
assay (as described in chapter 2.0 Materials and 
Method section 2.2.3 ii). LG45 Ros cell culture total 
protein concentrations were compared to LG42 cell 
culture total protein concentrations by using the 
Student t-Test (N=6, Error bar 1 SD) and were 
significantly different as P<0.05. 
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Figure 3.28 LG42 associated Ros cell cultures (1.3 x lO5 cells) 
were more active than LG45 associated Ros cell cultures (0.8 x lO5 
cells) from the les varying in calcium tluoride. The cell activity 
was measured using the MIT assay (as described in chapter 2.0 of 
the Materials and Method section 2.2.3 ii). LG42 Ros cell culture 
activity was compared to LG45 Ros cell culture activity by using 
the Student t-Test (N=6. Error bar ISO) and were significantly 
different as P<O.05. 
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Figure 3.29 Ros cell cultures associated with the commercial 
cement HA had the greatest concentration of total protein (365 
J.1.g/ml) from all the commercial based materials analysed. Ros cell 
cultures associated with the commercial cement Chemfil Express 
had the least concentration of total protein (1 1 1J.1.g/ml). This was 
determined using the protein assay (as described in chapter 2.0 of 
the Materials and Method section 2.2.3 ii). HA Ros cell culture 
total protein concentrations were compared to Chemfil Express Ros 
cell culture total protein concentrations using the Student t-Test 
(N=6, Error bar 1 SD) where they were significantly different as 
P<0.05. V-os Ros cell culture total protein concentrations were 
compared to acrylic Ros cell culture total protein concentrations 
and were significantly different as P<0.05. Chemfil Express Ros 
cell culture total protein concentrations were compared to acrylic 
and V-os Ros cell culture total protein concentrations and were both 
significantly different as P<0.05. 
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Figure 3.30 HA associated Ros cell cultures were the most active 
(17.2 x Hf cells) compared to all other Ros cell cultures associated 
with commercial materials. Chemtil Express associated Ros cell 
cultures were the least active from all the commercial materials 
analysed (11.7 x 105cells). These were determined using the MIT 
assay (as described in chapter 2.0 of the Materials and Method section 
2.2.3 ii). HA Ros cell culture activity was compared to Chemtil 
Express Ros cell culture activity by using the Student t-Test (N=6. 
Error bar ISD) and were signiticantly different with P<O.OS. V-os 
Ros cell culture activity was compared to acrylic Ros cell culture 
activity and were significantly different with P-dU)5. Chemtil 
Express Ros cell culture activity was compared to V-os Ros cell 
culture activity and were signiticantly different as P-dlOS. However. 
PTFE Ros cell culture activity and TCP Ros cell culture activity were 
compared and were not signiticantly different as P><).OS. Chemfil 
Express Ros cell culture activity was compared to acrylic Ros cell 
culture.activity and were not signiticantly different as P><105. 
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3.4 In vivo Results 
3.4.1 Histological assessment of In IIiI'll surgical implantation 
Of the 144 operations all healed uneventfully except for one with the IC LGl19. In 
this case at day 7 a large swelling had developed around the area of the implant. The 
abdominal muscle was damaged by the reaction and tom and this could not be 
repaired. It was concluded by Dr Brian Howard, the University Vet, that the rat 
should be put to rest. 
The controls (with no surgery, Figure 3.31 and 332) showed normal marrow and 
mature cancellous trabeculae through the mid-shaft of the femur. All the set ICs 
exhibited formation of new bone on their sUlfaces and generally new bone was 
formed in continuity with the implant surface from the woven bone at the surgical 
site into the marrow space as was with the set Ie LG63 with a high sodium content 
(Figure 3.33). 
Histological examination of les in the midshaft of the femur at four weeks revealed 
healed bone with no great difference in biological response subjectively as are shown 
in Figures 3.33 to 3.39. At the same time the response of the tissues to wet Ies 
was more varied as assessed subjectively and objectively as are presented in Figures 
3.40 to 3.46 and Tables 3.54 and 3.56. Only the Ies LG26 and LG30 were used set 
tJ4 
and wet. The set ICs were significantly more osteoconductive and better integrated 
than the wet ICs (Tables 3.54 and 3.55) 
The remodelling of bone at four weeks served to repair damaged tissue and establish 
a new bone IIC interface. When the wet IC is first introduced to bone in the in vivo 
situation the IC is acidic and toxic to soft and hard tissue?4. 46 however by four 
weeks the rat bone has time to repair as shown in Figure 3.33. 
In most cases, the interface between set implants and host was characterized by a 
layer of notably cellular and. variably mineralized immature bone as with the set Ie 
LG26, which has a high calcium fluoride content as shown in Figure 3.35 and Figure 
3.36. In demineralized sections variably mineralized tissues were judged by pale 
pink staining of hematoxylin and eosin that signifies non-mineralized bone tissue 
and the darker pink staining represents mineralized bone. thus variably mineralized 
bone tissue as can be shown in Figure 3.36. In places the cellularity of newly 
formed bone resulted in woven bone: marrow spaces close to the interface were 
lined by prominent osteoblasts. Judged subjectively. the layer of new bone varied 
in thickness for different ICs. for example LG63 with a high concentration of 
sodium (Figure 3.33 and Figure 3.34) showed less bone thickness than the apatite-
stoichiometric glass LG26 with no sodium and high calcium fluoride concentration 
(Figure 3.36 and 3.37). 
In all cases, the periosteal end of the implant was covered by a layer of partly 
remodelled woven bone for set ICs LG2 to LG63 of the sodium based ICs and 
LG26 to LG30 of the apatite-stoichiometric based series (Figure 3.36). Similarly, 
that portion of each implant which projected endosteally (Figure 3.37) was 
separated from the adjacent vital marrow tissue by a thin layer of mineralized 
woven bone (Figure 3.38) as is specified with LG26 as a set IC (with a high calcium 
fluoride content). In demineralized sections mineralized tissue is dark pink using 
haematoxylin and eosin staining and non-mineralized tissue in comparison is much 
paler in appearance. 
Compared to set ICs particles of wet ICs were less frequently surrounded by newly 
formed bone and separated from the adjacent healthy marrow tissue as was with the 
wet IC LG125 which has a high strontium concentration (Figure 3.39). In some 
cases, wet ICs such as LG 125 with a high strontium concentration were surrounded 
by a combination of woven and more mature bone with partly mineralized osteoid 
situated more peripherally (Figure 3.40 and Figure 3.41). Some wet ICs such as 
LGl19 with a low strontium concentration appeared to be still evoking a vigorous 
response at four weeks and were surrounded by combinations of mature bone, 
osteoid and cellular osteogenic connective tissue (Figure 3.42). The interface 
136 
between these wet ICs with a low strontium concentration is demonstrated with 
LGl19 showing cellular osteogenic connective tissue (Figure 3.43). 
In places, wet ICs with a high zinc concentration, such as LG 130, were surrounded 
by compressed cellular connective tissue with minimal evidence of new bone 
apposition (Figure 3.44). Additionally, wet ICs with a high calcium fluoride 
concentration from the apatite-stoichiometric series, such as LG26, were also 
surrounded by acellular connective tissue (Figure 3.45). 
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Figure 3.31 Transverse section through mid-shaft of femur showing extent of 
normal marrow and minimal cancellous trabeculae~ Haematoxylin and Eosin x 42. 
138 
Figure 3.32 Detail from Figure 3.31 showing the surface between normal marrow 
tissue and mature cancellous trabeculae (CT)~ Haematoxylin and Eosin x 212. 
139 
Figure 3.33 Transverse section of femur showing a rod of ion om eric cement LG63 
(Ie) completely surrounded by bone; arrows depict six points around the perimeter 
at which osteoconduction might be evaluated; Haematoxylin and Eosin x 16. 
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Ie 
Figure 3.34 Interface between "set" ionomeric cement LG63 (IC) and bone~ the 
opposing arrows demarcate the thickness of newly formed bone and its 
measurement formed the basis for evaluating osteoconductive potential ~ 
Haematoxylin and Eosin x 162. 
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Ie 
Figure 3.35 Interface (narrow arrows) between the set ionomeric cement LG26 
(Ie) and newly formed bone~ note its cellularity and the chondroid appearance seen 
focally (small wide arrow); osteoblasts line marrow spaces adjacent to the interface 
(large wide arrow)~ Haematoxylin and Eosin x 162. 
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Figure 3.36 Partly remodelled cortex and new bone (arrows) at the periosteal 
interface of the set IC implant LG26 (IC)~ P = periosteum; M = skeletal muscle; 
Haematoxylin and Eosin x 162. 
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Figure 3.37 Set IC implant LG26 (IC) projecting into marrow cavity and separated 
from vital marrow (M) by a thin layer of new bone ( wide arrows); Haematoxylin 
and Eosin x 16. 
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Ie 
Figure 3.38 Detail from Figure 3.37 showing a thin layer of partly mineralized 
woven bone (arrows) separating the set implant LG26 (IC) from vital marrow 
tissue~ Haematoxylin and Eosin x 162. 
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Figure 3.39 Particles ofthe wet cement LG 125 (Ie) surrounded by newly fonned 
bone (arrow) and separated from the adjacent healthy marrow tissue (M); 
Haematoxylin and Eosin x 42 . 
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Figure 3.40 Higher power view of Figure 3.39 showing the wet cement LG125 (Ie) 
surrounded by a combination of woven (W) and more mature bone (M) with partly 
minerali d osteoid (0) situated more peripherally. The wide arrows demarcate the 
thickness of newly formed bone and its measurement formed the basis for 
evaluating osteoconductive potential; Haematoxylin and Eosin x 106. 
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Figure 3.41 Detail from Figure 3.40 showing interface between the wet cement 
LG125 (Ie) and relatively mature bone (M); Haematoxylin and Eosin x 212. 
148 
Figure 3.42 Wet cement LG 119 (IC) surrounded by a combination of mature bone 
(MB), osteoid (0) and cellular osteogenic connective tissue (C)~ Haematoxylin and 
Eosin x 42. 
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Ie 
Figure 3.43 Interface between the wet cement LG 119 (Ie) and notably cellular 
osteogenic connective tissue (c) (bold arrow); Haematoxylin and Eosin x 212. 
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Figure 3.44 PartIcle of the wet cement LG 130 (lC ) surrounded by compre ed 
cellular connectIve tl ue (C) WIth mInImal e\ldence of new bone appo tion~ 
Haematoxylin and Eosin x 106 
151 
Figure 3.45 The wet cement LG26 (Ie) surrounded by acellular connective tissue 
(C)~ new bone fonnation is present peripherally (arrow); Haematoxylin and Eosin x 
212. 
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3.4.2 Histomorphometric results 
There were differences in the amount of new bone in contact with the implanted ICs 
i.e. with the length of the bonelimplant interfacial contact (osseointegration) and in 
the amount of bone formed adjacent to the implants (osteoconduction) as assessed 
after four weeks (Turn to Appendix and see Tables A I-A 16). 
Table 3_~ Sununary of mean and SD of cach sct lonomcric ccmcnt at four weeks implantation 
N=S 
Ionomeric cement 
LG2 
LG6 
LG63 
LG26 
LG27 
LG30 
% Osscointcgratloll 
:no ± ox 
61.0 ± H, 
6KII ± IIX 
XOX ± 2 (, 
7K2 ± I 1 
706 ± 2.1 
Ostcoconduction (mm) 
005 ± 0.112 
o III) ± (I()(, 
01 ± om 
o 16 ± 0.2 
O.OK ± 11.112 
0117 ± 002 
LG26 had the grCcltcst ''I., osscointegration and ostcocolldIlCt,,·C ,·alllcs. whcreas LG2 has the least 
% osseointegration and ostcoconductivc valllcs 
Table 3.!Fi!Fi Summary mean and SD of cach wct IOllolllcnc ccmcnt at four wccks implantation N=5 
Ionomeric ccmcnt 
LG23 1:2:3 
LG23 1:2:2 
LG26 
LG30 
LG1l9 
LGI2S 
lOl30 
lOl32 
% Osscointcgration 
655 ± 15 
50 (, ± 2 ') 
67.1 ± I') 
5·U ± 11 
56.2 ± 1.X 
770 ± 2.6 
72.4 ± :U 
42 5 ± 1 1 
Ostcocondllction (nllll) 
004 ± 001 
002 ± 001 
otl6 ± 002 
0.04 ± 0.01 
0.05 ± 002 
OOX ± (UII 
o 05 ± 0.01 
005 ± 001 
LGl2S had the greatest % osscointcgration and ostcoconduct,,·c valucs LG 112 had thc ICclst valuc 
for%osseointcgration. howevcr. LG21 122 If had thc least ostcocondllCtivc valuc 
1~3 
Table 3.56 SUl1una~' mean and SO of each of thc ACJ'\hc cemcnts at four weeks implantation N=; 
Aaylic type 
ACJYlics set 
ACJY lies wet 
% Osseointcgration 
29.9 ± 2.3 
25.9 ± 2.8 
Ostcoconduction (nun) 
0.0; ± 0.02 
om ± 0.02 
ACJYlic set cements had greater % osscointcgratl\'c and osteoconductive values than the wet cements. 
The following are all based on the paired Student's t-Test 
-Rods of LG26 (apatite-stoichiometric based cement) were significantly better 
integrated than the other set rods (p< OOS in all cases) 
-Rods ofLG2 (sodium based cement) were signiticantly less well integrated than 
other set rods (p< 0.05 in all cases) 
-Rods ofLG26 (apatite-stoichiometric based cement) were significantly more 
osteoconductive than the other set rods (p< 0 as in all cases) 
-Rods ofLG2 (sodium based cement) were signiticantly less osteoconductive than 
other set rods (p< 005 in all cases) 
-Rods of LG 125 ( radiopaque strontium based cement) were significantly better 
integrated than the other wet cements (p" 0 os in all cases) 
-Rods ofLG23 high powderlliquid ratio ( sodium based cement) were significantly 
less osteoconductive than the other wet cements (p < 005 in all cases). 
-Rods ofLG 125 ( radiopaque strontium based cement) were significantly more 
osteoconductive than the other wet cements (p < 0.05 in all cases). 
3.3.2 Immunohistochemical evaluation 
3.3.2.1 General Histology 
Of the 15 implant sites all healed uneventfully All the ionomeric cements 
exhibited formation of new bone on their surface and generally new bone was 
formed in continuity with the implant surface from the woven bone at the surgical 
site into the marrow space (Fig 3.31) The operation site was entirely healed and 
the cortex was repaired. In places the cellularity of the newly formed bone resulted 
in a chondroid-like appearance: marrow spaces close to the interface were lined by 
prominent osteoblasts. Even as judged subjectively, the layer of new bone varied in 
thickness for different ionomeric cements In all cases, the periosteal end of the 
implant was covered by a layer of partly remodelled woven bone. 
3.3.2.3 Immunohistochemical assessment 
LG23 
-
The greatest amount of osteopontin staining (OPN) was in bone associated with the 
Ie LG23 (Figure 3.46). Demineralization of the sections had little effect on OPN. 
FN and TN staining. There was a significant amount of differential staining of the 
reversal lines (Figure 3.47) that were densely thread-like in appearance. Reversal 
lines indicate the borders between new layers of bone that have been formed on old 
layers. The brighter staining signified the new woven bone in comparison to the less 
dense staining showing the mature bone, as OPN was staining the reversal lines but 
with less intensity. 
FN was clearly present as it was staining the woven bone associated with the 
implant surface of LG23 (Figure 348) and megacaryocytes. FN was found in the 
mineralized matrix of woven bone in a diffuse granular or fibrous arrangement. TN 
was distributed in soft tissues in the periphery of the endosteum in a diffuse 
granular pattern immediately adjacent to and within sites of ossification. 
LG6 
-
Reversal line staining was apparent at the regions of woven bone greater than that of 
mature bone. However, the amount of OPN staining was less than that of LG23 
associated woven bone (Figure 349) FN was again abundant at the implant-bone 
interface, and in woven bone, staining megacaryocytes TN was present in the 
bone associated with the implant interface (Figure 3 50), clearly showing intense 
staining at the periphery of the endosteum 
LGZ 
-
There was less OPN thread-like fluorescence in woven bone associated with LG2, 
the control, (Figure 3.51) in comparison to LG2J and LG6 Intense staining was 
situated at the woven bone in contact with the implant. FN was stained for at the 
megacaryocytes and was abundant in the bone. TN again stained the bone adjacent 
to the Ie-implant, LG2, at the peri phery of the endosteum (Figure 3.52). 
t~7 
Figure 3 . ./6. OPN immunofluorescenece stain at the new woven bone (NB) and 
with less brightly stained mature bone (MB) with the Ie -implant LG23 (Ie); x 200. 
I~X 
Figure 3.-17. OP immuofluore eenee stain at new woven bone den ely staining 
the reversal lines (R) signitied by pointed arrm in new bone (NB) and to a lesser 
degree staining mature bone (MB) with the Ie -implant LG23 : x 400 
I 'i') 
Figure 3AN. F immunot1uore cence tain at the mineralized matrix of woven bone 
diffuse granular arrangement indicated by arrows pointing at the new woven bone in 
contact with the Ie-implant LG23 , x 200 
Figure 3. -19. OP immunotluore eenee stain at the reversal line (indicated by 
arrow) in cl ose pro -imity to the lC-imrlant l G() . x 200 
1< 01 
Figure 3.50 , TN immunofluore cenee stain at the periphery of the endosteum (P), 
arrows indicate the granular appearance v, ith close contact to the bone associated 
with the IC- implant (I) LG6, x 100 
Figure 3.51 OPN immunotluore cent stain in new wo en bone (NB) in 
comparison to mature bone (MB) with the Ie implant (I) LG2, x 300 
Figure 3.52. TN (T) immunotluorescent ,taln at the periphery of the endo teum 
Note a diffused granular appearance of thL' 1lL'\\ \\ men hone (1 'B) a, sociated with 
the Ie-implant LG2 (l) (Indicated bv alltl\\'). ·HlI) 
4. GENERAL DISCUSSION 
From the review presented in Chapter One (pages 1-22), it is clear that certain 
formulations of IC have potential as osteoconductive bone substitutes and 
cements?4. 35.45.46. 4R. 57. 72. 77. 110. R2 The evidence presented in previous studies has 
relied largely on the use of commercial dental materials or minor variations in 
formulation.35. 45. 4&. RI A minority of groups have had access to experimental 
materials from the Laboratory of the Government Chemist and industry (e.g. MP4 
from Pilkingtons), but precise and reliable data on composition is again lacking.34. 46. 
62 The situation is further complicated by very recent reports that aluminium ions 
leached from ICs may be undesirable, inhibiting local bone tissue mineralization 190 
and even causing patient death after inappropriate placement. lOR 
Despite the inadequate data on IC formulation, most authors agree that glass 
composition is an important factor determining both biocompatibility and 
osteoconduction However, to date no reports on the biological response to IC's 
for biomedical application have been based on a series of defined glass formulations. 
The development of a large number of well defined materials by Hill et al 
(University of Limerick) presented an excellent opportunity to address this issue. 
The experiments presented in Chapters Two and Three were designed specifically 
to investigate the relationship between formulation and biocompatibility. In 
addition, the potential for clinical use of Ies as bone substitutes and cements was 
addressed. The following sections discuss the relationship between glass 
composition, ion release and biological response ill vitro and in vivo. Clinical 
handling characteristics are also important and these are discussed first. 
4.1 Setting and working times 
Setting and working times are very important characteristics. If the material is 
difficult to handle in the operating theatre or sets too quickly, it will be totally 
unsuitable for use as a bone cement. To date, no appropriate times have been 
described for IC bone cements, although these parameters have been defined for 
acrylic bone cements (4 to 15 min by the "International Standard Organisation" 
(ISO). Some attempt has been made by the author to define the needs in an IC 
system (Section 2.2.1). In brief, it was decided that a material required a working 
time> 150 seconds to have a practical application in the operating theatre. 
The setting and working times required for the surgical placement of ICs for use as a 
bone substitute in maxillofacial surgery or as a hip replacement were studied. No 
attempt was made during this study to modify the setting and working times of 
cements. There is however potential to modify the setting characteristics of these 
ICs by the addition of tartaric acid, which may improve the manipulation of the 
cement paste, sharpen the set by accelerating the precipitation process, and may 
increase the cements strength. The addition of tartaric acid would be suitable for 
cements with less fluoride. 
Other factors affecting the setting time would be the glass composition, especially 
with the alumina/silicate ratio and fluoride content. Particle size of the glass powder 
is important as the finer the powder the faster the set and the shorter the working 
time. The relative proportions of the constituents in the cement mix i.e. glass, 
poly(acrylic) acid and water are important as the greater the proportion of the glass 
and the lower the proportion of water the faster the set and the shorter the working 
time. On mixing, all the ICs, with the exception of LG23 at a low powder !liquid 
ratio, were sufficiently viscous to prevent flow and loss from the surgical field 
during placement. This would assist the surgeon and avoid displacement of material 
into adjacent tissues. 
Some of the glasses evaluated did not form a cement at the ratios investigated. After 
being mixed with 0.2 g ofpoly(acrylic) acid, OJ ml water the Ig of the glass 
powder, LG94, LG93, LG92 and LG91 had not undergone gelation after 40 min. 
It has been reported that fluoride prolongs working time,~l glasses LG91-LG94 had 
a high calcium fluoride content (2.2-2.6 mole fractions) which may explain their 
poor cement forming properties. The glasses used in Tables 3.1-3.5 had fluoride 
mole fractions ofless than 2.0, which may explain why they had shorter setting and 
working times.S2.191 Formulation clearly has an effect on the mixing and working 
properties of ICs (Introduction, page 8). 
The acrylic cements had the longest setting time (540 seconds) (Table 3.5) and were 
found to be the least biocompatible (Table 3 56) this could be from the exothermic 
setting reaction that may cause thermal necrosis or the release of monomer.2R-32 
Despite their poor performance in this study, many surgeons are familiar with the 
behaviour of this biomaterial in the theatre. 
Of the materials tested under simulated surgical conditions, those with setting times 
> 150 seconds and working times> 120 seconds might be considered most suitable 
for use as an in situ setting bone substitute or cement for low-load bearing 
applications. Materials that met this requirement were LG26, LG27, LG30 and the 
acrylics. LG26 had a longer working time as it had a greater concentration of 
fluoride than LG27 and LG30. 51,191 
4.2 Relationship between glass composition and ion release 
Ion release is believed to be an important determinant ofbiocompatibility of ICs. 
Ion release experiments were designed to model these events prior to cell culture 
experiments. The results of extensive ion release studies are given in Chapter 
Three (Tables 3.6 to 3.49). 
In general, it was observed that the ions released from a set IC reflected closely to 
the cement formulation. However, a number of subtle but important deviations 
from this trend were observed. There was a relation between calcium and phosphate 
with some of the ICs. In that as the calcium content of the glass increased there 
was less phosphate released (see Table 3.45 of Results chapter). 
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The importance of some of these deviations will be more clear in the discussion of 
biocompatibility (Section 4.3). The influence of composition On the release of each 
ion will be considered separately before looking at the effect of this phenomenon on 
biocompatibility. 
4.2.1 Fluoride ion release 
Ion release experiments were carried out by placing various glasses as set IC discs 
(see Chapter 2, Materials and Method section 2.1.1) into SO ml of pure water. 
While fluoride ion release is clearly one of the critical factors determining 
biocompatibility and osteoconduction, no groups have yet reported an optimum 
range for elution of this ion. In this study, LG26 and LG 125 were found to perform 
best in the il1 vivo implantation experiments (see Tables 3.54 and 3.55). It is not 
unreasonable to assume that fluoride release was near optimum for this animal 
model. 
Care must be taken when extrapolating these results to the human clinical situation. 
Firstly, the young rat model may have a different metabolism to an adult human 
who may be compromised by trauma or disease. The shape of set IC bone cement 
in the body would be of an irregular shape and would present a greater surface area 
for ion release. Therefore further experiments are required to optimise the release of 
fluoride for a medical grade Ie. It is important to remember that a range of other 
ions such as aluminium, silicate, calcium and phosphate have biological activity and 
are implicated in the osteoconductive behaviour ofIes (see Section 1.1.4). 34-36,46, 
81,84,92-99,114,192-195 
Much evidence suggests that there is more than one mechanism responsible for 
fluoride ion release. The most accepted theory to date is the counter ion 
mechanism. 50 The counter ion mechanism involves the simultaneous release of an 
alkali metal cation, for example a sodium counter ion. 50 The monovalent sodium 
cation and the negative fluoride ions have a charge balancing effect, where fluoride 
is released as sodium fluoride. LG6 with a high sodium concentration released the 
greatest amount of free fluoride (section 2.1.1a and Table 3.16). This also applied 
to LG69 (Table 3.6 and section 2.1.1 a ii) from the monovalent cation based les, 
releasing the greatest initial burst of fluoride from all the les used in this study 
(Table 3.6) and has a high sodium content (0.5 mole fraction, Figure 3.1 to Figure 
3.3) relating ion release to cement formulation. 
The ion exchange mechanism explains how cements with no alkali metal content 
are still able to release fluoride indicating that a soluble counter ion is not always 
required. At all times the cements in this study demonstrated a negative ion 
balance where there were more negative ions leaving the cement than positive ions. 
While this experiment was not designed to specifically study ion release mechanism 
the results (Table 3.6 to 3.49) indicate that the cements may also release fluoride 
ions by an ion exchange mechanism where the fluoride ion in the cement would be 
exchanged for a hydroxyl group from the water in the elution medium. 195 
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Glasses containing a low fluoride concentration released a low concentration of 
fluoride ions, for example LG45 (Table 3.8 and section 2.1.1 h) showing a positive 
relation between fluoride ion release and cement formulae i.e. less fluoride in the 
cement resulted in less fluoride ion release. Figure 3.5 showed a strong correlation 
coefficient of 1 between fluoride glass content and fluoride ion release. Fluoride 
ion release was found to increase as the sodium or calcium fluoride content of the 
glass increased. 
There was a greater fluoride release in glasses with an increased silica 
concentration and decreasing aluminium concentration glass composition, for 
example, LG81 (Table 3.10 and section 2.1.1 k). While fluoride ion release was 
clearly one of the critical factors determining biocompatibility and 
osteoconduction, no groups have yet reported an optimum range for elution of this 
ion. 
The total and free fluoride ion results for the monovalent cation series (Table 3.6 
and Table 3.16) and apatite-stoichiometric based series (Table 3.7, Table 3.17 and 
Figure 3.4) showed no significant difference between the measurements made with 
and without TISAB ill indicating that virtually all the fluoride ions eluted were 
released as free fluoride ions and were not chelated to metal cations, such as with 
aluminium. 
171 
4.2.1 b) Fluoride ion release of LG2 and LG26 in alpha-minimal essential 
medium and autoclaving 
ICs were placed in a-Minimal essential media (a-MEM) to determine the amount 
of fluoride eluted in simulated body fluid. a-MEM contained inorganic ions close in 
concentration to those in human blood plasma. LG26 had a high calcium fluoride 
concentration and for this reason released more fluoride (see Table 3.13 and section 
2.1.1 b) than LG2. This was beneficial as fluoride ions at certain concentrations are 
potentially osteoconductive. 34-36.46. X4. 'J2-'J5 
Less fluoride ions were released by LG2 and LG26 a-MEM (Table 3.13) than in 
water (Table 3.6 and 3.7). Autoclaving effects of the ICs were investigated because 
the set rods were sterilised by autoclaving. There was an initial burst of fluoride 
ions in the water during autoclaving. Contact with aqueous fluids must be avoided, 
for these removed ions such as fluoride 51 and prior to placing Ie discs into a-MEM. 
The fluoride release from a material depends upon the length of maturation of the 
matrix prior to first exposure to moisture. The shorter the maturation period the 
greater the fluoride ion release. 196 The maturation time for these cements was 24 
hours therefore a low amount of fluoride was released. This also applied to results 
. 
in Table 3.15 An alternative method to sterilise ICs to avoid water contact would 
be to 'Y-irradiate the ICs. 
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During setting of an IC a paste was formed where the basic glass powder reacted 
with poly(acrylic) acid to form a salt hydrogel This hydrogel was the cement 
binding matrix. This ionic reaction took place in three stages. Firstly, a surface 
decomposition of the glass particles by hydronium ions (H30 +) from poly(acryJic) 
acid solution took place. This resulted in the release of AI 3+ and Ca 2+ leading to 
the aqueous phase. Fluoride ions in the form of sodium fluoride were also released 
from the IC for a sustained period of time. 1'J7 
Secondly, a calcium poly(acrylic) gel resulted from reaction of calcium with 
poly(acryJic) acid. The final reaction was the formation of aluminium poly(acrylic) 
acid which cross-linked the poly(anion) chains The diffusion of Ca + and AI 3+ ions 
from the glass into the aqueous phase was facilitated by formation of fluoro-
complexes. l97 Only a thin surface layer of glass particles was involved in the 
cement formation reaction. The set cement consisted of a solid insoluble aluminium-
calcium poly(acrylic) matrix in which non-reacted glass powder particles were 
surrounded by a thin silica gel layer (filling materials) and water molecules. In the 
early stage of setting, a proportion of the cement-forming aluminium, calcium and 
fluoride ions were present in soluble form and could be dissolved out of the cement 
by aqueous fluids. Once these ions were leached out, they were unavailable for 
matrix formation and the surface was softened. The cement was sensitive to loss of 
water during the third step of the setting reaction and for some time in its set form, 
which may have lead to shrinkage and surface cracking \')7 Under conditions of 
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complete desiccation the cement was dramatically weakened. In a biological 
system, for instance in the bone cavity, this could not happen. Al 3+ and Ca 2+ were 
solidly fixed in the cement phase and only appeared as trace elements. 197 
4.2.2 Sodium ion release 
The sodium (Na +) monovalent cation is an important charge balance in the 
counter ion mechanism proposed to account for fluoride ion release from ICs 50 and 
does have some physiological importance.91 Increasing sodium glass content lead 
to increased sodium ion release in the monovalent cation series of ICs relating to 
cement formulation(Section 2.1.1 a). For example, LG6 released the most sodium 
(51.2 J..lmolg- l of sodium at 84 days) and had a high sodium glass content (see Table 
3.18 and Chapter 2, section 2.1.1, Figure 3.1 to Figure 3.3). There was a strong 
correlation between sodium glass content and sodium ion release as shown in 
Figure 3.6 where the correlation coefficient was 0.99. This indicted that sodium ion 
release was dependent on the sodium glass content. 
Sodium ion release was detected from all ICs, even the apatite stoichiometric series 
of glasses, that had a non-sodium formula (Chapter 2, section 2.1.1 and Table 3.19 
of Results chapter). The sodium ion release from this series was explained by 
possible contamination during glass preparation, grinding, washing or handling of 
the glass. LG6 released a high concentration of fluoride and sodium from the 
monovalent cation series ofICs (see Tables 3.6 and 3.18). It may be that fluoride is 
partially released as sodium fluoride via the counter ion mechanism. 50 
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4.2.3 Potassium ion release 
The potassium(K) monovalent cation may be considered a charge balance in the 
counter ion mechanism. However, no group as yet has demonstrated the ability of 
potassium to be released with fluoride via the counter ion mechanism. 50 Selected 
les were measured for potassium ion release as it does have some physiological 
importance 91 and is considered important in the body with respect to cell mass. 91 
LG8 eluted a greater amount of fluoride ions than L07 showing a possible relation 
between fluoride ion release (Table 3.6) and potassium ion release (Table 3.20) 
with the monovalent cation series. L08 has a greater potassium glass content than 
L07 showing a relation to cement formulation, and for this reason it may be the 
potassium ion, a monovalent cation, that could be partially eluted with fluoride by 
the counter ion mechanism 50 as a counter ion. 
Aluminium ion release 
Aluminium is important in the formation of Ies and with their biological properties. 
Aluminium in Ies determined whether the glass network would breakdown at all 
when exposed to acids, and the rate at which the breakdown occured51 and was an 
important constituent for cement formation. 51 Ies that were high in aluminium 
content are opaque. 51 Alumina reduces the setting time of the cements 51 and 
increases their compressive strength. 5 1 Although strength may be increased by 
these means it is achieved at the expense of translucency, 51 which is an important 
factor in dental applications. It has been reported that aluminium ions are released 
for a short period and can be absorbed by tooth enamel, conferring acid-resistance. 
198,199 
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Aluminium has many disadvantages and advantages in a physiological system (see 
Section 1.1.4 d). It has been reported to bind to constituents of bone tissue such as 
collagen that may build a positive potential on coHagen fibrils and prevent 
mineralization. 190.192 The binding of aluminium on HA crystals and bone 
constituents, such as coHagen, may be building a positive surface potential which is 
responsible for the inhibition ofHA crystal growth and bone mineralization. 192 
In addition to this aluminium has been reported to enhance the mobilisation of 
calcium from bone by a cell-independent mechanism 107 and can disrupt the 
conversion of the initial formed soluble amorphous bone mineral to its crystalline 
form. If this occurs, the amorphous form of the mineral could be readily dissolved 
and eluted from the tissue. Ul7 Chronic aluminium toxicity has been reported to have 
lead to Alzheimer's disease'H and aluminium encephalopathy. lOR 
By contrast, other groups have found that aluminium at low concentrations have 
stimulated the expansion of osteoblast (and the subsequent apposition of lamellar 
bone). W2, 10] These conflicting results may be from small variations in aluminium 
concentration. Trabecular generation has been reported lOl and may be an indication 
of a latent potential for skeletal regeneration without re-enacting de novo processes. 
For these reasons it would be safer if aluminium levels were kept low. Recently it 
has been reported that in fish silicic acid protects against the toxicity of aluminium 
by the formation of hydroxy aluminosilicates (HAS) and a mechanism of formation 
of these species has been suggested. 20U-202 
While aluminium ion release is a major factor in determining biocompatibility and 
perhaps osteoconduction, no groups have yet reported an optimum range for elution 
of this ion. In this study, LG26 and LG 125 were found to perform best in the in 
vivo implantation experiments ( Table 3.54 and 3.55). It is not unreasonable to 
assume that aluminium release was near optimum for this animal model. These 
materials were expected to be suitable at aluminium levels less than 0.2 nmolg-1 as 
this was the maximum aluminium ion release from the ICs tested (Chapter 3, Table 
3.22 to Table 3.27 and Figure 3.10). However, care must be taken when 
extrapolating these results to the human clinical situation as with fluoride. 
Aluminium is recommended to be kept at low levels as the binding of aluminium 
ions to hydroxyapatite nuclei in bone can inhibit further precipitation and crystal 
wth 190. 192 gro . 
The monovalent cation based IC LG69 eluted the greatest amount of aluminium 
from all the ICs tested in this study (2.6 nmol/g in 42 days). There was no 
distinctive relation as to why there was a higher aluminium elution from LG69 than 
the other ICs tested, only that there was a higher sodium concentration (O.S mole 
fractions) in LG69 glass than others tested that can be shown in Figure 3.7 (Results 
chapter) where there was a relation between increased sodium glass composition and 
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positive correlation with aluminium ion release with a correlation coefficient of 
0.97. This strong correlation of aluminium ion release increase was evident in 
Figure 3.8 with increasing sodium glass content at 21 days showing a relation to its 
Ie formulation. Figure 3.9 showed a positive correlation between increasing 
potassium glass content and aluminium release increase (correlation 
coefficient=O.87). 
The low aluminium release from the set cements indicated that there was no 
significant dissolution of the cement matrix and that ion release occurred largely by 
a diffusion process, rather than by surface dissolution. Aluminium ions were small 
and of high charge (AI 3+) and were strongly chelated by the poly( acrylic) acid of 
the polysalt matrix and were bound in the cement reducing diffusion. Diffusion is 
the process by which matter is transported from one part of the system to another as 
a result of random molecular motion. The diffusional aspects in polymer systems 
have been strongly related to the fractional free volume present. In polymers, 
segmental molecular motion allowed diffusion of molecules to jump from one 
sorption site to the next. Diffusive motion depends on penetrant size, shape and 
concentration, component interactions and temperature. The morphology and the 
number or type of structural defects in the polymer were also important. Ficks first 
law was the rate of transport of a diffusing substance through a unit area into an 
absorbing solid or fluid is: 
J=-D dcJdx (203) 
Where J is the rate of transfer of diffusing substance, 
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C is the concentration. 
X is some distance into absorbing solid or fluid and 
D is the diffusional coefficient. 
Frequently diffusion occurs in one direction only. Hence, a concentration gradient 
exists only along the x-axis. In such cases the rate of mass transfer was given by 
Ficks second law which stated: 
dC/dt = Dx d2 C/dx2 (2113 ) 
where t is the time. The most common equation used for the absorption/desorption 
processes, for short times was: 
Mt/M* =4(Dtl7th2)1'2 
Where M§is the equilibrium mass uptake, 
Mt is the mass uptake at time t and 
H is the thickness. (2m) 
H was usually small to minimise edge effects and to permit one dimensional 
penetrant diffusion. In general, the diffusional behaviour and transport mechanisms 
in glass polymers were classified according to the relative rates of mobility of the 
penetrant and the polymer segments. Three basic categories exist, which may be 
described as follows:-
(1) Fickian Diffusion was where the rate of penetrant diffusion was much less than 
that of the polymer segmental mobility. Sorption equilibrium was rapidly 
obtained. with no dependence on swelling kinetics being observed. In mass 
17') 
uptake profiles, a linear relationship was seen between Mtl Moo-Q.6. D, diffusional 
coefficient, may be calculated from the linear slope. 
(2) Extreme Fickian diffusion occured when the penetrant mobility was much 
greater than the polymer relaxation process. Here sorption processes were found to 
be strongly dependent on swelling kinetics and mass uptake profiles showed a 
linear relationship with time. The diffusing penetrant moved as a sharp front of 
constant velocity. Many polymeric systems exhibit this type of behaviour, 
especially the alcohol/glass polymer systems e.g. methanollPMMA. 
(3) Non-Fickian or anomalous diffusion occurs when the penetrant mobility and 
the polymer segmental relaxation were comparable. (1) and (2) may be as the two 
limiting types of transport behaviour, with anamalous diffusion being between 
them. They could be distinguished by the slope of the sorption-time curve 
represented as follows:-MtlMoo=Kf 
Where Mt is the relative weight gain at time t, 
Moo is the equilibrium relative weight gain and 
K and n are constants. 
For (1 )n=112 
(2)n=1 
(3)112 <n<1. 
Permeation was a three part process, involving 
(a) a solution of small molecules in a polymer, 
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(b) molecule migration or diffusion through the polymer according to the 
concentration gradient and 
(c) the molecule emergence at the outer surface. 
Permeability, P, was the product of the solubility, S, and diffusivity, D, and where 
solubility obeys Henry's law P=DS. 2/)4 The permeation of water molecules varied 
greatly from polymer to polymer. This variation was greatly influenced by the 
degree of interaction which was possible between the water molecule and polar 
substitutes of the polymer chains. If mass, as in ions, were transferred from an IC 
to an immersion medium and vice versa as in Ie fluoride uptake studies, the 
mechanism by which this process occured could only be by diffusion. 
If ICs were partly insoluble due to a combination of thermodynamic, kinetic and 
structural factors, the only mechanism which will allow structural degradation to 
occur in water would be by diffusion. Water molecules, which are relatively small in 
contrast with macromolecules, were strongly associated through hydrogen bond 
formation, in both the liquid and solid states In polar molecules, strong localised 
interactions may develop while in non-polar materials, clustering or association of 
the absorbed water molecules may have occured 203 
As aluminium release from the set cements was negligible and there was no 
significant difference between the free fluoride and the total fluoride released. This 
suggests that little or no fluorine was released in the form of aluminium complexes. 
lXl 
The cements with no alkali metal content still released fluoride indicating that a 
soluble counter ion is not required. 50 At all times the cements demonstrated a 
negative ion balance where there were more negative ions leaving the cement than 
positive ions (see Results chapter 3.0 page 114-115). The results demonstrated 
that the ion exchange mechanism may be responsible whereby the fluoride ion in 
the cement is exchanged for a hydroxyl group from water in the elution medium. 195 
It must also be pointed out that cement discs were allowed to set for 24 hours prior 
to elution. Exposure to water at earlier times may have lead to possible dissolution 
and greater ion release. The aluminium results (see Table 3.22-3.27) showed that 
the les used in this study would not be expected to reach a level to cause 
bl S 81, 108, 190 pro em. 
Ion release levels were probably dependent on the mass of the cement material 
implanted. Dissolution at the cement surface in setting cements was a factor in ion 
elution. Protecting the cement surface or extending the time prior to immersion had 
been shown to reduce ion elution. In addition, for any given Ie system, the total 
loss in mass terms due to ion elution was negligible. 
Long term changes in the properties of les were generally regarded as being due to 
continued degradation of the glass and a cross-linking reaction that took place over 
an extended time period exceeding one year. Thus the concentration of ions, 
including fluoride ions in the polysalt matrix was likely to increase with time. The 
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low release of aluminium from the set cements indicated that there was no 
significant dissolution of the cement matrix and that ion release occurred largely by 
the diffusion process. 
Erbe et al reported that the most striking feature of the IC-group was the abundant 
amount of osteoid tissue seen one year post-operatively. This was probably an 
expression of a disturbance of mineralization comparable to the osteomalacia 
produced by administration of aluminium and magnesium antacids205 Carter DH et 
al concluded that the defect in mineralization in the bone apposed to the implant 
could then be attributed to the eluted ions and that aluminium ions have stimulated 
the apposition of lamellar bone.206 
Blades et af 1997 reported that the interface tissue of these les showed good 
integration but poor mineralized tissue and osteoid-like in appearance. 207 Two 
possible local mechanisms were acting to upset normal bone mineralization. The 
release ofWions from unpolymerised poly(acrylic) acid component of the wet ICs 
would have created a locally low pH environment, or set cement and would have 
incorporated into mineralizing osteoid that may be responsible for the inhibition of 
mineralization observed in all ICs implanted (LG26 and LG30). Further 
optimisation of cement formulation to minimise aluminium and W release from the 
setting cement may improve the biocompatibility and mechanical properties of the 
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bone-Ie interface. 207 This may have indicated that the effect of the aluminium ion 
depended upon small variations in its concentration. 206 
4.2.5 Silicate release 
It was important to keep the silicate release levels low as high levels of silicon have 
been related to autoimmune diseases208 and as Meyer et al concluded silicon may 
lead to disturbances in mineralization. 102 It has been reported that silicic acid 
prevents aluminium toxicity in fish.200-202 The protection by silicic acid is believed 
to involve the formation of hydroxy alumino silicate (HAS) and a mechanism of 
formation of these species has been suggested.202 HAS remains sufficiently stable 
on a biological time scale and to have significant inflUence upon the toxicity of 
aluminium in fish and in biological systems in general. 201,202 From this it can be 
concluded that silicon at low concentrations is non-harmful. 200-202 The greater the 
silica content of the glass the greater the amount of silicate ion release from the 
cement matrix. 
While silicate release was a critical factor determining biocompatibility, no groups 
have yet reported an optimum range for the elution of this ion. In this study, LG26 
and LGl25 were found to perform best in the in vivo osteoconductive experiments 
(Table 3.54 and Table 3.55). It is not unreasonable to assume that silicate release 
was near optimum for this animal model. In the elution experiments LG26 (Table 
3.29) silicon was detected early on in the experiment. At day one 2.3 J.UIlolg-1 was 
released and at day forty-two 50.1 J.1molg-1 of silicon was measured. Perhaps silica 
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IC concentrations of 4.5 mole fractions could be suitable and be a safe range for 
silicate release as a dental material and as an orthopaedic cement. However, care 
must be taken when extrapolating these results to the human clinical situation. 
No relation was found between sodium glass composition and measured silicon 
release as shown in Figure 3.11, that had a correlation coefficient of 0.3. There was 
no relation between potassium glass composition and silicon release (Table 3.38). 
However, a wider range of potassium glass concentrations would have confirmed 
this confidently. There was a relation between increasing silicon release and 
decreased CaF2 in glasses (Table 3.29 and Table 3.30) e.g. L045 had no CaF2 and 
eluted the greatest amount of silicon measured at 42 days compared to all other 
glasses tested (Table 3.30). Measured silicon, as expected showed a relation to 
silica glass composition e.g. at day 1 L081, containing a mole fraction of6.75 of 
Si02 eluted the greatest levels of measured silicon from the series varying in silica 
:alumina ratio showing a relation between ion release and IC formulation. As 
aluminium glass composition increased less silicon levels were detected (Table 
3.32). 
Measured silicon release increased as phosphorus pentoxide composition increased 
for generic compositions derived from the apatite stoichiometric based glass LG26, 
as shown in Figure 3.12, where there was a strong correlation of 0.96 correlation 
coefficient (Table 3.33). However, silica glass composition also increased making 
it difficult to conclude whether improved phosphorus pentoxide glass composition 
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increased the measured silicon release from these ICs The testing of phosphorus 
pentoxide based glasses may have concluded this There was no relation between 
the calcium based series and measured silicon release (Table 3.34). 
A possible pattern emerges with some ICs releasing low levels of measured silicon 
and aluminium from the same ICs. For example, LG22 was measured as eluting the 
least amount of aluminium and silicon from the monovalent cation series (Tables 
3.22 and 3.28). This pattern also applied to LG77 of the series varying in 
silica:alumina ratios, which released the least amount of measured silicon (Table 
3.32) and aluminium (Table 3.24). 
4.2.6 Calcium ion release 
Calcium is important as it is a constituent of teeth and bones as hydroxyapatite 91 is 
responsible, partially, for the release oftluoride ions from ICs. 51 Calcium is both 
physiologically useful and highly mobile in the human body. Osteoclast activity is 
thought to be partially activated by the level of ionised calcium generated locally as 
a result of bone resorption. 110. 20<) 
Calcium ion release from IC was largely dependent on the calcium concentration of 
the glass. so, 51 For example, LG7 of the monovalent cation based series, released the 
greatest amount of calcium from this series of ICs as it had a high composition of 
calcium in its glass (Table 3.36 in Results section) Calcium ion release increased as 
the calcium fluoride content in the apatite stoichiometric based glasses increased 
(section 2.1.lb in Materials and Methods section and Table 3.37 in Results section). 
The series varying in silica:alumina ratios all had the same calcium concentration 
(see section 2.1.1 k and Table 3.40) and yet showed an increase in calcium ion 
release as the silica Ie content increased and the alumina content decreased. These 
results implicated that calcium ion release was also dependent on the concentration 
of silica and alumina in the glasses for this series (Table 3.42). 
While fluoride, aluminium and silicate ions are critical factors determining 
biocompatibility, and in the cases of fluoride and aluminium, osteoconduction, no 
groups have yet reported on an optimum range for elution for the calcium ion. In 
this study, LG26 and LG125 were found to perform best in the wet and set in vivo 
implantation experiments (see Tables 3.54 and 3.55). It is not unreasonable to 
assume that calcium release was near optimum for this animal model. These 
materials had an early calcium elution of 0.9 J.Ul10Ig-1 at day 3, increasing to 4.9 
).lmolg -I at day 42 in the ion release experiments (Table 3.37). Another Ie with 
two mole fractions of calcium was LG53 that eluted the greatest amount of calcium 
for the series varying in silica, alumina and calcium. 
There was no relation between sodium glass composition and calcium ion release 
(Table 3.36 showing calcium ion release of the monovalent cation series). An 
increase in phosphorus pentoxide glass composition showed a decrease in 
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calcium ion release (Table 3.41) from analysis of the series varying in generic 
compositions derived from the apatite stoichiometric based glass LG26. However, 
the mole fraction of CaO in this range of glasses increases and calcium ion release 
increases showing a positive relation between calcium ion release and calcium IC 
formulation. 
4.2.7 Phosphate ion release 
Phosphorus is important as it is involved with the mineral hydroxyapatite. 
Phosphorus improves translucency and adds body to ICS. 51 Phosphorus is assumed 
to leave the cement as P043-. Phosphorus influences alkaline phosphatase 
.• 210 
actIVIty. 
There was no relation between sodium glass composition and phosphate ion release 
(Table 3.43). There may be a relation between potassium glass composition and 
phosphate ion release from these results (Table 3.43). However, by analysing a 
wider range of potassium based glasses it may be shown that there was a definite 
relation between potassium glass composition and phosphate ion release. Table 
3.47 at day 1 showed that there was a relation between phosphate ion release and 
silica glass composition and decreasing alumina glass composition. 
There was a relation between calcium and phosphate with some of the ICs. In that 
as calcium glass content increased there was less phosphate released (Table 3.48 of 
Results chapter). Phosphate (P04 3-) ion release increased as phosphorus 
pentoxide concentration ofICs increased as was shown in Figure 3.13 where there 
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was a strong correlation (0.97). This showed a positive relation between 
phosphate ion release and IC formulation. For example, the ICs LG83 to LG85, 
derivatives from LG26 at day 3, showed an increase in phosphate ion release as the 
phosphorus pentoxide content increased (Table 3.48 and section 2.1.1 e). All the 
Limerick based glasses released greater phosphate ion release levels than the 
controls Chemfil and Chemfil Express (Table 3.51). 
Phosphate ion release was one of the critical factors determining biocompatibility 
and osteoconduction, no groups have yet reported an optimum range for elution of 
this ion. In this study LG26 and LG125 were found to perform best in the in vivo 
implantation experiments (see Tables 3.54 and 3.55) and it may be added that 
perhaps an IC with the same mole fraction of phosphorus pentoxide, i.e. 1.5 as that 
of LG26 may perhaps be a suitable concentration for a bone cement or bone 
substitute. 
4.2.8 pH effects on the Ie discs 
Extracellular fluid (ECF) has a hydrogen ion concentration of about 4 x 10 -8 mollL 
(pH 7.4) which is slightly alkaline. Intracellular fluids tend to be slightly more 
acidic than ECF. In ECF the pH, ranges from 6.8 to 7.8 and is compatible with 
human life. Even small changes in the hydrogen ion concentration can greatly 
change the physiological functioning of the body even for a brief period of time. 211 
Buffering prevents large changes in hydrogen ion concentration when hydrogen 
ions are added to or removed? 11 
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The fluoride ion exchange mechanism does have important consequences for 
biocompatibility studies particularly in cell culture, the measurement of fluoride ion 
release and its clinical significance. The pH fell as fluoride ions were exchanged 
with the hydroxyl ions 195 (Table 3.50). The pH reduction depended on time, but 
also on the mass of the cement, its surface area, the quantity of water used and how 
frequently the water was changed.83 A small pH reduction reduced the ion 
exchange process by reducing the number of hydroxyl ions available for ion 
exchange. The effects of pH changes on fluoride ion release were therefore likely 
to be complex. 
Cell culture studies (see Results section 3.3, Figures 3.17 and 3.30) indicated that 
increasing sodium content ofICs and increasing ion release were beneficial for the 
cells. For these reasons two glasses, LG2 and LG6, were monitored over 14 days 
for pH changes in the eluting water. There was a reduction in pH, where LG6 was 
in the biocompatible pH range, but LG2 fell outside the acceptable pH range for 
biocompatibility. 
LG6 released more fluoride ions (Table 3.6) than LG2. Ions were released from the 
matrix of bone cement by either counter ion mechanismso or by the ion exchange 
mechanism. 195 There was an imbalance of the measured anions to cations released 
from the set cements with an excess of negative ions (Results section 
pp 114), which strongly indicated that fluoride ions were exchanged for hydroxyl 
. 195 
IOns. 
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This was supported by a reduction of pH in tissue culture indicated by its colour 
change (from red-orange to yellow). LG2 (no sodium) showed a greater pH 
reduction than LG6 (contained sodium and fluoride) because of the effect of 
monovalent ions, e.g. Na +, enhanced their uptake and re-release of ions e.g. 
fluoride, which may explain why there was less of a pH reduction with LG6, 
because of the possible uptake of fluoride ions, than with LG2 which had no sodium 
and therefore no enhanced amount of fluoride and sodium re-release or uptake 
(Table 3.6 and Table 3.18). 212 
A drop in the pH (Table 3.51) was expected for the autoclaved les as the initial 
burst of fluoride ions was eluted into the water from autoclaving, 51 (Ion balance 
calculation pp 114). Fluoride and hydroxyl ions were exchanged in this early 
contact with water in the autoclave. 195 
Table 3.52 and Table 3.53 showed that the les LG2 and LG26 in a-MEM had 
higher pH's than those tested in water and there was a pH rise in water but released 
less fluoride in a-MEM (see Table 3.13). Prior to placing Ie discs into a-MEM, 
the Ie discs were autoclaved. This would have lead to an initial burst of fluoride 
ions from the Ie discs in the water from autoclaving.51 The low pH is a critical 
factor responsible for microbial inhibition by these materials.213 
The les LG2 and LG26 in a-MEM were both biocompatible when compared to the 
intracellular fluid pH limits. There was a pH drop in a-MEM which may indicate 
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fluoride ion exchange with the hydroxyl ion as was the situation in cell culture 
where fluoride elutes into the a-MEM. 
LG2 and LG26 in water (Table 3.52) showed a pH rise. This could be from the 
uptake of fluoride ions 2 la,:t 14 as the initial burst of fluoride ions occurred before 24 
hours and these fluoride ions may have been exchanged back into the IC in 
exchange for the hydroxyl ion back into the water and as a result showing a pH rise. 
The pH ofLG26 in a-MEM pH 6.0 - 7.0 could perhaps be suitable as LG26 was one 
of the most biocompatible ICs. The pH range ofLG26 ~ould be the most 
osteoconductive where it may inhibit microbial activity. As a dental cement LG26 
would be expected as having anti-caries properties. It could be used as an 
orthopaedic cement and having such anti-microbial properties would expect the IC 
to reduce infection after bone implantation. 
4.3 Total protein and MTT assays for bone marrow cells and Ros cells 
An adequate intake of protein is essential for higher animals since only the simple 
forms of life are able to synthesise their protein from other nitrogen sources. The 
protein content of cell culture is widely used for estimating total cellular material 
215 and was used to determine the total protein concentration in cultures containing 
ICs using two different cell lines. The MTT method (see Section 2.2.3c iii) was 
used to determine the cellular activity (mitochondrial respiration) after prolonged 
exposure 
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to the Ie. Cell activity is defined as the retention of metabolic or proliferative 
ability of a cell population as a whole 215 
The effect of ions on biocompatibility was complex depending on the ion mix and 
concentration of specific ionic species. Fluoride as mentioned earlier in this chapter 
(Section 4.2.2, Fluoride ion release) has been reported to be osteoconductive.34-36.46. 
48.87,90,93-95 The ICs giving the best cellular response were LG22, LG63, LG6, 
LG23 and LG2 with bone marrow cells and Ros cells (Figure 3.14, Figure 3.15, 
Figure 3.17 and Figure 3.23). Fluoride elution levels for some of these ICs were 
relatively high (Table 3.6). 
However, LG2, LG6, LG23 and LG63 all eluted low levels of aluminium ions (Table 
3.22 & Figures 3.17 and Figure 3.23). The results for protein and MTT assays 
showed that there was an inverse relationship between the aluminium ion release 
(Table 3.22) from ICs and cellular activity (Figure 3.18 and Figure 3.24). 
Interestingly, LG6 had a low aluminium ion release (Table 3.22) in combination with 
a high fluoride ion release (Table 3.6) and showed a good cellular response, 
indicating that it may not be fluoride that was responsible for ill vitro toxicity as 
was shown by other studies. 34 
LG69 eluted the greatest amount of aluminium having a low cell activity count in 
both types of cells (Figure 3.18 and Figure 3.20 and Table 3.22), whereas LG2, 
LG6, LG23, LG69 and LG22 eluted very low levels of aluminium (Table 3.22) and 
were well tolerated by cells in culture ( Figure 3.18 and Figure 3.24). A low level of 
aluminium ion release appeared beneficial in our culture studies. It has previously 
been reported that low levels of aluminium ions showed stimulation of cell 
growth. 102·107. 216 
However, aluminium ions have been reported to be cytotoxic at high levels. 102. )(>4. 
lOS. WI! From these results the toxic effects of high concentrations of aluminium\02. 
104. lOS. lOR restricted the growth ofRos cells. The effect of aluminium ions on bone 
metabolism is an area of continuing debate as at low concentrations it is beneficial. 
\OI.IOI!. 200, 205·207 
All the apatite-stoichiometric based ICs had released very low levels of aluminium 
where LG26 eluted the most from this series (Figure 3.10) This higher aluminium 
ion release from LG26 compared to LG27, LG28, LG29 and LG30 was the reason 
why bone marrow cell cultures exposed to LG26 were less active (Figure 3.20) as 
. . d' II d ·)01 IO~ )0(, 101( alumInIUm was reporte as potentia y amagmg .. .. , 
LG72 in with Ros cell culture gave positive cell activity results (Figure 3.26). LG72 
had a lower mole fraction of alumina than LG73-LG75, and eluted low 
concentrations of aluminium (see Table 323) and a high level of fluoride (see Table 
3.9). LG74 also eluted very low levels of aluminium «0 I nmol/g) ( see Table 3.23) 
this added to its good biocompatibility ofRos cell cultures. IOJ. 1O~. 1OC,. lOR Greater 
cell activity and thus biocompatibility of cell cultures was associated with 
decreasing alumina concentrations with regards to ion release and glass content. The 
alumina glass content and its low release levels in the region of <0.2 nmolg-1 from 
Ies may have determined the biocompatibility of the IC with respect to Ros and 
bone marrow cell activity. 
Silicon could be harmful but its exact effect on bone-forming cells is unknown. It has 
been reported to be linked to autoimmune diseases at high levels 20R for this reason 
the amount in the Ie should be low. LG27 and LG26 were detected eluting low 
amounts of silicon which was perhaps why bone marrow cell cultures associated 
with LG27 and LG26 produced greater protein concentrations (see Table 3.29 and 
Figure 3.19).~4.1I1. 109 
LG72 was well tolerated in cell culture and had a low mole fraction of silica (see 
section 2.1.1 I) and was measured as eluting less silicon than the other Ies from the 
same series ofICs varying in alumina and silica and calcium ~4. 10') (Table 3.31). 
LG72 did however have a low alumina glass content than others in this series and 
this may have contributed to the positive biocompatibility result (see Figure 3.25 
and Figure 3.26). 
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There was a relation between high phosphate ion release of ICs LG6 and LG2 
(Table 3.43) and bone marrow cell cultures associated with LG2 and LG6 producing 
high concentrations of protein (Figure 3.17 and Figure 3.23). Phosphorus is 
potentially beneficial as it is a constituent of the mineral hydroxyapatite in bone, the 
IC was thus acting as a source of phosphate for the production of natural 
mineralized tissue and was reported to regulate the level of skeletal ALP. 210 
The high phosphate ion release of apatite-stoichiometric based IC LG29 (Table 
3.44) may have resulted in the higher protein production of the BMC cultures 
(Table 3.44, and Figure 3.19).210 LG27 eluted the least amount of phosphate which 
perhaps explained the reduced protein production in the BMC cultures?J() 
The most promising ill vitro results from the series varying in silica / alumina and 
calcium were with cell cultures associated with LG74, LG72 and LG55 (see Figure 
3.25 and 3.26) where LG74 associated Ros cell cultures (Figure 3.25) produced high 
concentrations of protein perhaps from the high amount of phosphate ion release. 
210 Cell cultures associated with HA produced the best response in vitro testing for 
protein production and cell activity compared to all the other materials used in this 
study (Figure 3.21, Figure 3.22, Figure 3.29 and Figure 3.30). 
The response of the bone marrow cell cultures and Ros cell cultures to HA 
confirmed the inert nature of this material and its good illl'ilm response (Figure 
1% 
3.21, Figure 3.22, Figure 3.29 and Figure 3.30). In addition to this, recent studies 
suggest that the possibility of non-biological precipitation ofminerael6, 217 as 
hydrolysis of ~-glycerophosphate produced high local concentrations of phosphate 
ions. 217 HA consisting of calcium phosphate showed osteoconductive potential13-15 
TCP with Ros cell culture produced very high protein concentrations and cell 
activity results (Figure 3.29 and Figure 3.30). 
The in vitro cell culture results confirmed that lCs were not inert and that their 
ability to leach ions,50,51 affected the in vitro response of cells dependent upon the 
type, amount and combination of ions released. 
Recently, Oliva et at found that certain commercial lCs were biocompatible when 
tested using human osteoblasts in vitro. 218 The results from this thesis support that 
there was an exchange of ions with adjacent tissues at the implant site, which was 
the basis of osteoconduction and bone-bonding properties OfICS.8l, 219 The in vitro 
cell culture results lead to the next step of which glasses to use for in vivo 
implantation studies. 
4.4 In vivo evaluation of les 
lCs in the set and wet form were osteoconductive and can therefore be used as bone 
cements and/or bone substitutes. The integration and interaction of these lCs with 
bone is of importance for clinical application which is why bone proteins, such as 
osteopontin, fibronectin and tenascin are important to show normal bone 
197 
development. However, it must be taken into account that observations made were 
in a healing (three week old) rat model where the metabolism differs to that of the 
human body. 
4.4 <a> Evaluation of set Ionomeric cements 
Semi-quantitative histomorphometric analysis and histological evaluation revealed 
that there was a more positive response from the surrounding bone associated with 
the Ie implants in the apatite-stoichiometric based Ie series as compared to those 
in the monovalent cation series (Table 3.54). LG26 was the most osteoconductive 
(0.16 mm) and was the most integrated (80.8%, Figure 3.35 to Figure 3.38) whereas 
LG2 was the least osteoconductive (0.05 mm) and least integrated (37%) from all 
the les used in this study (Table 3.54). Sodium fluoride at low levels has been 
shown to have pronounced effects on the skeleton, it may be possible to modify the 
therapeutic use of fluoride in osteoporosis and other brittle bone. 35,36,46,48,87,90-95 
The results (Table 3.54) appeared to be correlated with the composition of the les 
(Section 2.1.1). Increasing the fluoride content in the apatite-stoichiometric based 
series (LG30 to LG26) was associated with increased bone formation (Figure 3.35-
Figure 3.38) and confirms the results seen in this study and by others as to the 
beneficial effect of this ion in appropriate concentration on bone formation.46, 81 
Work previously reported on this series of glasses has demonstrated that increasing 
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the sodium content of Ie increases the rate and amount of fluoride release from the 
cement matrix. This has been proposed to be due to increasing the mobility of 
fluoride ions in the matrix and by facilitating an ion exchange mechanism between 
the Ie and the environment. 19S From analysing ion release from Ies taken together 
with those of this study demonstrate that while the total amount of fluoride present 
is an important determinant of biological response, the mobility of ions within the 
cement matrix and their release characteristics are significant factors affecting the 
induced biological response. 
In the apatite-stoichiometric based series (see section 2.1.I.b) the fluoride content 
was increased in order to investigate osteoconductive effects i.e. bone growth and 
osseointegration and ensure glass formation. The mole fraction of alumina was 
increased throughout the series with LG26 containing 3 mole fractions. LG27 with 
4 mole fractions. and LG30 containing 5 mole fractions. The amount of new bone 
was thus negatively correlated with alumina content, LG30 being associated with 
the least amount of new bone formation. Increasing aluminium ion release from 
ionomeric materials has been demonstrated to be negatively correlated with the in 
vitro response of osteoblasts III as was found in this study (see Figure 3.17 to 
3.30). 
The effect of aluminium ions on bone metabolism is however an area of continuing 
debate. lOS Aluminium ions have been shown to reduce new bone formation HII and 
11)1) 
, h'b' b ' I' , 191 20~ 206207 Th "d ' , m I It one mmera IzatlOn. ., '" ere IS eVI ence that alummlUm can 
enhance the mobilisation of calcium from bone by a cell-independent mechanism. Hl7 
In contrast, low concentrations of aluminium have been reported by Lau et al to 
stimulate the proliferation and differentiation of osteoblasts ill vitro. 170 While in 
vivo, administration of aluminium has been shown to increase bone volume by 
positively influencing trabecular networking in the axial skeleton. 10) The set Ie 
LG26 shows that aluminium at a low concentration, e.g. 3 mole fractions of 
aluminium, positively influenced osteoconduction. 
The results of the set les show that biological response was reduced with increased 
alumina content associated with reduced fluoride content. Thus, the effects of 
aluminium and fluorine are likely to be dependent on the concentration of their ions. 
The beneficial effects of fluoride were thought to be due to promotion of 
osteoblastic activity and increasing trabecular bone density.!!1 However, the effects 
of fluorine, like aluminium, appear to be dose-dependent ;11 vitro 93 and ill VivO.220 
The formulation of defined les enables controlled evaluation of the parameters that 
effect the biological response of bone to ICs. 
The biocompatibility and composition of ICs are of great importance because they 
need to be in direct contact with bone for any chemical adhesion to occur. These 
model Ie formulations induced favourable biological response from the tissues of 
the implant bed. Improved osseointegration and osteoconduction being associated 
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with increased calcium fluoride or sodium content and reduction in alumina content. 
In vitro work from this thesis demonstrated a link between glass composition, and 
ion release, with fluoride ion release increasing as the sodium or calcium fluoride 
content of the glass increases. Improved osseointegration and osteoconduction 
appear to be mediated by increased fluoride ion release. Increased calcium fluoride 
content and fluoride release were positively correlated with osteoconduction. 
Calcium also plays an important role with osteoconduction as it is also used in the 
prevention of osteoporosis and in protecting what bone mass a woman may have at 
her current age. The evidence is strong that prevailing calcium intakes contribute to 
the low bone mass component of osteoporotic fragility and that increases in intake 
would reduce the osteoporotic fracture burden.221 
The most osteoconductive set IC was LG26 of the apatite stoichiometric based 
series that has the same calcium:phosphate ratio as bone (1.66). It also had a high 
calcium fluoride content of 2 mole fractions. LG26 consisted of an alumina content 
of3.0 mole fractions, and eluted a low amount of aluminium «0.2 nmolg- I ). At 
these levels LG26 influenced cell activity il1 vivo to an extent where maximum 
osteoconduction and maximum osseointegration of bone was produced. As an in 
situ setting bone substitute or as a bone cement, the setting and working time made 
the IC LG26 the most manageable and workable cement as a bone substitute and as 
a potential bone cement. 
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4.4 (b) Evaluation of wet Ionomeric cements used for surgical implantation 
LG125 had the greatest amount of bone-implant contact (77.0%) (Table 3.55, 
Figure 3.39 to Figure 3.41) and the greatest amount of bone growth (0.08 mm) from 
all other wet les. LG132 had the least amount of bone-implant contact (42.5%) and 
LG23 with a 1 :0.2:0.2 composition (0.2 ml water) was the least osteoconductive 
(0.02 mm). LG125 has a strontium oxide mole fraction of 3, whereas LG119 has a 
strontium mole fraction of 1.5 (section 2.1.1c, Figure 3.42 and 3.43). From these 
results it would suggest that strontium has a strong osteoconductive 
·nfl e 112-114,222-225 1 uenc. 
More importantly, it has been reported that low doses of strontium and fluoride 
increases the number of bone forming sites and vertebral bone volume in rats, but 
does not have detectable adverse effects on the mineralization of bone. 225 
Strontium may be able to prevent the changes in bone turnover by oestrogen 
deficiency.223 Strontium at low doses has been used to treat osteoporosis. I \3 
The potentially positive effects of strontium on bone appear to be dose-dependent 
as it has also been found that treatment of mineralizing tissues with strontium both 
in vitro and in vivo may result in defective mineralization and an accumulation of 
complexed acidic phospholipid.226 Strontium appears to perturb mineralization, 
partly by a direct effect on the cells of mineralizing tissues. Excessive doses of 
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strontium can disturb calcium metabolism III Strontium must only be used at low 
levels to avoid these excessive defects in bone m 
Fluoride has also contributed to the osteoconductive properties 34-36.46.411.96-99, 110 
ofLG125 and LG119 (Figure 3.43 and Figure 3.42), as well as strontium and with 
this chemical composition ofLG125 the greatest amount of bone formation and 
integration was formed. Fluoride has been associated with an increase in periosteal 
bone formation and an increase in endosteal bone resorption. <)<) 
Zinc plays an important role in the growth and stimulation of bone formation 1114. 194 
and as a ceramic was considered an osteoconductive agentI'J4 The results ofLG130 
and LG132 from this study confirmed its osteoconductive property (Table 3.55). 
LG 130 was significantly better integrated with bone than LG 132 (figure 3.44). This 
is probably because LG 130 had a greater zinc oxide mole fraction (l.S) than 
LG132 194 (section 2.1.1d). 
LG23 in the 1 :0.2:0.3 ratio was significantly better integrated and osteoconductive 
than the LG23 1 :0.2:0.2 ratio as there was less water (0.2 ml) to mix the 1 g glass 
and 0.2 g of poly(acrylic) acid. Ies are water based materials, and as water played 
an important role in their setting and stnlcture Water was the reaction medium into 
which the cement forming cations, i.e. calcium and aluminium are leached and in 
which they are transported to react with the polyacid to form a poly(acrylate) 
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matrix. Water also served to hydrate the siliceous hydrogel and the metal 
poly(acrylate) salts formed. It was an essential part of the cement structure. If 
there was less water or if water was lost from the cement by desiccation while it 
was setting, the cement forming reactions would stop.227 
As cement aged, the degree of hydration increased. This was accompanied by an 
increase in strength and modulus and a decrease in plasticity.22K. 229 This was why 
the 1 :0.2:0.3 ratio composition for IC formation was important to maintain. More 
importantly, lack or loss of water retarded cement formation and prevented the 
strength of the IC from fully developing as it was a requirement for the hydration of 
the matrix salts.51 
LG26 (Figure 3.35-3.38) and LG30 set rod cements were more osteoconductive and 
better integrated than LG26 (Figure 3.45)and LG30 wet cements. This is probably 
because of the 'toxic' responses when the ICs were placed 'wet' during the early 
phases of gelation. Preformed IC bone cement induced a favourable response from 
hard tissues or are inert. 34• 35, 46, 41< It was this' toxic' phase of the IC that has to be 
understood by the surgeon, for while an improved bone substitute has some clinical 
value the main clinical need was for an improved cement, which would induce a 
predictable healing response and maintain a long term functional bond with bone. 
20", 
However, it must be noted that the Ie implants in the rat femur were observed at a 
duration of 4 weeks. This concealed early i e.I-2 weeks, damage associated with the 
implant in the wet and set Ie usually at the 2 week stage, progresses to 
encapsulation by a layer of new bone at the 4 week stage of bone growth. 
Initially, after direct surgical placement an unset Ie bonds to the underlying bone. 
This was followed by a period of remodelling and periosteal reaction prior to 
stabilisation of the interface.46• l!2 The effect of the wet cement was probably 
mediated by a combination of reduction of tissue pH, thus an acidic environment, 
due to the release of free poly(acrylic) acid, release of glass particles and metal ions 
from wet cements contaminated by tissue fluidlblood. Set cement rapidly became 
surrounded by a layer of relatively mature bone .l5. 4X. X2 
LG 125 and LG26 have similar chemical formulae with the exception of LG 125 
having an additional 3 mole fractions of Strontium. However, LG 125 had a working 
and setting time ofless than 150 seconds. This faster working and setting time 
made it a less manageable and workable cement as a bone cement or bone substitute. 
LG125 had a calcium:phosphate ratio that was the same as that of bone (1.66). It 
had a high calcium fluoride content of 2 mole fractions LG 125 consisted of an 
alumina mole fraction of 3. From LG26 and LG 125 osteoconductive and integration 
results it seemed that these quantities were the appropriate levels that influenced 
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maximum bone growth ill vivo. LG26 seemed to be the most manageable and 
workable cement. 
The control acrylic set rods (Table 3.56) were significantly more osteoconductive 
and better integrated in bone than the acrylic wet cements. However. neither 
acrylic set nor wet control cements were as osteoconductive or as well integrated 
with bone than any of the implanted ICs. The poor response was probably related 
to the exothermic polymerisation and by the I eachi ng effects of residual monomer29-
31 causing thermal 27.2R and chemical necrosis 2 <J . .10 
Problems did arise and were as follows 
a) Difficulty in recognising the wet implant as it was irregularly shaped and not rod 
shaped. 
b) Sometimes difficulty arose in drilling the hole into the midshaft of the femora. 
For example. the hip joint was drilled. as some rats had very narrow femurs. 
c) When paraffin sectioning the knife would sometimes leave grazed marks on the 
section, and on a few occasions it damaged the whole bloc because of a fault in the 
microtome and damage the section. 
d) When handling paraffin sections. the implant would sometimes lift off the rest of 
the section when placed in warm water to expand the section. Only after staining 
and mounting would this absence of the implant and tearing in the section be 
observed microscopically. 
e) When placing the paraffin section on the glass slide, sections occasionally left 
creases. When attempting to displace the crease from the section sometimes the 
section would be ruined. 
t) The paraffin blocks with bone had to be cooled for at least 15 min to produce a 
lean, non-creased bone section with the implant, and if the room temperature was 
above 21°C, it took longer to cool the block. 
4.4 (c) Bone Proteins 
The amount of new bone formation (% integration) was ordered LG23>LG6>LG2. 
This trend was applicable with the amount ofOPN staining (Figure 3.46 to Figure 
3.47, Figure 3.49 and Figure 3.51). The control material, LG2 with no sodium, 
showed the least bone formation and least staining for OPN (Figure 3.51), while 
LG23 (Na +=0. 15M) with the greatest new bone formation, showed the most 
staining (Figure 3.46 and Figure 3.47). 
This suggested that more bone had more OPN as the sodium content increased 
(Figure 3.46, Figure 3.47, Figure 3.49 and Figure 3.51). OPN staining was 
prominent in the new bone formed adjacent to the IC-implants where it was 
concentrated at the reversal lines. The reversal line is found between the edge of a 
resorption cavity that will become a new haversian system in new bone in bone 
remodelling. 
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The remodelling of bone can only be achieved by bone resorption. The association 
of OPN, with IC-implants, integrated with bone may explain their osteoconductive 
properties and the differences that occur with varying IC formulations. From these 
observations and past studiesI71-17) it can be suggested that OPN is involved in 
initial bone formation with these IC-implants. 
The amount of staining with FN and TN did not increase with more sodium. FN 
was widely distributed staining regions of woven bone with all the IC-implants 
(Figure 3.48). However, this does correlate with past immunohistochemical in vitro 
studies that have located FN and TN on fibers that were aligned within the plane in 
which bone formation was occurring, in areas of intramembranous osteogenic 
differentiation. 174 From the results in this study it may be suggested that FN was 
involved in the initial ECM-cell interactions involved in endochondral bone 
developmentl74-177 with these IC-implants. It would also relate to what Yamada et 
al reported that FN, as adhesive protein, influenced cell migration ill vivo2J() 
TN was distributed in the periphery of the endosteum (Figure 3.50 and Figure 3.52) 
a site of osteogenesis with all the IC-implants used in this study. The presence of 
TN on the fibers in a beaded pattern may also be related as it has been found to be 
important in normal bone formation,2Jl as its absence seems to be characteristic of 
dysplastic bone development. This correlates with proposed functions of TN, that 
it is involved in wound healing and tissue remodellingI71<-u(J with these Ie-implants. 
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Problems did arise with immunohistochemical techniques. For example, the 
sections slid otT the glass slide after fixing the sections with neutral butTered 
formalin for 3 min. The problem was with the temperature of the room, as it was 
35°C. Sections had to be cut again on a cooler day. 
5. FINAL DISCUSSION 
Materials designed for use in the construction of medical devices must be 
biocompatible. Furthermore, it is important to consider their interaction with the 
biological environment following surgical implantation. The study of implant-
tissue interaction is therefore essential to gain an understanding of those factors 
which may ultimately determine clinical success. Cell activity, interfacial 
interaction and implant material toxicity are factors that have been amenable to the 
in vitro cell culture study. In vivo evaluation was undertaken to determine the 
initial response of bone and the interface between bone and implant materials. 232-
234 The in vivo model used provided a rapid assess~ent of the initial response and 
healing of bone around the implanted material. 232-228 
As mentioned earlier in Chapter 1 (Section 4.2) it is difficult to define levels of 
elution for the ions fluoride, aluminium, silicate, calcium and phosphate. There are 
differences ( between the two organisms) in metabolism between rat and man 
because of size and other differences such as bone turnover and metabolic rate 
would be less in a rodent e.g. rat. The chronology of healing in the rodent model 
can be related to the clinical situation. The events of healing are the same for both 
the rodent model and for humans, that is the proliferation of fibroblasts and 
capillary sprouts grow into a blood clot and injured area forming granulation tissue. 
The area is also invaded by polymorphonuclear leukocytes and later by 
macrophages that phagocytize the tissue debris. The granulation tissue gradually 
becomes denser and cartilage forms. This newly formed connective tissue and 
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cartilage is callus. It serves temporarily in stabilizing and binding together the 
fractured bone. At the same time, the dormant osteogenic cells of the periosteum 
enlarge and become active osteoblasts. Osseous tissue is deposited. This formation 
of new bone continues toward the fractured ends of the bone and finally forms a 
sheathlike layer of bone over the fibrocartilaginous callus. As the bone increases in 
amount. Osteogenic buds invade the fibrous and cartilaginous callus and replace it 
with a bony tissue. The cartilage undergoes calcification and absorption. The 
newly formed bone is spongy which later becomes transformed into a compact type, 
and the callus becomes reduced in diameter. At the time when this subperiosteal 
bone formation is taking place, bone also forms in the marrow cavity. The 
medullary bone growing centripetally from each side of the fracture unites, thus 
aiding the bony union. Healed bone in young individuals assumes its original 
contour which applies in both the rodent model and in humans. 
In a three week old rat this healing process will be faster than the healing process in 
a three year old rat. This correlates with the fact that a 6 year old child will have a 
faster bone turnover than a 60 year old adult, hence the age of the subject was of 
importance with respect to healing time. In some cases the protein anabolic 
functions are poor so that the bone matrix cannot be deposited satisfactorily in 
some old people which as a result can then be diagnosed as osteoporosis. In the 
bones of children, in whom the rates of deposition and absorption are rapid, 
brittleness is evident in comparison with bones of old age, at which time the rates of 
deposition and absorption are slow. 
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The elution data were obtained from water in vitro, and differences in surface areas 
for the models exist. However, some conclusions can be made when combined 
with in vitro cell culture results and from the various Ie formulations. It can be 
said that ion release concentrations were dependent on IC chemical formulations, 
for example, an IC with a high phosphorus pentoxide content eluted high levels of 
phosphate. 
Aluminium ions appear to be the determining ions influencing cell activity (see 
section 3.3.2 and Figures 3.7-3.20). From these results the biocompatibility of ICs 
as assessed by in vitro cell growth is inversely proportional to aluminium ion 
release. Fluoride may also have been effective as an influencing agent in the 
activity of cells studied. 35-36,46, SO, 87, 90, 93-100 Phosphate appears to be influencing 
protein concentration in the cells used (see Section 3.2.1g and Figures 3.8-3.20) The 
results obtained show that as the elution of phosphate from Ies increases there is a 
positive correlation with the cells protein concentration. 
From the Results presented in Chapter 3.0 and the General Discussion in Chapter 
4.0 it can be determined that the in vivo method and in vivo results were more 
reliable than the in vitro cell culture method and cell culture results. The in vivo 
animal implantation model is still required to investigate the response of a whole 
animal to a material. 239 From successful in vivo surgical implantation results 
positive conclusions can be made to use these Ie implants in humans leading to 
clinical success of the IC as a bone substitute or bone cement. Using the in vivo 
model accurate measurements of bone growth and intimate bone-implant surface 
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contact were determined using histomorphometric analysis. In addition to this, by 
using the in vivo method pathological reactions can be identified by histologically 
examining other organs of the same animal, for example, the kidney. 
However, a combination of in vitro (ion release and cell culture) and in vivo 
(surgical implantation and immunohistochemistry) techniques have produced 
conclusions that are confident in this study. L026 was the most osteoconductive 
and well integrated IC implant in bone from all the ICs used in this study. L0125 
was also osteoconductive and well integrated in bone. However, L026 was in vitro 
tested for its ion elution and cell culture using bone marrow cells and Ros cells. 
L026 was also tested in vivo for surgical implantation in its set and wet form. 
Hence, confident conclusions can be made about LG26. LO 125 was not in vitro 
tested which gives less firm conclusions as no comments can 
be made on its ion release qualities which are important, e.g. when determining the 
aluminium ion release, or by cell culture. 
For these reasons, and as it is the most workable and managable cement with 
suitable working and setting times, L026 would be the most well recommended IC 
as a bone substitute or bone cement as good results were obtained in most tests. If 
time permitted it would have been useful to determine the localisation of the bone 
proteins OPN, FN and TN for the IC implants L026 and LO 125 to show that there 
was interaction of these non-collagenous ECM proteins with these chosen IC 
implants during hard tissue healing. 
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6. CONCLUSION 
Conclusions were made as follows: 
(i) Of the materials tested, those with setting times> 150 seconds and working 
times> 120 seconds were considered most suitable for use as an in situ setting bone 
substitute or bone cement for low-load bearing applications. Materials that met this 
requirement were LG26, LG27 and LG30. LG26 was the most manageable and 
workable IC as a bone substitute, as a potential bone cement for orthopaedic use 
and as a dental cement. 
(ii) As fluoride, sodium, potassium, alumina, silica, calcium and 
phosphorus pentoxide glass contents increased the corresponding ions also 
increased in elution. Ion release levels for small mammals may be considered as 
follows: 
Fluoride ion measurements carried out were considered to be of levels up to 26 
J.1molg- l . Aluminium ion measurements carried out may be considered to be of 
levels < 0.2 nmolg-1. Silicon ion measurements carried out were considered to be 
of levels < 50.1 J.1molg- l . Silica levels in ICs used as bone cements or bone 
substitutes should be kept low. Calcium ion measurements carried out were 
considered to be of levels up to 4.9 J.1molg-1. Phosphate ion measurements carried 
out were considered to be of levels up to 3.8 J.1molg-1. 
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(iii) The most biocompatible ICs as evaluated from III vitro cell culture assays were 
LG22, LG63, LG6, LG23 and LG2. All of these ICs were also from the monovalent 
cation based series of ICs. 
(iv) The total protein produced by cultures of rat bone marrow cells and Ros cells 
increased as phosphate and fluoride ion levels increased. It could be the phosphate 
ion that encourages cell protein production Cell activity was also inversely 
proportional to aluminium ion release. It could therefore be the aluminium ion that 
is the dominant ion determining cell activity 
(v) LG26 set rods were the most well integrated and osteoconductive in this 
study. LG125 wet Ies with high mole fractions of radiopaque constituents (srO 
and ZnO) were the most well integrated and osteoconductive wet ICs in this study. 
(vi) Set Ies were significantly better integrated and osteoconductive than wet Ies. 
(vii) LG26 and LG125 had the same calcium:phosphate ratio (1.66) as that of bone 
and with 2 mole fractions of calcium fluoride. LG26 and LG 125 had the same 
alumina composition (3 mole fractions). From these studies it might be concluded 
that the compositions of LG26 and LG 12S are approaching the ideal as bone cement 
and bone substitutes in non-load bearing situations 
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(viii) From ill vitro and ill vivo studies it may be concluded that LG26 is the most 
promising IC of the formulations tested in this thesis for clinical evaluation as a 
bone cement and substitute. 
(ix) In vitro and il1 vivo studies suggest that a high aluminium concentration is 
associated with toxicity and poor biocompatibility. Taken in addition to our 
knowledge of inhibition of calcium/phosphate mineralization. this component 
should be reduced in future developments. 
(x) OPN is involved in initial bone formation with the IC-implants. There was an 
increase in OPN as sodium content in ICs increased. FN and TN did not increase 
with more sodium and as a result with more bone growth. All the IC-implants 
integrated with bone and ECM proteins FN. TN and OPN were prominently found 
in new bone suggesting that they play an important role in the interactions of the 
healing of hard tissues with the IC implants 
(xi) ICs have potential for use as bone cements and bone substitutes, however 
further work is required. 
7. FtJTlJRE CONSIDERATIONS 
The following points can be considered for future work: 
(i) Aluminium free materials or aluminium-reduced materials are required as bone 
response was found to be negatively correlated with increasing aluminium. 
(ii) To further investigate chemical and surface analysis that forms an integral part 
of the development or manufacture of any material. A number of techniques are 
available that enable characterisation of the surface of a material. These techniques 
include x-ray photoelectron spectroscopy (XPS) 
(iii) To further investigate Ie implants in vivo at longer lengths of time to give 
clear indications of how biocompatible the Ie implants are after 12 weeks, 24 
weeks, 52 weeks and 2 years in larger mammals. 
(iv) To further investigate les with bovine bone morphogenetic protein and other 
growth factors at varying concentrations to determine the rate of osteoconduction. 
To further immunohistochemical work, e.g to determine the amount of osteocalcin 
and osteonectin. To identify osteopontin on non-decalcified bone tissue and 
compare with decalcified bone tissue and measure the areas of fluorescence by 
confocal microscopy. 
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(v) Further ion release studies are required in larger volumes of water and in 
simulated body fluid after y-irradiating the set IC discs to imitate a larger 
mammal.e.g. human. 
(vi) To use more cell lines, e.g. calvarial osteoblast culture model to evaluate 
biocompatibility and biodegradation of ICs to give confident biocompatibility 
results. 
(vii) Further attempts at observing the ultra structural interactions of Ie implants in 
bone ill vivo using TEM and SEM and investigate bone-implant bonding, hence the 
bone-implant interface. 
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APPENDIX 
Key to Tables 
I = Perimeter of implant (mm) 
C = Length of intimate implant/ bone contact (mm) 
CII x 100 = % Osseointegration 
T = Thickness of new bone, Osteoconduction(mm) 
Distance from implant to mature bone 
(New bone / unit length) 
2V) 
Tables Al to A3 The % osseointegration and the degree of osteoconductivity 
of the set Sodium based ionomeric cement rods 
Table A I Material : LG2 
I C CII T 
3.0 1.1 36.7 0.07 
2.9 1.08 37.2 0.04 
3.4 1.3 38.2 0.06 
5.0 1.8 360 0.03 
3.5 1.3 37 I 0.03 
Mean=37.04 Mean=0.05 
SD=O.8 SD=0.02 
Table A2 Material :LG6 
I C CII T 
3.2 1.94 60.6 0.09 
2.9 1.8 62.1 0.10 
2.3 1.4 609 0.17 
3.6 2.3 63.9 0.06 
3.7 2.1 56.8 0.02 
Mean=610 Mean=0.09 
SD=26 SD=006 
Table A3 Material: LG63 
I C ell T 
4.7 3.2 68 I 0.09 
4.5 3.0 66.7 0.11 
4.2 2.85 67.9 0.15 
3.5 2.4 686 0.09 
3.2 2.2 688 0.08 
Mean=6802 Mean=O.1O 
SD=082 SD=003 
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Tables A4 to A6 The % osseointegration and the degree of osteoconductivity of 
the apatite-stoichiometric based series (Ca:P-1.66) set rods 
Table A4 Material:LG26 
I C CII T 
3.5 2.8 80.0 0.14 
2.6 2.18 83.8 0.13 
5.6 4.3 76.8 0.17 
4.8 3.9 81.3 0.16 
2.8 2.3 82.1 0.18 
Mean=80.8 Mean=O.16 
SD=2.63 SD=O.2 
Table A5 Material: LG27 
I C CII T 
2.8 2.2 78.6 0.10 
5.5 4.2 76.4 0.06 
4.5 3.5 77.8 0.08 
3.5 2.8 80.0 0.07 
3.8 2.98 78.4 0.10 
Mean=78.2 Mean=O.08 
SD=1.31 SD=0.02 
Table A6 Material: LG30 
I C CII T 
5.5 3.7 67.3 0.08 
6.1 4.3 70.5 0.06 
3.2 2.3 71.9 0.09 
3.3 2.3 69.7 0.09 
3.1 2.28 73.5 0.05 
Mean=70.6 Mean=O.07 
SD=2.3 SD=O.02 
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Tables A 7 to AS showing the 1% osseointegration and the degree of 
osteoconductivity of the sodium based wet ionomeric cements 
Table A 7 Material: LG23 1 :2:3 
I C C/I T 
8.3 5.8 69.5 0.02 
5.7 3.7 65.0 0.03 
8.6 58 67.4 0.03 
2.5 l.5 60.0 0.03 
2.6 1.7 65.4 0.09 
Mean=655 Mean=0.04 
SD=35 SD=0.03 
Table AS Material: LG23 1 :2:2 
I C C/l T 
5.3 2.8 52.8 0.02 
3.1 1.5 48.4 0.01 
6.7 3.5 52.2 0.04 
4.9 2.6 53.1 0.02 
4.5 2.1 46.7 0.01 
Mean=506 Mean=0.02 
SD=29 SD=O.Ol 
Tables A9 to AIO showing the % osseointegration and the degree of 
osteoconductivity of the apatite-stoichiometric based wet ionomeric cements 
Table A9 Material: LG26 
I C C/I T 
8.4 5.8 69.0 0.07 
5.0 33 660 007 
10.2 6.9 676 0.07 
2.8 1.8 643 003 
1.9 1 3 684 007 
Mean=67 I Mean=006 
SD=19 SD=002 
Table Al 0 Material: LG30 
I C C/I T 
3.7 1.9 514 0.01 
2.2 13 59 I 0.05 
3.5 1.8 514 0.05 
3.3 1.8 54 S 0.07 
3.2 1.8 Sed 001 
Mean=S4 S Mean=0.04 
SD=J J SD=003 
Tables All to Al2 showing the % osseointegration and the degree of 
osteocondudivity for the Strontioum based radiopaque wet ionomeric cements 
Table All Material: LG 119 
I C CII T 
10.9 6.5 59.6 0.06 
7.1 4.1 57.7 0.08 
2.7 1.6 59.3 0.03 
4.0 2.1 52.5 0.04 
2.9 1.5 51.7 0.06 
Mean=56.2 Mean=O.05 
SD=3.8 SD=O.02 
Table AU Material: LG125 
I C CII T 
1.5 1.1 73.3 0.09 
8.5 6.4 75.3 0.07 
6.9 5.5 79.7 0.07 
6.2 4.8 77.4 0.09 
8.1 6.4 79.0 0.08 
Mean=77.0 Mean=O.08 
SD=2.6 SD=O.OI 
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Tables Al3 to Al4 showing the % osseointegration and the degree of 
osteoconductivity of the Zinc based radiopaque wet ionomeric cements 
Table Al3 Material: LG 130 
I C CII T 
S.6 3.9 69.6 0.04 
11.1 8.1 72.9 0.02 
3.1 2.3 74.2 0.09 
12.5 8.6 68.8 O.OS 
4.3 3.3 76.7 0.03 
Mean=72.4 Mean=O.OS 
S0=3.3 SD=O.03 
Table A14 Material: LG 132 
I C CII T 
11.5 4.7 42.3 0.07 
18.8 7.6 40.4 0.04 
2.8 1.2 42.9 0.06 
2.5 1.1 44.0 0.06 
2.8 1.2 42.9 0.04 
Mean=42.S Mean=O.OS 
SO= 1. 3 SD=O.OI 
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Tables A15 to A16 showing the % osseointegration and the degree of 
osteoconductivity of the PMMA controls 
Table A15 Materials: Set Acrylic 
I C CII T 
22.8 6.9 30.3 0.05 
1.4 0.4 28.6 0.02 
5.9 1.6 27.1 0.04 
2.0 0.6 30.0 0.05 
1.2 0.4 33.3 0.07 
Mean=29.9 Mean=O.05 
SD=2.3 SO=O.02 
Table A16 Materials: Wet Acrylics 
I C CII T 
15.7 3.5 22.3 0.03 
10.4 2.8 26.9 0.06 
7.1 1.7 23.9 0.02 
32.6 9.2 28.2 0.01 
6.3 1.8 28.6 0.02 
Mean=25.9 Mean=O.03 
SD=2.8 SD=O.02 
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ABBREVIATIONS 
HA: Hydroxyapatite 
PMMA: Polymethylmethacrylate 
ICs: Ionomeric cements 
GICs: Glass ionomer cements 
XRMA: X-ray microanalysis 
P/L: powderlliquid 
CFS: Cerebral spinal fluid 
A13+: Aluminium 
Ca2+: Calcium 
Ca-P: Calcium-phosphate 
CNS: Central nervous system 
ALP: Alkaline phosphatase 
SaOS-2: Human osteosarcoma cells 
Ca3 [P04 h : J3-Tricalcium phosphate 
J3-TCP: Beta-Tricalcium phosphate 
TEM: Transmission electron microscopy 
ECM: Extracellular matrix 
OPN: Osteopontin 
FN: Fibronectin 
TN: Tenascin 
mRNA: Messenger ribonucleic acid 
LG: Limerick Glass 
PTFE: Poly(tetrafluoroethane) 
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PMMA:Poly( methylmethacrylate) 
Si: Silicon 
Si02 : Silica 
0: Oxygen 
AI: Aluminium 
P: Phosphate 
Ca: Calcium 
F: Fluoride 
Na: Sodium 
Fe3+: Iron ill 
K: Potassium 
Sr: Strontium 
Zn: Zinc 
H: Hydrogen 
OH: Hydroxide 
mm: Millimeters 
ml: Milliliters 
g: Grammes 
ppm: Parts per million 
mgll: Milligramme per liter 
MP: MegaPascals 
M: Moles 
Mf: Mole fraction 
AAS: Atomic absorption spectroscopy 
ACQ: Analytical quality control 
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AQCS: Analytical Quality Control Standard 
HPLC: High pressure liquid chromatography 
°C: Degrees centigrade 
%: percent 
SEM: Scanning electron microscopy 
kV: Kilo volt 
DOC: Deoxycholate 
TCA: Trichloracetic acid 
EDT A: Ethyldiaminotetracetic acid 
Ilglml: Microgramme per milliliter 
Ill: Microlitre 
MTT: Methyl tetrazolium test or 3-4,5-[diamethylthiazol-2-yl]-2,5-diphenyl 
tetrazolium bromide 
run: Nanometers 
y: Gamma 
w/v: water per volume 
M: Molar 
SBT: South Bay Technology 
FITC: fluorisothiocyanate 
s: Seconds 
SD: Standard deviation 
n: Numbers 
na: Not applicable 
Ca:P: Calcium phosphate 
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USA: United States of America 
UK: United Kingdom 
UV: Ultra violet 
autc: Autoclaved 
w: Water 
m: media 
BM: Basic medium 
BSM: Basic supplemented medium 
DOC: Deoxycholate 
TCA: Trichloracetic acid 
HAS: Hydroxyaluminosilicates 
a-MEM: Minimal essential media 
ECF: Extracellular fluid 
XPS: X-ray photoelectron Spectroscopy 
I: Perimeter of implant 
C: Length of intimate implantlbone contact 
T: Thickness of new bone, osteoconduction 
NB: New bone 
MB: Mature bone 
0: osteoid 
C: Connective tissue 
P: Endosteum 
R: Reversal line 
I: Implant 
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vivo response of ionomeric cements: effect of glass 
·comp.osition, increasing soda or calcium fluoride 
content 
K. K. JOHAL, G. T. CRAIG, A. J. DEVLIN, I. M. BROOK* 
University of Sheffield, Biomaterials Group, School of Clinical Dentistry, Claremonr 
Crescent, Sheffield. S10 2TA UK 
R. HILL 
University of Limerick, Department of Materials Science, National Technological Park, 
Limerick, Ireland 
The in vivo response of two defined groups of set ionomeric cements (lCs), were evaluated 
following implantation in the midshaft of three week old Wistar rat femora for four weeks. 
New bone formation was associated with all the IC implants, the amount of new bone 
increasing with increasing sodium or calcium fluoride content of the basic glass component. 
Previous work has shown that there is a link between glass composition and ion release, 
fluoride ion release increasing as the sodium or fluoride content of the glass increases. It 
thus appears that in the series studied improved bone formation associated with the les was 
mediated by increased fluoride ion release. 
1. Introduction 
Ionomer cements are hybrid glass polymer composites 
formed by the neutralization reaction of a basic ion 
leachable inorganic glass and an orpnic polyelec-
trolyte lpolyacrylic) acid. Their properties include 
a rapid snap set. high compressive strength. adhesion 
to enamel and dentine. and the release or" potentiaily 
osteoconductive ions such as fluoride and calcium [1]. 
Additional prope:Lies that make them attractive bone 
substitutes include a non-exothermic setting reaction. 
chemical adhesion to bone and metals. and the J.biiity 
to mould and shape the cement at the impiant site 
with minimal setting shrinkage C2]. 
Ionomer cements are established restorative dental 
materials and more recently have b~n used as 
preformed implants and cements in otolaryngology 
and cranial surgery [3.4]. Further development of 
this group of materials for orthopaedic use is being 
undertaken [2. 5J. 
Clinical success of biomaterials depends largely 
Utlon the structure. composition and stability oi the 
b~ne:implant interface achieved. The purpose of this 
study was to evaluate the in vieo response of bone to 
six different formulations of ionomer cements based 
upon two defined series oi ionomeric glasse~. Tne first 
series had a constant duoride content but mcreasIng 
soda content and the other an increasing C:llcium 
fluoride content. 
-To wnom correspondence snould be addressed 
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2. Materials and methods 
2.1. Materials 
Six fluoroaluminosilicate glass-based ionomer ce-
ments were used in this study. The first series oi 
ionomer cements were sodium based LG2. LG6. and 
LG63 (Department of Materials Science. University oi 
Limerick. Ireland). They had the following chemical 
structure. WSiO;l. yp~O~. Ah03' (l-Z:"fa~O.) CaO. 
CaF ~ where W,Y and Z are the mole fractions and 
where Z for ionomer cements LG2 = 0, LG6 = 0.1 
and LG63 = 0.2. The second series of ionomeric ce-
ments (LG26, LG27 and LG30) wah a COl: P ratio of 
1.66 were based on the general formula (P) SiO:(Q) 
Al z0 3(5-X) CaO l.5P:O~(X) CaF 2' With the produc-
tion oi glasses having a larger content of modifying 
oxide (CaO) the mole fraction of silica and alumina 
were increased to ensure glass formation. As the TIuor-
ide content of the glass varied by the addition of CJ.F:, 
the CaO content present was influenced by the vari-
abie "X" where X in LG26 = 2, LG27 = 1 and 
LG30 = O. The glass LG2 can be considered to be in 
both series having no soda and a value of X = 0.75. 
2.2. Formation of implant rods 
Ionomeric cements were produced using a ratio oi 
1.0 g glass. and 0.2 g freeze dried mercaptan free 
polyacrylic acid (Advanced Healthcare, UK) and 
254 09574530 e 1995 Chapman & HIIII 
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:igllr!! 1 Tr:msverse sectlon of femur showing a rod of ionomeric 
:"'%fIc:u IIC) completely surrounded by bone: arrows depict SIX 
- intS .lround the perimeter at which Ostcoconduc:ion might be ~a1U:lted: Jaematoxylin Jnd eosin x 16. 
0.3 mi sterile non-pyrogenic wa~er. Smooth rods 
(tlominally 2 ~m length x 1 mI? d.tam.:~er) were pro-
duced by piacmg unset matenal In slilcone moulds. 
ltle rods were cured for at least 5 h at 37 ~C 
t 100% relative humidity. The rods were then 
ate:lm sterilized remrned to room temperature ~nd stored overnight at 100% humidity prior to 
itnplantation. 
2.3. Implantation 
for each oi the six mat.erials a single rod was im-
planted. und~r anaesthes~a (Haloth.ane 2% (.May and 
Ba.ker. uK); In oxygen 2~% and nitrous OXIde 75%), 
intO the midshaft oi the femora in groups of five 
we:lned inbred Wistar rats. Under saline irrigation 
a. slow speed 1 mm diameter Tungsten Carbide burr 
was used to cut a hole :natched to the diameter of the 
itnplant. through one cortex into the marrow space. 
ltl'lplants were placed to lie le'/e! with the surface 
of the bone penetrating through the cortex into 
the marrow cavity. The overlying periosteum 
and soit tissues were replaced and the wound sutured. 
antibiotics were not used. Post-operatively, wounds 
were inspected to monitor healing and rats were 
JJ1nintained on a standard laboratory diet. After 
four weeks, animals were sacrificed and the femora 
..; Ie 
\ 
# 
~ 
, . 
-, 
... 
... 
Figure 2 Interiace between ionomeric cement (10 and bone: the 
opposing arrows demarcate the thickness of newly formed bone :md 
irs measurement formed the basis for evaluating osteoconductive 
potential: haematoxylin and eosin x 162. 
removed. fixed in neutral buffered formalin. and deca-
lcified in 4 N formic acid for one week prior to 
trimming, routine histological processing and paraffin 
wax embedding. 
2.4. Light microscopy/histomorphometry 
Five stepped serial sections 7 I.lIIl thick. each separated 
by 70 ~m. were cut from the impiant bed in each 
femora using a rotary microtome. mounted on glass 
slides and stained using haematoxylin and eosin. The 
biological response to the different ionomer implants 
was studied by determining the degree of osteocon-
duction and percentage osseointegration, using 
a transmission microscope linked to an image ana-
lyser system (Optimas 5.1, Biosoft. USA). Osteocon-
duction was determined by taking six points at ran-
dom around the perimeter oi each ionomeric rod and 
measuring the thickness of new bone formed (Figs I.:! 
and 3). The degree of osteoconduction being taken as 
the average thickness of new bone produced on the 
implant surface. Percentage osseointegration was de· 
termined by measuring the proportion of the total 
implant perimeter in contact with bone (Figs 1, 4-6). 
Statistical analysis was undertaken usinll the Unistat 
statistical package (University software,-UK) and by 
applying Student'S t-test. 
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: '::S-l~ 3 l~!e:-:·lce. is!:'ligh! lr.'O~) ':e:wen :onome~c c=:~! ! 10 
• !ntl "":..:· ... ·1:: :o~~~ :or.:: :':ote :ts ~':~~:.lI:;-::Y me ~~e ;h\Jr:..::cic.i .!;:;:t::!:. 
~ InC: ~e:!1 :·cc:.iiy 'c-..:r:ci .u-:-owt: OSt~oct~;s ~ine ~:'::"C'.v 3C~C.:s :c::.c-
~ CIt :0 the :nte:i:.ce (open lrrO~l: h:1em:1toxylin md eosl~ x 16i 
3. Results 
3.1. Histological assessment 
Of :h~ 36 impiant sites :lil iea!ed. :.me'/e~tfully .. ~11 the 
ionome:-:c c::ne:m ~:thibit~d :'urr:1:ltion oi ne';Y bone 
on :h~!r 5uriace and generally new bone W:lS (or:ned :n 
continuity with the impiant sur:'ac: from the c:mic::.l 
bone :lot the sUr2!Cal5ite into the mar~ow s'Oac: \ F:~ 1). 
In most C:lSes. ~he interiace between im!=l;nt and host 
Was char::.c:erized by a layer oi notably c::h..:iar lnci. 
apparently, variabiy mmer::liiz:d :nature bone (F:gs ~ 
and 3); in piac:s the cei!ub.rity of the newly formed 
bone resulted in a chondroid appear::.nc:: marrow 
Spac:s close to the :nte,:'ace were lined by ;Jromine~t 
Osteobl:lSts. E'len 15 judged sucjedvely, the layer oi 
:lew :one varied in thic:~ness for different ionomeric 
C=~e~ts. In ail cases. the t'erioste::l.i end oi the impiant 
'NOlS ;:o'/e~:d 'Y 3. layer oi i'arely re:::.odeiled :ortic::.i 
cone IFig. J.). Simii:l.riy, that ;Jor-ion oi e:lc~ :r:1;:!::.nt 
"Nbc:' ;::rojec::d e~cioste::l.lly IF:g. 5', W:lS )e;:a:::.ted 
:·:"~m :~~ lcjac~::t 'rit~i ~arro'.v :is3ue ~:' 1 ::an :~ye:­
of ·/ilr.aclY :ninedized woven oene i F:g. S'l. 
t 3,2. Histamarphometry asteoconducticn 
and osseointegratian 
Inc:oe:lSed "leveis oi new bone formation were obse:-ved 
as th~ soda or c:11cium duonde content of the gl:lSS 
692 
... - . 
. " -
...... i~ 
Ie 
:""~ ,,-'" 
:,:': -:; ~ 
.... 
'- .. '~ ~--":" 
. ' 
FfT-V! J ?:lr!!Y :-:mot.!!U:::: =o:--::~ l::d ~ew ~O~: ·:lr:-J'.~·s: It :~: 
;:e~os,:::.l ;::t~~:·::'':': JI ::1: :mpi::.r.t ! lCi:;l ,. pe~ost::.:m:::'I - ";ci· 
un:::.::: :nw;.::e: ::aem:ltc:otyiin :.md ~osin ,( lei':' 
com~or.e~t oi the ionomer ce:nents :nc~e::.sed. T.:e:: 
was a $igninc::.nr difference in the me:l.n thic!G:ess ·)i 
ne';v ,one ~,d~;:-e-e Jf ~sLeocondl!c:ion) ~"or:::ed lci;:lc" 
~nt :0 the soda ;:ontaining gillSs based series ~his Je::1g 
.il. mean oi 0.1: mm for LG63 greatest soda c=nte~" 
O,0i mm (or LG6 ;lnd 0.005 mm for LG:2 (no socb. 
The difference between LG63 and LG: being 5ignin-
C:lnt (c = 5,2.. .if = 3. P < 0.00i). In .he second seri~s 
significantly more new ban~ formation ' .... as ;lSsociate~ 
with the ionomer ce:::ent LG:5 (highest nuance ;;0 n-
tentl compared :0 the ionomers in the )oaa series Jr 
other ionomeric ce:::ents in the same 3e"es 
(t = :2.16. df =- 3. P < 0.04). The me::l.n new bone 
for.nation (osteoconduc:ion) observed in the caic;um 
duende series being: 1.55 :nm fer LG:S. 0.08 rr.~ fer 
LG1i and O.Oi mm :'or LG30 with the dir.e:-enc: Je· 
tw~n LG26 and LG:i LG30 being sigr:inc::.r:t 
it = l.S • .if =3, P < O.!JO:). 
1:1e res~its :or the ?erce~tage o:iseointeg~t:cn )i 
the :onc~er!c ::e~e~tS ~howed J. ;ir:.ii:u ,4':::'- .lS :::;:.t 
5e:~ :or 'Js~~oc~nd\!c:icn o:\-it:t :h~ jiff~!"!:-:c: =~~·.ve~:1 
the c:liciurn nuor.de lr.d 30ca s~::es ;cing :iig:-jnc::.r.t 
(LG:6 versus LGo3 , = J..S. dt' = 3. P < 0.00:') . 7~e 
'C'::l ~n.se:i :enomeric :e:ne;tS :'oilowing the orcer 
:"':";'3> LG6 > LG2 (being 68%, 6L % and 3i% reo 
spec:ively). The difference bcm'leen LG1 and LG63 
being significant (c = 3i.il, df:a 8. P < 0.0001) . T.1~ 
calcium duende based g1:lSses fenowing the order ef 
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... l.U ..... > LG27 > LG30 (being 80.3% > is.:% > 
resp~tive!y). The difference in integntion be-
: .• ~IJI~·" LG26 and LG30 being significant (r = 1.953, 
... 8, P < 0.05). 
Discussion 
Semi-quantitative histomorphometic analysis and his-
tolo2ica! evaluation revealed that there was ::1 more 
positive response from the surrounding bone asso-
ciated with the ionomeric cement implants in the 
calcium fluoride series as compared to those in the 
soda containing series. The responses :ieen appe:lred 
to be correlated with the composition of the ionomer 
glasses. Increasing the fluoride content in the c:l!cium 
fluoride series (LG30 to LG26) was associated with 
inc;re!1SCd bone formation and confirms the results 
seen by ourselves and others lS to the beneficial effect 
of this ion in appropriate concentration on bone 
formation [5-7]. Work previously reponed on this 
series of glasses has however. demonstr.l.ted that in-
ere:Wng the soda ::ontent of ionomeric cements in-
cresses the rate and lIDOUDt of duoride re!e:ue from 
the cement :nacr .. 't [6]. This has been proposed to be 
due to incre:lSing the mobility of duo ride ions in the 
aultrix and by facilitating an io~ e.'tchange mechanism 
between ecment and the en~onmen~ The results 
from studying ion relC3SC from lonomenc cements [6] 
\. 
Ie 
., 
Fig",., 6 Det:Ul from F1g. S shOwinl a thin layer 'OC partly min-
er:1liz~ woven bone lurows) seplltl1tin, the implant (IC) from vital 
marrow I~Ue: llacmatll.,\ylin :md :osin 'l( 162. 
taken together with those of the present study demon-
str:ue that while the total amount of fluoride present is 
an iIIiponant determinant of biological response, the 
mobility of ions within the cement matrix. and their 
release characteristics are significant factors affecting 
the induced biologic:u response. 
In the c:ucium fluoride series as well as increasing 
fluoride content in order to ensure glass formation the 
mole frac:ion of alumina was increased throughout 
the series with LG26 containing 3 mole fractions, 
LG27 with ~ mole fnctions. and LG30 containing 
5 mole fractions. The amount of new bone was thus 
negatively correlated with alumina content. LG30 
being associated with the le:lSt amount of new bone 
formation. Increasing aluminium ion release from 
ionomeric materials has been demonstra~ed to be 
negatively correlated with the in virro response of 
osteoblasts [7]. The effect of aluminium ions on bone 
meubolism is however an area of continuing debate 
[3]. Aluminium ions have been shown to reduce new 
bone formation [9], at high concentrations inhibit 
bone mineralization [10.11] and there is evidence :hat 
aluminium can enhance the mobilization of calcium 
from bone by a cell-independent mechanism [121 In 
contrast, low concentr:1tions of aluminium have been 
reported to stimulate the proiife~3.t:on and differenti-
ation of osteoblasts in l1irro [10]. While in 1:ivo, admin-
istration of aluininium llas been shown to incre:1Se 
693 
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bone volume by positively influencing trabecular net-
working in the axial skeleton [9]. Such enhancement 
of bone histogenesis contrasts with the effects of other 
pharmacologic agents that solely alter the thickness of 
existing trabecular plates or rods within the vertebral 
spongiosa [14, 15]. 
The results of this study show that biological re-
sponse is reduced with increased alumina content as-
sociated with reduced fluoride content. Thus, the ef-
fects of aluminium and fluorine are likely to be depen-
dent on the concentration of their ions. The beneficial 
effects of fluoride are thought to be due to promotion 
of osteobfastic activity and increasing trabecular bone 
density [7]. However, the effects of fluoride, like alu-
ariniwn. appear to be dose-dependent in uiao [16, 17] 
and in uivo [18,19]. The formulation of defined 
ionomeric cements enables controUed evaluation of 
the parameters that affect the biological response of 
bone to ionomeric cements. The biocompatibility and 
composition of ionomeric cements are of great im-
portance because they need to be in direct ~ontact 
with bone for any chemical adhesion to occur. The 
model ionomeric cement formulations studied he,e 
induced a favourable biological response from the 
tissues of the implant bed. Improved osseointegration 
and osteoconduction being associated with increased 
c:llcium fluoride or soda content and reduction in 
alumina content. Our previous work [6] demon-
str:lted a link between glass composition., and ion 
release. with fluoride ion release incre:l.Sing as the 
sodium or calcium duoride content of the glass in-
creases. Improved osseointegration and osteoconduc-
tion appe!lr to be mediated by increased duo ride ion 
release. 
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FLUORIDE RELEASE FROl\tI GLASS POLYALKENOATE 
(IONOMER)CElYIENTS 
R.G. Hill, E. De Barra, S.Griffin and G.Henn. 
Department of Materials Science and Technology, University of Limerick Limerick 
IRELAND 
J. Devlin P.V. Hatton I Brook, K. Johal and G. Craig Dental School 
University of Sheffield 'UK. 
ABSTRACT 
Fluoride release studies from model glass polyalkenoate cements show the rele3Se to be 
proportional to the fluorine content of the glass. Tae dominant fluoride relc:lSe mechanism is 
by an ion exchange mechanism. where fluoride ions are exchanged for hydroxyl ions in water, 
racher than via a councer ion mechanism involving simult:Uleous rele:lSe of an aJ.k:ili metal Ion. 
Tae ion exc!l:mge mecb.~ expiair.s the rec:nt reduction in pH observed in cell culture 
sruciies. Neg.!igJ.bl~ amour.ts of alumiI:ium are rel~::l.Sed and virtually no fluorine is released 
bound to aluminium from the set cement 
Th"TRODCCTION 
Fluoride ion rele3Se ar.d its pote:lti:ll c:J.riostatic role is an aetr:lCtive feature of glass 
polyalkenoate de:lcl c:ments. Tne fluoride ion is readily exchanged for the hydroxyl ion of 
hydroxyapatite. Since the fluoride ion is smaller than the hydroxyl ion it packs more re:ldily 
intO the apatite lattice with the result that fiuocpatitc is cb.c:IJi~y and chcr.modynamically 
more stable than hydroxyapatite[l]. Fluorapatite is also far less soluble in acidic solution than 
hydroxyapatite and ion exchange of fluoride ions for hydroxyl ions in teeth. makes them f:J.I' 
more resistant to dec:ly(2].In addition fluoride rele3Se is thought to have a bacteriocidal 
action([3]. 
Tae importllIlce of fluoride rele:lSe is becoming of even g:re:lter significance with the inCIe:lSing 
use of cooth saving prepar"I..tlon methods, such as runnel and other underminjng techniques. In 
these techniques bec:wse of the limited vislbility there is a greater risk of leaving c:u-eous 
dentine behind thlD. with conventional box C:lvitics. The inc:e:lSing use of lasers in c.cntistry is 
also llk.;:!y to facilitate the move tow:u-cis minjmal C:lvity preparation. The will!"] of glass 
polyalk!noate ceoents to rele:lSe tluor:cie ions ar.d reminer:ilise the c:lIious dentin is 
p:r.:c:.lbry at:I'"'..c:ive with these cecb.nic;ues. 
There is an e:t:ensive licc!':ltU1'e on fluoride ion reiC:lSc from glass polyalkenoate cements( 4) 
Tne m:ljority of studies are of fluoride reiC:lSe from commeI'cially available rnace:":~ in which 
the glass component is frequcn?y muitipililse. The e."tperimentS have been performed using 
widely diffe.~t procedures. different geometry specimens and the results e:qJressed in 
numerous different units consequently it is difficult to drnw any finn conciusions from the 
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on fluoride release. Furthermore whilst many papers discuss whether fluoride is 
!A.lC~C:o. by a diffusion or a disssolution process very few papers discuss the poSSIble 
'd:cmlD,.lSIlJ.S~ of fluoride ion release or the relationship between glass composition and fluoride 
release. 
second reason for studying fluoride ion release from glass polyalkenoate cements is that 
materials are now being developed for use as in situ setting bone cements and preset 
bOne substitutes[51· In these new applications of glass polyalkenoate cements the 
biocompanoility of the cement is important. Fluoride ion release is known to stimulate apatite 
s.k:pOSltJ.on in bone[6] as well as osteoblast mitosis. However excessive fluoride ion release has 
associated with a cytotoxic response in cell culture determinations of biocompatibility[7-
10]. Furthermore admjnistration of bigh doses of fluoride in the treatment of osteoporosis is 
thought to result in bone embrittlement. The ability to control and understand fluoride release 
are critic31 to being able to optimise the biocompat1.'bility of glass polyalkenoate cements and 
. clinic31 performance. 
, }ul understanding of the mechanism of fluoride release and the form in which fluoride is 
released also has implications for how fluoride release should be measured from ~Iass 
polyaIkenoate cements and may resolve some of the many co~ting reports in the literature. 
The present paper investig3.tes the relationship between glass composition and fluoride ion 
, . release with the objective of trying to understand and control fluoride ion release. In the 
present paper a range of specially synthesised fluoro-alumino-silic:lte glasses were produced. 
In contr:lSt to the ionomer glasses currently used in commerci31 materials and e3rly ionomer 
g1:lSSes. t!:e gl:!sses produced for this sn:.c.y were sm~ie phase homog~nous glasses free of 
c:ystall.ine inclusions or glass in ~Iass phase serantion. Synthesis of such homogenous glass~s 
enables the possibility of obccining correlations between glass composition and cement 
properties. :y1any or the glasses used in cOJl1.mercial. ~Iass polyaL1(enoate cements can not be 
produced reproducibly and 'his may be a c:mse of me conr1icting results in the literature. 
Crisp and \Vilson( 111 postuiatec m:lt fluor~e is :e!eased from glass polyalkenoate cements not 
only as the free fluoride ion. but also complexed to aluminium so in the present paper not only 
has both the free fluoric!e ion concentration, but the comple::ted fluoride ion concentotion 
rele:lSed been measured. In addition the release of all other signific:lnt ions and ~ecies from 
the set: cement has been me:lSurec. Thus phosphorous. silicon. aluminium. sodium and calcium 
rele:lSe have all been measured from the set cementS at the same times as the fluoride release. 
Tae kinetics of fluoride ion rele:lSe from glass polyalkenoate cements is a complicated 
phenomena. Glass polyalkenoate cements are not single phase systems. but at least two phase 
and possibly three phase system systems. The three phases are: glass. polysalt mau-i..'t and 
"silica gel". Tae laner phase is controversial with a minority of workers regarding the "silica" 
being dispersed withln the poLysalt ~ ... "t and being responsible for the long te:m changes in 
mec~anic:l.l properties. However the long term changes in the properties of glass polya1kenoate 
cementS are gener:illy reprded as being due continued degradation of the glass and a 
c:osslin.'cing rexticn m:ll ~lces ?i:lce over 111 extended time period exceeding one ye:lI'[ 12 -131. 
Taus ete c:ncentr:Uion of ions. inc!cding fluoric.e ions in the polysait m.:;ur; ... 't is likely (0 
inc.-:ase with time. At the S<lme time the glass tr:lIlSition temt:erature of the colvsait tn:lr:.: .. 't 
- . . 
would be expected to incre:lSe llld this lIllly reduce the mobili~! of the fluoride ion in the 
polys<llt matri't and hinder itS release. 
A full kinetic analysis of fluoride rele!1Sc is therefore premacure until an understlnding of the 
bllSic mechnnisms of fluoride reie:lSe have b~:l established.. 
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EXPERIMENTAL 
The glasses used for this study were produced by melting the appropriate amouaa 
alllmin~. phosphorous pentoxide, c:1lcium C3rbonate, C3lcium fluoride and SOClliUl:lD.C 
dense sintered mullite crucibles at temperatures beween 1300 and 1550°C for · .. ·~"'iliAIII 
resulting melts were rapidly shock quenched into demineralised water to 
separation and crystallisation occurring. The glass frit produced was subsequentlj 
ground in a vibratory mill. The powder produced was sieved to give particles <45JUri,.·~!(I1 
were used in subsequent cement formation. The composition of the glasses produced 
based on previous studies(14-16] and chosen to prevent silicon tetrafluoride fonnation ana 
loss during melting. Two series of glasses were produced based on the following series: 
PSi02-QAl20y3P20S-S-XCaO-XCaF2 (A Series) 
1.sSi02·-~203·O~-P20S·(1-Z)CaO·O.75 CaF2'L'fa20 (B Series) 
The first series was designed to study the influenc~ of the fluorine content of the g.i3ss,wbilst 
the second series was designed to test the counter ion proposal. Tae glasses produced differ 
from the existing commercial glass compositions in having a basic oxide component in the 
prefired composition. Tae presence of the basic oxide is. thought to result in the fluorine 
bonding to the aluminium of the glass network rather than to the silicon. The weight loss from 
the crucible after firing was recorded and in all c~es indic:ued. minimal fluorine loss. The 
preEred compositions cm the:efore be assumed. to be ide~tic:ll to the final ~1:lSS compositions, 
which are give:J. in Table 1. Tae hig±:er fluori~e cement ~1:lSS compositions produced for the 
present paper are however similar to current commercial compositions after they have 
undergone loss of fluor..ne during melting. 
Cement discs('20mm in di::une~e: x "'''T1ID thick) we:e prepared by mi-cng the lppropr'~e g!:lSS 
powder with 40% poly(acrylic acid) in distilled water in a weight ratio of 1:0 . .5. TLle c~n::.e:lt 
discs were allowed to set for 24 hours at 37°C before elution under sink conditions intO high 
purity distilled water at 3'i°C, samples were taken for evaluation at time periods from 3 to 84 
d.3.vs. Tae free md bound fluoride was me:lSured using a calibr::ued ion selective elec:rode both 
. -
with and without TISAB m. All other ions were determined by atomic absorption 
spectroscopy 
Table 1 Glass Compositions Studied 
Glass Code I Series I X Z 
LG26 I A I 2 
-
LG27 I A I 1 
-
LG2S I A i 0.5 
-
LG19 I A i 0.15 
-
LG30 i A I 0 
-
LG2 i B 
-
0 
LG4 I B 
- 0.015 
LGS I B 
- 0.05 
LGO I B . I 
-
0.10 
. 
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tmSULTS AND DISCUSSION 
1"he ~ults for fluoride release are shown in Tables 2. There was no signifiC3D.t difference 
between the measurements made with and without TISAE m indicating that viituany all the 
fluoride released is released as the free fluoride ion and is not chelated to metal cations. 
Previous studies (1 1] have suggested that fluoride is released complexed to aluminiun ions. All 
the cements released negligIble amounts of aluminiUin( <O.6~ moles) and therefore could not 
release signIDc:lIlt amounts of fluoride comple:ted to aluminium confirming the fluoride data. 
The low release of aluminium from the set cements indicates that there is no significant' 
dissolution of the cement matrix and that ion release occurs largely by a diffusion process, 
rather than by sutface dissolution. Aluminium ions are small and of high charge and are 
the..~fore strongly chelated by the poly(acrylic acid) of the polysalt matrix and are not free to 
diffuse out of the cement However it must be pointed out that cement samples were allowed 
to set for 24 hours prior to elution and exposure to water at e:u:lier times may lead to possible 
dissolution and greater ion release. 
Table 2 Cumulative Fluoride Release (J.unoles.g-1 cement) 
Glass 1 64Hours IIW~ks 13W~ks 1 6W~ks 
LG26 I 4.2 17.4 I r-I ..J.~ I 20.2 
LG::7 I ., ~ 1 __ !4.4 ! 7.7 111.4 
LG2S 11.27 12.38 l·t2 I 6.S 
LG29 I 0.95 11.72 I 3.1 I 4.6 
LG30 ! 0.09 i O.~i 10.5 I 0.6 
IIW~k 13 W~ks I 6 Weeks 112 'Weeks 
LG2 i U.S ! 26.7 I ~~., . -.~ I 60.1 
LG4 I 13.6 I 26.1 139.3 I 53.1 
LGS 120.1 : 36.7 152.7 169.0 
LG6 127.1 148.3 I 66.4 I 83.8 
Previous fluoride release studies in the literature have often reg3Ided the release of fluoride as 
being by a dissolution process. such a view ar.ses from the similarity of glass polyalkenoate 
cementS to the silicate cementS formed from similar glasses and orthophosphoric acid. These 
latter cementS were prone to bulk dissolution. which the c.!.osely related glass polyalke:loate 
cementS are not because of their high molecular weight poly(a.cryUc acid) component. 
Evidence for a diffusion mech:u:ism has previously come from kinetic studies and the fact mat 
the reie:lSe is proportional to the inve.--se of the square root of time. However given that the 
crosslinking re::u:tion is continuing and Uut the fluoride ion content of the cement mau-:'''t is 
ctan2inO' bv continued re::lCtion such correlations are probabiy fortuitous. 
- :: . 
T~ere is a strong cor:re!:ltion beween the duoride content of the glass and the reie:lSe or 
fluoride from me set cementS at all me::surcment timesCFifJre1). Tnis result is to be ex;ec:ed, 
but contr:lSts with a previous st"JCiy that indicated no correlation between fluoride reie:lSe JIld 
fluorine content of the gWs for comme:'Ci:illy available cements(17]. The lack of direct 
correlation may be a result of some of th~ fluorine in the commercial glasses being in the fo~ 
262 
1 
i 
.i 
of crystalline inclusions of fluorite and therefore bein~ "« .' 
as well as diifere!lces in the .chemistry of the polysalt matrix and ~ ......... 
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T~e rele:l£~ of sociuI:l. ions from ti:.e second series of glasses correlated with the scc!iUI:l 
conre:lt or ~e gi:lSs. There W:lS J.n il"'c:'e:.se in the amount or nuorice rele:lSed as the sodium 
conre:lr or ti:.e zbss W:lS inc:e:lSed,"Nhic~ atme:l.."'"ed to SUDDon the counter ion mecomp;sm 
- .. .. . ... 
;:rccosed by Wilson ar:d Kuhn(lSJ. Tae d:J.u is plotted in Figure 2 for the 12 week results. 
Eo~ever it is c:e:rr ili:u ce:J:ents 'Nith no alk:ili. content rele3Se significant quantities of fluoride 
and even wr:e:l the data is ploned in terms of ~oles there is no 1:1 correlation between 
flue rice rele:lSe and sodium reie::l.Se even for glasses containing sodium. Wilson and Kuhn 
:ll'6'.led that fluoride was rele::l.Sed exciusively in association with a sodium counter ion. 
Wilson(19] went on to argue that ~cium could also act as a counter ion and that fluoride 
rele:lSe was resu.-:c:ed by the availability of both c::ucium and sodium counter ions. Closer 
exmlinaUon or the present d:lta indic~tes a poor correlation, since more fluoride is being 
reie:lSed than can be accounted for by a counter ion mechanism involving both sodium and 
c:Ucium. Tocalling the number of positive and negative ions rele:lSed and c::uc~ating the 
c:;mulat'/e ion b~ce indic:ues that ct:ere is a surplus of negative ions over positive ions 
le:lving: the :e!r.ent at all ames, In C:llc~ating: the ion balance it is assumed that ohos"Ohorous 
ieJ.ves-the ce:l:ent as (?04)3-, cJ.icium lS C;2~, sodium as Na~ aluminium is n~gle;::ed and 
silic:n is lSsi.A:::.ed ~o :eJ.ve ~e :e:::.e:lt as 1 ne~L.-:ll s~ecies. It is possible :hJ.t ::b.e silic:n le:lves 
±e ce=e~[ lS Jll l.rlleric S"Fec:es ::hus tte ;lC:"..l~ ion bai:mce will be even ~ore JegJ.tive ±~ 
ili:lt c:.ic:.llare~ Tue only SllUS;:":lC:Or"! ::::?ian:uion or the ion babnce fi~..!res is thJ.t :legative 
ions Jre ente~.:lg the cement from the e:ae:n:ll solution. Tile only negative ion present is ::.he 
hvdroxvl ion from the distilled w:lter and the d:ltJ. therefore indicates that fluoride iens Jre 
p~b:lbiy being ion exchanged for hydroxyl ions. Such an ion e:tchange mechahism will result 
in the e:tteo::u solution incrc:.lS~g in hydrogen ion concentmtion and reducing in pH. Such pH 
eifec:s h:ve be::n observed pre'llously(9], 
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Figure 2 
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T.:e ne:z:lli.ve ion bal:mce inc~::ses wit.' time md inc~es :lS the ailo.li :ne~ content of the 
gi:lSS is- inct'e::.sed(Figure 3) This would iadic:lce that llloli metJ.! ions facilic.te fluoride ion 
rele:lSe from the set cement by anocher mech6lIlism ocher thllI1 by providing counter ions. One 
possibility is that :illoli metJl ions hinder the C:'Osslinking of the cement matrix. lower the 
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effective glass transition of the polysalt matrix and .... -=,~­
fluoride ions for hydroxyl ions by increasing the mObility of these 
Glass polyaikenoate cements have recently been shown to 
subsquently release them by an ion exchange mechanism(201 so Tn •. -_ .......... 
surprising. Tne dominance of the ion exchange mechanism does ll.aVe 
for biocompatibility studies parriculary in cell culture, the ~-~~~--'" 
and its clinical significance. Oearly the pH will fall as fluoride iODS-~are::S~iil 
in pH c:m be very significant and results in the cytotoxic effect nl 
polyalkenoate cements in cell culture [7 -10] where the mass of the c:ment s;-~~~ 
large compared to the volume of culture medium. Tae pH reduction will. ---
also oa the mass of the cement, its surface area, the quantity of water used 
the water is changed. A large reduction in pH below the pKa of the c:u'boxylic: -
group is likely to result in dissolution of the cement mac:i"C and therefore an inc=_'fL;~~~~:t 
ions rele3.Sed as observed in solutions of low pH. In contrast a small pH reduc::iaa. 1'1 
the ion exchange process by reducing the number of hydroxyl ions av3ilable for ian =:SEli~~;5; 
Tae eEec:.s of pH changes on fluoride ion re!e3.Se are therefore likely to be complex. ._~~ 
not surprising that there are mar..{edly diferent results in the liter:lrure for supposedly ide:mc::aI" 
materials. 
AC~O~LEDGE~ffi~lS 
T.1e aut::ors would lii(e to th::L'l.i( the Eurocean Ccien for fun6n2: under the Brite EuR3m 
.. - .- .. -
Sc~e=e Ccn~c: ~l!mber BRE2.CT9:.03~9. 
REFERE~CES 
1 Ok"7" k: :VI. and Sara:V1. B iorr.aceri:lis 1990 II S~3-3 
2.0k:lZ"ki ~L. Tl..lc:.h:.lSn 1.. ICrm.:r:J. E.;md A\Joa T J. 3icr.:e:: ~(~ce:-. Res. 198: li 8:1-050 
3. Forss E. ,Jckine:1 1. SgetS-Ell?Ponen S. Seppa!... lIla L: .. lOr.la 2. F CJries Res. 1991 ~ 
454-8. 
4 Forsten L. Sc:md. 1. De:1t. Res.1991 99 2~1-5 
5. Zollner W. and Rucei C. Medic:ll Appiic~ons of g!:lss-icnomers S7 -50 in Giass-ionomers 
the next genennon Ed P.Eunt In~ernational Symposia in Dentistry Philacelphia PA. 19103 
6. Turner R.T .• Fr:mcis R., Brown D., Garand J., Emnon K.5. and 3d N.H. l. Bone Miner. 
Res . ..d (1989) J,T;' -84. 
7. Doherty PJ. Clinic:!.i :V{:u:eriais 19911 335~ 
3 u. Meyer U.,. SZ'..!1c::ewski ,Barck.1aus R.H., Atkinson :VC and lones.D.B. Biom:lterials 
1993 l.;! 917 . 
9. Sas:maluckit P., Abust:my K.R., Doche~"f PJ.l11d Wiili:uns D.:. Biomateriais 1993 H 906 
10. Brook L3., C~g G.T. lIld Luno D.1. Clinic:ll y!:lteri:Jls 1991 :! 295 
Il.Cnsp S., Le'.vls B.G. and Wilson A.D. l.Denc Res.l9i6 53 1032..!.1 
12.Crisp S., Abe! G. lIla Wilson A.D. l.Denc. 1977 2. 117 
~ '·"1" ~ J ',( c:: • 100 ... ..,oQ ~8"1 3 t..;. r.11 ;:\. . ..J ••• y :'.Ier. wCl .,~" ~) .J -
~J, ::E1. R.G .. Goat. C. lIld Weed. D. l. Arner. C!:':."!l. Sec. ,:: 99:) '75 773-35 
l :. W coco D. lIld r'..ill. R. G. Clinic:ll :V(:uer:~ (t 99:) : ::0 ! . ~ ~ : 
16. Weed. D. lnd Elil. R. Biomareri:lis U (1991) lc..!.-70 
17. :V1c:"'!on S.D .:md Smith AJ lot Ended l. 1984 r: 16-~J. 
13 Wilson A.D. Groffman D.R.:lIld Kuhn A. T. 1985 n o!j [-::3 
19.'Niison A.D. and McLe:m l.W. Glass-ionomc::r c~:ne:1C Quintessence Publishing Co., Inc. 1988 
Chapter 3 ._ .._ 
lO.Billington R.W l.Denc Res (1987) 663-4 .: .~ --. 
265 
EFFECT OF N~l+ IONS ON EXTRACELLULAR PROTEINS AROUND IONOMERIC BONE 
... Joh:1I KK; ® Cartcr DH: ® Sloan P and ... Brook 1M 
... Universitics of Shemeld and. ®M,lIlchcster UK. [S.C.D. Cltuemol\t Cres. 
Sheffield SIO 2TA. UK. E.mail K.KJohal@shcffield.ac.ukl 
INTRODUCTION 
TIle nonco\lagenolls c)(trncellular matrix proteins (ECMP) 
osteopontin (OPN). librolll:ctin (FN). and t~:na:;cin (IN) are 
involved in the intc:grntion of biomah:rials with bonl!. OPN is 
llSSOCiated with initial bonl! tonllationili. FN promotes cdl 
adbesion and is thought to inllucnce cell migrntion ill vivoI2\. 
Tenascin is selectively t:.'(pressed at sit~ of tissue moodling in 
developing c:lrtililge and bolle to stimulate cell migrntion and 
proliferntionp\. TIl has also been associated with tissue 
remodelling. :lIld wound healing. TIle aim of this stuuy \'llas 
to detennine the distribution of the:;c proteins in bone 
following implantation of ionomeric (glass-polyalkenonte) 
cements. 
MA TERIALS AND METHODS 
TIlTee ionomeric cements (Ie) prodllCl!d by rc;acting 
Illerc:lptan free polyacrylic ueid (AuvmlCl!d Heatheun.:. UK.) 
with ionomer g.lassl!s bused on the general 1'0n\1I1I,1 
WSiOl.YP20~.Ah()).(I.II-ZNnzO.).Ca(). CaFl wherl! W. Y 
and Z are mole l'mctions and wilerl! Z lor ICs Lli2=O. 
LG6=O.I. and LG23=OJ (fkpurtmenl 01' Malcri:lis SClcm;e 
University of Limc:rick. lrt:land) were studied. \Iuckr 
annestht:.<;iu (hnlothanc: 2% Ma~' &. Tluk...... llK)~ in oxygen 
25% and nitrous oxic.!e! 75%) stt!rile sct Ie rods (2111111 \ 1 mill 
diamet~r) were imprant~d in the midshali of wcnnt:c.! wistar 
rats (n=8). 
Alier four weeks. lcmora wen~ harveslo::c.l snnp froze!n in 
isopellt.1n~ ovc:r liquic.! nitrogl!n. and e!mbl.:ddcc.! iu 
c:lrbox'vlllethylce1lulose al -25'·C. S~rinl c.:ryoscctions (I ()lIIn) 
were: nxo::c.l in nClItral butTered lon11:llin. u"'C.1lc.:ilieu in ZO% 
EDTA and washcc.! in PBS Ihen stained using rnhbit [lolvclonnl 
primary Abs raisec.! against FN (Dako.tJK. c.lilution I: I O()), TN 
(Chemicoll. UK. dilution 1 All). using \luoroiosthiocyanate 
(F1TC) conjugated sc:coudury Ab raiseU against rabbit I~s. 
Monoclonal mouse primary Ab raised against OI'N (Ohio 
Hvbridorna Bank. lISA. dilution 1:IIKl). using FITC 
~nillgated secondary Abs raisec.! agninst mouse Igs. Scc;tions 
were Illoulll.:u in DABCO. and I!Xmnilled unuc:r UV ligbt 
lIsing II uiss Axoplnn microscope. Photogrnphs were taken 
lIsing Agrn IOOASA colour lillll. 
RESULTS I DISCUSSION 
TIle amount of ncw bone lannation (% inh:grntion) was 
ordcrcu LG23>LG6>LG2. TIll! control material (LG2 with 
Na"=O) showeulhe: least bone fonlllltiolllllld least staining for 
OPN. while: LG2J (Ntt=O.3M) with the grentest new bone 
fonllation, showed lhe most staining. TIlis suggested tlult more 
OPN difl"erenliated as the sodilun content increased. Howevc:r, 
the amount of staining with FN and TN did not incrense with 
more sodium. FN wns widely distributed staining regions of 
chondroid bone with nl! the ICs . TN was uistributed in the 
periphery of t!le: pe:riostclIIn. a site of osteogenesis with all ICs. 
OPN stnining was prominent in the new bone tanned adjacent 
to the les where! it wns conccntrntcd nt the reversnllines. TIle 
as:;ocintion of OPN. with ICs, inte:grnto::c.l with bone: llll1Y 
c:xplnin their ostc:oconullctive: propertic:s and the ditlerences 
Ihat occur with varying IC lonlllliulions. 
CONCLUSION 
I. l1lcse sodium containing ICs wilh n sc:t t1l1oride content 
cxhibitl!c.! c.lilli.:renccs in bone lonllation. 
2. All IC:; inlegrat.:d with bone und cxtracellular Illatrix 
proteins FN. TN anc.l OPN we:n: prominc::ntly tound in new 
bone.: suggesling Ihat thcy piny all important role in the 
interactions of the healing or hard lissuc:s wilh IC:>. 
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• 'a "ow had a chance to look through the sheets you passed round at the meeting on Friday, l 
"~"to do some analysis of the results in m~ own way. As shown in Tables 1 and 2, this indicates 
"'~~A osseointegration and osteocondudion (for cured implants) increase with increase in 
.:. 1nd sodium content of the glass, and decrease with increased content of fluoride. [ , 
i 
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Tl'Iis d~es not aJree with your analysis regarcfmg the fluoride, and I have tried to s~e whY thj~1$. 
Initially· I thoughttthe ab,?ve ccrrelat!on'~ ~ust be wrong, but on thinking about it I think they are 
correct, and that/maybe we have been mISlead by the way the glass. compositions are tabulated. 
I wiD try to explain this below. The arguments are the same for either osseointegr8t!on or 
osteocenductiort . i . . 
In Table 3 are. ~ glass· compositions and the osseointegration results fer the dry ~ecimens as 
given in your 1dcul . ' : 
~atch' Si02 A1203 P205 CaO CaF2 Na20 K20 % Osteo -I 
t pJnductior: j 
osSeoint ~urnber i mm I 
~G 2 1.500 1.000 O.SOO 1.000 0.750 0.000 0.000 37.00 0.05 
~G 6 1.500 1.000 0.500 0.900 0.750 0.100 0.000 61.00 0.07 
ii-G 63 1.500 1.000 0.500 0.800 0.750 0.200 0.000 68.00 0.10 
l..G 26 4.500 3.000 1.500 3.000 2.000 0.000 0.000 80.80 0.16 
~G 2716.000 4.000 1.500 4.000 1.000 0.000 0.000 78.20 . 0.08 
I'-G 30 7.500 5.000 1.500 5.000 0.000 0.000 0.000 70.60 . 0.07 
Table:3 r 
. 
At flrst sight th~ looks like a series of inaeasing Na content (glasses 2. 6, .and 63), and a series of 
decreasing CaFf content (glasses 26, 27, and SO). However it looks different when the 
compositions a~ recalculated so that the Al203 is always 1, as in Table 4. (All values are divided 
by the A1203 value. The Si02 content then also becomes constant). 
I 
i 
lBat~ Si02 A1203 P205 CaO CaF2 Na20 K20 % I 
t 
"umber l osseoim ! 
I 
I 
LG 2 1..500 1.000 0.500 1.000 0.750 0.000 0.000 37.00 . 
~G 6 1.500 1.000 0.500 0.900 0.750 0.100 0.000 61.00' 
It..G 63 1.!500 1.000 0.500 0.800 0.750 0.200 0.000 68.00 
ILG 26 1.:500 1.000 0.500 1.000 0.667 0.000 0.000 80.80' 
ILG 27 11500 1.000 0.375 1.000 0.250 0.000 0.000 78.20 
[G 30 11500 1.000 0.300 1.000 0.000 0.000 0.000 70.60 
TabJe4 '1 . 
From. Table 4 ~u can see that as well as a trend of decreasing GaF2'ln going ~m LG2 to LG30, 
there is also a trend of deaeasing P205. In fact the CaF2 content is highly correlated with the 
P20S content,lmeanirig that when one decieases, so does the other, the only exception to this 
being LG26. This m~ tt:mwe can't reatly be sure Whether it is the CaF2 or th~ P205 content 
_~"""'" : ~.2.orJO(3 
~ 
269 
. \
~! 
I I 
D8RP:! I 
. I 
I 
. which is having ~e effect on the osseointegration. However LG2 and LG2e fonn a minl-saries In 
which all components are the same except the CaF2 content The glass LG26 has a lower CaF2 
centent that LG 12 but the osseointegration is higher, indicating that osseointegration increases 
with decreasing!CaF2 content. as reflected in the negative coefficient for CaF2 in: Table 1. 
! . 
Finally In Table 5 I have sorted the results in order of increasing osseo integration. I "think this 
makaS !he "'ilips dearer.· . . 
Batch Si()2 Al203 P205 CaO CaF2 Na2Q K20 % Osteo -
I I conduction ! numb~r i osseoint 
~ 
~G 2 1.500 1.000 0.500 1.000 0.750 0.000 0.000 37.00 . 0.05 
I_G 6 1.500 1.000 0.500 0.900 0.750 0.100 0.000 61.00 : 0.07 
I-G 63 1.500 1.000 0.500 0.800 0.750 0.200 0.000 68.00 0.10 
LG ' 30\ 1.500 1.000 0.300 1.000 0.000 0.000 0.000 70.60 0.07 
LG 271 1.500 1.000 0.375 1.000 0.250 0.000 0.000 78.20 . 0.08 
~G 26 1.500 1.000 0.500 1.000 0.667 0.000 0.000 80.80 0.16 
TableS I 
I 
I have done a.similar analysis with the osteocondudion, and with the same arguments the same 
conclusions are ~ched. The results are given in Table 5. 
I hope. this is US~ful and not too confusing. Even with the reseJVations about the ~OS/CaF2 
correlation I think you should reconsider you~ condusions. Please let me know your thoughts 
about the abo~ or if you find a flaw in my arguments. I'm not at all famiHar with the literature in 
this area - is thei-e any evidence that the above is wrong? J'm afraid I don't have enough data to do 
anything with the other series (wet) because these Introduce new variables such as strontium. I . : 
Regards, j 
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